id	sid	tid	token	lemma	pos
bam-9165	1	1	plasmapheresis	plasmapheresis	NOUN
bam-9165	1	2	methods	method	NOUN
bam-9165	1	3	for	for	ADP
bam-9165	1	4	covid-19	covid-19	PROPN
bam-9165	1	5	eur	eur	PROPN
bam-9165	1	6	j	j	PROPN
bam-9165	1	7	transl	transl	PROPN
bam-9165	1	8	myol	myol	NOUN
bam-9165	1	9	2020	2020	NUM
bam-9165	1	10	;	;	PUNCT
bam-9165	1	11	30	30	NUM
bam-9165	1	12	(	(	PUNCT
bam-9165	1	13	3	3	NUM
bam-9165	1	14	):	):	PUNCT
bam-9165	1	15	9165	9165	NUM
bam-9165	1	16	.	.	PUNCT
bam-9165	2	1	doi	doi	NOUN
bam-9165	2	2	:	:	PUNCT
bam-9165	2	3	10.4081	10.4081	NUM
bam-9165	2	4	/	/	SYM
bam-9165	2	5	ejtm.2020.9165	ejtm.2020.9165	VERB
bam-9165	2	6	1	1	NUM
bam-9165	2	7	prospects	prospect	NOUN
bam-9165	2	8	of	of	ADP
bam-9165	2	9	plasmapheresis	plasmapheresis	NOUN
bam-9165	2	10	for	for	ADP
bam-9165	2	11	patients	patient	NOUN
bam-9165	2	12	with	with	ADP
bam-9165	2	13	severe	severe	ADJ
bam-9165	2	14	covid-19	covid-19	PROPN
bam-9165	2	15	ilmira	ilmira	PROPN
bam-9165	2	16	r.	r.	PROPN
bam-9165	2	17	gilmutdinova	gilmutdinova	PROPN
bam-9165	2	18	,	,	PUNCT
bam-9165	2	19	maksim	maksim	PROPN
bam-9165	2	20	yu	yu	PROPN
bam-9165	2	21	.	.	PROPN
bam-9165	2	22	yakovlev	yakovlev	PROPN
bam-9165	2	23	,	,	PUNCT
bam-9165	2	24	petr	petr	PROPN
bam-9165	2	25	s.	s.	PROPN
bam-9165	2	26	eremin	eremin	PROPN
bam-9165	2	27	,	,	PUNCT
bam-9165	2	28	anatoliy	anatoliy	PROPN
bam-9165	2	29	d.	d.	PROPN
bam-9165	2	30	fesun	fesun	PROPN
bam-9165	2	31	federal	federal	ADJ
bam-9165	2	32	state	state	PROPN
bam-9165	2	33	budgetary	budgetary	ADJ
bam-9165	2	34	institution	institution	NOUN
bam-9165	2	35	“	"	PUNCT
bam-9165	2	36	national	national	PROPN
bam-9165	2	37	medical	medical	ADJ
bam-9165	2	38	research	research	NOUN
bam-9165	2	39	centre	centre	NOUN
bam-9165	2	40	for	for	ADP
bam-9165	2	41	rehabilitation	rehabilitation	NOUN
bam-9165	2	42	and	and	CCONJ
bam-9165	2	43	balneology	balneology	NOUN
bam-9165	2	44	”	"	PUNCT
bam-9165	2	45	of	of	ADP
bam-9165	2	46	the	the	DET
bam-9165	2	47	ministry	ministry	PROPN
bam-9165	2	48	of	of	ADP
bam-9165	2	49	health	health	PROPN
bam-9165	2	50	of	of	ADP
bam-9165	2	51	russia	russia	PROPN
bam-9165	2	52	,	,	PUNCT
bam-9165	2	53	moscow	moscow	PROPN
bam-9165	2	54	,	,	PUNCT
bam-9165	2	55	russia	russia	PROPN
bam-9165	2	56	this	this	DET
bam-9165	2	57	article	article	NOUN
bam-9165	2	58	is	be	AUX
bam-9165	2	59	distributed	distribute	VERB
bam-9165	2	60	under	under	ADP
bam-9165	2	61	the	the	DET
bam-9165	2	62	terms	term	NOUN
bam-9165	2	63	of	of	ADP
bam-9165	2	64	the	the	DET
bam-9165	2	65	creative	creative	ADJ
bam-9165	2	66	commons	common	NOUN
bam-9165	2	67	attribution	attribution	NOUN
bam-9165	2	68	noncommercial	noncommercial	ADJ
bam-9165	2	69	license	license	NOUN
bam-9165	2	70	(	(	PUNCT
bam-9165	2	71	cc	cc	NOUN
bam-9165	2	72	by	by	ADP
bam-9165	2	73	-	-	PUNCT
bam-9165	2	74	nc	nc	PROPN
bam-9165	2	75	4.0	4.0	NUM
bam-9165	2	76	)	)	PUNCT
bam-9165	2	77	which	which	PRON
bam-9165	2	78	permits	permit	VERB
bam-9165	2	79	any	any	DET
bam-9165	2	80	noncommercial	noncommercial	ADJ
bam-9165	2	81	use	use	NOUN
bam-9165	2	82	,	,	PUNCT
bam-9165	2	83	distribution	distribution	NOUN
bam-9165	2	84	,	,	PUNCT
bam-9165	2	85	and	and	CCONJ
bam-9165	2	86	reproduction	reproduction	NOUN
bam-9165	2	87	in	in	ADP
bam-9165	2	88	any	any	DET
bam-9165	2	89	medium	medium	NOUN
bam-9165	2	90	,	,	PUNCT
bam-9165	2	91	provided	provide	VERB
bam-9165	2	92	the	the	DET
bam-9165	2	93	original	original	ADJ
bam-9165	2	94	author(s	author(s	NOUN
bam-9165	2	95	)	)	PUNCT
bam-9165	2	96	and	and	CCONJ
bam-9165	2	97	source	source	NOUN
bam-9165	2	98	are	be	AUX
bam-9165	2	99	credited	credit	VERB
bam-9165	2	100	.	.	PUNCT
bam-9165	3	1	abstract	abstract	ADV
bam-9165	3	2	on	on	ADP
bam-9165	3	3	february	february	PROPN
bam-9165	3	4	11	11	NUM
bam-9165	3	5	,	,	PUNCT
bam-9165	3	6	2020	2020	NUM
bam-9165	3	7	,	,	PUNCT
bam-9165	3	8	the	the	DET
bam-9165	3	9	world	world	PROPN
bam-9165	3	10	health	health	PROPN
bam-9165	3	11	organization	organization	NOUN
bam-9165	3	12	officially	officially	ADV
bam-9165	3	13	named	name	VERB
bam-9165	3	14	the	the	DET
bam-9165	3	15	infection	infection	NOUN
bam-9165	3	16	caused	cause	VERB
bam-9165	3	17	by	by	ADP
bam-9165	3	18	the	the	DET
bam-9165	3	19	new	new	ADJ
bam-9165	3	20	coronavirus	coronavirus	NOUN
bam-9165	3	21	“	"	PUNCT
bam-9165	3	22	coronavirus	coronavirus	NOUN
bam-9165	3	23	disease	disease	NOUN
bam-9165	3	24	2019	2019	NUM
bam-9165	3	25	”	"	PUNCT
bam-9165	3	26	(	(	PUNCT
bam-9165	3	27	covid-19	covid-19	PROPN
bam-9165	3	28	)	)	PUNCT
bam-9165	3	29	.	.	PUNCT
bam-9165	4	1	on	on	ADP
bam-9165	4	2	february	february	PROPN
bam-9165	4	3	11	11	NUM
bam-9165	4	4	,	,	PUNCT
bam-9165	4	5	2020	2020	NUM
bam-9165	4	6	,	,	PUNCT
bam-9165	4	7	the	the	DET
bam-9165	4	8	international	international	ADJ
bam-9165	4	9	committee	committee	NOUN
bam-9165	4	10	on	on	ADP
bam-9165	4	11	taxonomy	taxonomy	NOUN
bam-9165	4	12	of	of	ADP
bam-9165	4	13	viruses	virus	NOUN
bam-9165	4	14	(	(	PUNCT
bam-9165	4	15	ictv	ictv	NOUN
bam-9165	4	16	)	)	PUNCT
bam-9165	4	17	officially	officially	ADV
bam-9165	4	18	named	name	VERB
bam-9165	4	19	the	the	DET
bam-9165	4	20	infectious	infectious	ADJ
bam-9165	4	21	matter	matter	NOUN
bam-9165	4	22	“	"	PUNCT
bam-9165	4	23	severe	severe	ADJ
bam-9165	4	24	acute	acute	ADJ
bam-9165	4	25	respiratory	respiratory	ADJ
bam-9165	4	26	syndrome	syndrome	NOUN
bam-9165	4	27	coronavirus	coronavirus	NOUN
bam-9165	4	28	2	2	NUM
bam-9165	4	29	”	"	PUNCT
bam-9165	4	30	(	(	PUNCT
bam-9165	4	31	sars	sar	NOUN
bam-9165	4	32	-	-	PUNCT
bam-9165	4	33	cov-2	cov-2	NOUN
bam-9165	4	34	)	)	PUNCT
bam-9165	4	35	.	.	PUNCT
bam-9165	5	1	emergence	emergence	NOUN
bam-9165	5	2	of	of	ADP
bam-9165	5	3	severe	severe	ADJ
bam-9165	5	4	complications	complication	NOUN
bam-9165	5	5	with	with	ADP
bam-9165	5	6	new	new	ADJ
bam-9165	5	7	coronavirus	coronavirus	NOUN
bam-9165	5	8	disease	disease	NOUN
bam-9165	5	9	is	be	AUX
bam-9165	5	10	due	due	ADJ
bam-9165	5	11	to	to	ADP
bam-9165	5	12	the	the	DET
bam-9165	5	13	development	development	NOUN
bam-9165	5	14	of	of	ADP
bam-9165	5	15	hypercytokinaemia	hypercytokinaemia	NOUN
bam-9165	5	16	,	,	PUNCT
bam-9165	5	17	also	also	ADV
bam-9165	5	18	known	know	VERB
bam-9165	5	19	as	as	ADP
bam-9165	5	20	“	"	PUNCT
bam-9165	5	21	cytokine	cytokine	ADJ
bam-9165	5	22	storm	storm	NOUN
bam-9165	5	23	”	"	PUNCT
bam-9165	5	24	.	.	PUNCT
bam-9165	6	1	these	these	DET
bam-9165	6	2	complications	complication	NOUN
bam-9165	6	3	comprise	comprise	VERB
bam-9165	6	4	acute	acute	ADJ
bam-9165	6	5	respiratory	respiratory	ADJ
bam-9165	6	6	distress	distress	NOUN
bam-9165	6	7	syndrome	syndrome	NOUN
bam-9165	6	8	(	(	PUNCT
bam-9165	6	9	ards	ard	NOUN
bam-9165	6	10	)	)	PUNCT
bam-9165	6	11	,	,	PUNCT
bam-9165	6	12	respiratory	respiratory	ADJ
bam-9165	6	13	failure	failure	NOUN
bam-9165	6	14	and	and	CCONJ
bam-9165	6	15	death	death	NOUN
bam-9165	6	16	.	.	PUNCT
bam-9165	7	1	emerging	emerge	VERB
bam-9165	7	2	data	datum	NOUN
bam-9165	7	3	point	point	NOUN
bam-9165	7	4	to	to	ADP
bam-9165	7	5	the	the	DET
bam-9165	7	6	logic	logic	NOUN
bam-9165	7	7	of	of	ADP
bam-9165	7	8	using	use	VERB
bam-9165	7	9	extracorporeal	extracorporeal	ADJ
bam-9165	7	10	haemocorrection	haemocorrection	NOUN
bam-9165	7	11	to	to	PART
bam-9165	7	12	normalise	normalise	VERB
bam-9165	7	13	cytokine	cytokine	ADJ
bam-9165	7	14	levels	level	NOUN
bam-9165	7	15	and	and	CCONJ
bam-9165	7	16	reduce	reduce	VERB
bam-9165	7	17	the	the	DET
bam-9165	7	18	severity	severity	NOUN
bam-9165	7	19	of	of	ADP
bam-9165	7	20	organ	organ	NOUN
bam-9165	7	21	disorders	disorder	NOUN
bam-9165	7	22	.	.	PUNCT
bam-9165	8	1	the	the	DET
bam-9165	8	2	analysis	analysis	NOUN
bam-9165	8	3	of	of	ADP
bam-9165	8	4	the	the	DET
bam-9165	8	5	literature	literature	NOUN
bam-9165	8	6	indicates	indicate	VERB
bam-9165	8	7	that	that	SCONJ
bam-9165	8	8	to	to	ADP
bam-9165	8	9	date	date	NOUN
bam-9165	8	10	,	,	PUNCT
bam-9165	8	11	a	a	DET
bam-9165	8	12	certain	certain	ADJ
bam-9165	8	13	positive	positive	ADJ
bam-9165	8	14	experience	experience	NOUN
bam-9165	8	15	has	have	AUX
bam-9165	8	16	been	be	AUX
bam-9165	8	17	accumulated	accumulate	VERB
bam-9165	8	18	in	in	ADP
bam-9165	8	19	the	the	DET
bam-9165	8	20	world	world	NOUN
bam-9165	8	21	in	in	ADP
bam-9165	8	22	the	the	DET
bam-9165	8	23	application	application	NOUN
bam-9165	8	24	of	of	ADP
bam-9165	8	25	extracorporeal	extracorporeal	NOUN
bam-9165	8	26	methods	method	NOUN
bam-9165	8	27	in	in	ADP
bam-9165	8	28	clinical	clinical	ADJ
bam-9165	8	29	practice	practice	NOUN
bam-9165	8	30	in	in	ADP
bam-9165	8	31	patients	patient	NOUN
bam-9165	8	32	with	with	ADP
bam-9165	8	33	covid-19	covid-19	PROPN
bam-9165	8	34	.	.	PUNCT
bam-9165	8	35	key	key	ADJ
bam-9165	8	36	words	word	NOUN
bam-9165	8	37	:	:	PUNCT
bam-9165	8	38	plasmapheresis	plasmapheresis	NOUN
bam-9165	8	39	,	,	PUNCT
bam-9165	8	40	extracorporeal	extracorporeal	NOUN
bam-9165	8	41	haemocorrection	haemocorrection	NOUN
bam-9165	8	42	,	,	PUNCT
bam-9165	8	43	covid-19	covid-19	PROPN
bam-9165	8	44	,	,	PUNCT
bam-9165	8	45	coronavirus	coronavirus	NOUN
bam-9165	8	46	.	.	PUNCT
bam-9165	9	1	eur	eur	PROPN
bam-9165	9	2	j	j	PROPN
bam-9165	9	3	transl	transl	PROPN
bam-9165	9	4	myol	myol	NOUN
bam-9165	9	5	2020	2020	NUM
bam-9165	9	6	;	;	PUNCT
bam-9165	9	7	30	30	NUM
bam-9165	9	8	(	(	PUNCT
bam-9165	9	9	3	3	NUM
bam-9165	9	10	):	):	PUNCT
bam-9165	9	11	9165	9165	NUM
bam-9165	9	12	.	.	PUNCT
bam-9165	10	1	doi	doi	NOUN
bam-9165	10	2	:	:	PUNCT
bam-9165	10	3	10.4081	10.4081	NUM
bam-9165	10	4	/	/	SYM
bam-9165	10	5	ejtm.2020.9165	ejtm.2020.9165	NOUN
bam-9165	10	6	on	on	ADP
bam-9165	10	7	february	february	PROPN
bam-9165	10	8	11	11	NUM
bam-9165	10	9	,	,	PUNCT
bam-9165	10	10	2020	2020	NUM
bam-9165	10	11	,	,	PUNCT
bam-9165	10	12	the	the	DET
bam-9165	10	13	world	world	PROPN
bam-9165	10	14	health	health	PROPN
bam-9165	10	15	organization	organization	NOUN
bam-9165	10	16	officially	officially	ADV
bam-9165	10	17	named	name	VERB
bam-9165	10	18	the	the	DET
bam-9165	10	19	infection	infection	NOUN
bam-9165	10	20	caused	cause	VERB
bam-9165	10	21	by	by	ADP
bam-9165	10	22	a	a	DET
bam-9165	10	23	new	new	ADJ
bam-9165	10	24	coronavirus	coronavirus	NOUN
bam-9165	10	25	“	"	PUNCT
bam-9165	10	26	coronavirus	coronavirus	NOUN
bam-9165	10	27	disease	disease	NOUN
bam-9165	10	28	2019	2019	NUM
bam-9165	10	29	”	"	PUNCT
bam-9165	10	30	(	(	PUNCT
bam-9165	10	31	covid-19	covid-19	PROPN
bam-9165	10	32	)	)	PUNCT
bam-9165	10	33	and	and	CCONJ
bam-9165	10	34	the	the	DET
bam-9165	10	35	international	international	ADJ
bam-9165	10	36	committee	committee	NOUN
bam-9165	10	37	on	on	ADP
bam-9165	10	38	taxonomy	taxonomy	NOUN
bam-9165	10	39	of	of	ADP
bam-9165	10	40	viruses	virus	NOUN
bam-9165	10	41	(	(	PUNCT
bam-9165	10	42	ictv	ictv	NOUN
bam-9165	10	43	)	)	PUNCT
bam-9165	10	44	officially	officially	ADV
bam-9165	10	45	named	name	VERB
bam-9165	10	46	the	the	DET
bam-9165	10	47	infectious	infectious	ADJ
bam-9165	10	48	matter	matter	NOUN
bam-9165	10	49	“	"	PUNCT
bam-9165	10	50	severe	severe	ADJ
bam-9165	10	51	acute	acute	ADJ
bam-9165	10	52	respiratory	respiratory	ADJ
bam-9165	10	53	syndrome	syndrome	NOUN
bam-9165	10	54	coronavirus	coronavirus	NOUN
bam-9165	10	55	2	2	NUM
bam-9165	10	56	”	"	PUNCT
bam-9165	10	57	(	(	PUNCT
bam-9165	10	58	sars	sar	NOUN
bam-9165	10	59	-	-	PUNCT
bam-9165	10	60	cov-2	cov-2	NOUN
bam-9165	10	61	)	)	PUNCT
bam-9165	10	62	.	.	PUNCT
bam-9165	11	1	throughout	throughout	ADP
bam-9165	11	2	the	the	DET
bam-9165	11	3	ongoing	ongoing	ADJ
bam-9165	11	4	covid-19	covid-19	PROPN
bam-9165	11	5	pandemic	pandemic	NOUN
bam-9165	11	6	,	,	PUNCT
bam-9165	11	7	over	over	ADP
bam-9165	11	8	13.8	13.8	NUM
bam-9165	11	9	%	%	NOUN
bam-9165	11	10	of	of	ADP
bam-9165	11	11	cases	case	NOUN
bam-9165	11	12	are	be	AUX
bam-9165	11	13	severe	severe	ADJ
bam-9165	11	14	and	and	CCONJ
bam-9165	11	15	over	over	ADP
bam-9165	11	16	6.1	6.1	NUM
bam-9165	11	17	%	%	NOUN
bam-9165	11	18	are	be	AUX
bam-9165	11	19	critical.1	critical.1	ADJ
bam-9165	11	20	the	the	DET
bam-9165	11	21	severity	severity	NOUN
bam-9165	11	22	of	of	ADP
bam-9165	11	23	the	the	DET
bam-9165	11	24	condition	condition	NOUN
bam-9165	11	25	in	in	ADP
bam-9165	11	26	patients	patient	NOUN
bam-9165	11	27	of	of	ADP
bam-9165	11	28	these	these	DET
bam-9165	11	29	subgroups	subgroup	NOUN
bam-9165	11	30	is	be	AUX
bam-9165	11	31	caused	cause	VERB
bam-9165	11	32	,	,	PUNCT
bam-9165	11	33	interalia	interalia	PROPN
bam-9165	11	34	,	,	PUNCT
bam-9165	11	35	by	by	ADP
bam-9165	11	36	the	the	DET
bam-9165	11	37	development	development	NOUN
bam-9165	11	38	of	of	ADP
bam-9165	11	39	hypercytokinaemia	hypercytokinaemia	NOUN
bam-9165	11	40	,	,	PUNCT
bam-9165	11	41	also	also	ADV
bam-9165	11	42	known	know	VERB
bam-9165	11	43	as	as	ADP
bam-9165	11	44	“	"	PUNCT
bam-9165	11	45	cytokine	cytokine	ADJ
bam-9165	11	46	storm”.2,3	storm”.2,3	NOUN
bam-9165	11	47	hypercytokinaemia	hypercytokinaemia	NOUN
bam-9165	11	48	cytokine	cytokine	NOUN
bam-9165	11	49	storm	storm	NOUN
bam-9165	11	50	syndrome	syndrome	NOUN
bam-9165	11	51	(	(	PUNCT
bam-9165	11	52	hypercytokinaemia	hypercytokinaemia	NOUN
bam-9165	11	53	)	)	PUNCT
bam-9165	11	54	is	be	AUX
bam-9165	11	55	a	a	DET
bam-9165	11	56	severe	severe	ADJ
bam-9165	11	57	uncontrolled	uncontrolled	ADJ
bam-9165	11	58	immune	immune	ADJ
bam-9165	11	59	response	response	NOUN
bam-9165	11	60	,	,	PUNCT
bam-9165	11	61	when	when	SCONJ
bam-9165	11	62	cells	cell	NOUN
bam-9165	11	63	of	of	ADP
bam-9165	11	64	the	the	DET
bam-9165	11	65	immune	immune	ADJ
bam-9165	11	66	system	system	NOUN
bam-9165	11	67	release	release	VERB
bam-9165	11	68	excessive	excessive	ADJ
bam-9165	11	69	amounts	amount	NOUN
bam-9165	11	70	of	of	ADP
bam-9165	11	71	cytokines	cytokine	NOUN
bam-9165	11	72	(	(	PUNCT
bam-9165	11	73	interferons	interferon	NOUN
bam-9165	11	74	,	,	PUNCT
bam-9165	11	75	interleukins	interleukin	NOUN
bam-9165	11	76	,	,	PUNCT
bam-9165	11	77	chemokines	chemokine	NOUN
bam-9165	11	78	,	,	PUNCT
bam-9165	11	79	colony	colony	NOUN
bam-9165	11	80	stimulating	stimulating	ADJ
bam-9165	11	81	factors	factor	NOUN
bam-9165	11	82	,	,	PUNCT
bam-9165	11	83	tumour	tumour	NOUN
bam-9165	11	84	necrosis	necrosis	NOUN
bam-9165	11	85	factors	factor	NOUN
bam-9165	11	86	,	,	PUNCT
bam-9165	11	87	etc	etc	X
bam-9165	11	88	.	.	X
bam-9165	11	89	)	)	PUNCT
bam-9165	11	90	into	into	ADP
bam-9165	11	91	the	the	DET
bam-9165	11	92	blood.2,4	blood.2,4	PROPN
bam-9165	11	93	for	for	ADP
bam-9165	11	94	instance	instance	NOUN
bam-9165	11	95	,	,	PUNCT
bam-9165	11	96	a	a	DET
bam-9165	11	97	study	study	NOUN
bam-9165	11	98	published	publish	VERB
bam-9165	11	99	in	in	ADP
bam-9165	11	100	lancet	lancet	PROPN
bam-9165	11	101	journal	journal	PROPN
bam-9165	11	102	by	by	ADP
bam-9165	11	103	chinese	chinese	ADJ
bam-9165	11	104	scientists	scientist	NOUN
bam-9165	11	105	showed	show	VERB
bam-9165	11	106	an	an	DET
bam-9165	11	107	increase	increase	NOUN
bam-9165	11	108	in	in	ADP
bam-9165	11	109	inflammatory	inflammatory	ADJ
bam-9165	11	110	cytokines	cytokine	NOUN
bam-9165	11	111	/	/	SYM
bam-9165	11	112	chemokines	chemokine	NOUN
bam-9165	11	113	(	(	PUNCT
bam-9165	11	114	il-2	il-2	NUM
bam-9165	11	115	,	,	PUNCT
bam-9165	11	116	il-7	il-7	X
bam-9165	11	117	,	,	PUNCT
bam-9165	11	118	il-10	il-10	PRON
bam-9165	11	119	,	,	PUNCT
bam-9165	11	120	gcsf	gcsf	NOUN
bam-9165	11	121	,	,	PUNCT
bam-9165	11	122	ip-10	ip-10	PRON
bam-9165	11	123	,	,	PUNCT
bam-9165	11	124	mcp-1	mcp-1	NOUN
bam-9165	11	125	,	,	PUNCT
bam-9165	11	126	mip1a	mip1a	PROPN
bam-9165	11	127	and	and	CCONJ
bam-9165	11	128	tnf	tnf	PROPN
bam-9165	11	129	-	-	PUNCT
bam-9165	11	130	α	α	NOUN
bam-9165	11	131	)	)	PUNCT
bam-9165	11	132	in	in	ADP
bam-9165	11	133	patients	patient	NOUN
bam-9165	11	134	with	with	ADP
bam-9165	11	135	severe	severe	ADJ
bam-9165	11	136	and	and	CCONJ
bam-9165	11	137	critical	critical	ADJ
bam-9165	11	138	covid-19	covid-19	PROPN
bam-9165	11	139	infection.5,6	infection.5,6	INTJ
bam-9165	11	140	it	it	PRON
bam-9165	11	141	has	have	AUX
bam-9165	11	142	been	be	AUX
bam-9165	11	143	proven	prove	VERB
bam-9165	11	144	that	that	SCONJ
bam-9165	11	145	the	the	DET
bam-9165	11	146	severity	severity	NOUN
bam-9165	11	147	of	of	ADP
bam-9165	11	148	covid-19	covid-19	PROPN
bam-9165	11	149	disease	disease	NOUN
bam-9165	11	150	is	be	AUX
bam-9165	11	151	directly	directly	ADV
bam-9165	11	152	related	relate	VERB
bam-9165	11	153	to	to	ADP
bam-9165	11	154	the	the	DET
bam-9165	11	155	cytokine	cytokine	NOUN
bam-9165	11	156	storm	storm	NOUN
bam-9165	11	157	and	and	CCONJ
bam-9165	11	158	the	the	DET
bam-9165	11	159	amount	amount	NOUN
bam-9165	11	160	of	of	ADP
bam-9165	11	161	pro	pro	ADJ
bam-9165	11	162	-	-	ADJ
bam-9165	11	163	inflammatory	inflammatory	ADJ
bam-9165	11	164	agents.7	agents.7	NOUN
bam-9165	11	165	under	under	ADP
bam-9165	11	166	normal	normal	ADJ
bam-9165	11	167	conditions	condition	NOUN
bam-9165	11	168	,	,	PUNCT
bam-9165	11	169	levels	level	NOUN
bam-9165	11	170	of	of	ADP
bam-9165	11	171	inflammatory	inflammatory	ADJ
bam-9165	11	172	and	and	CCONJ
bam-9165	11	173	anti	anti	ADJ
bam-9165	11	174	-	-	ADJ
bam-9165	11	175	inflammatory	inflammatory	ADJ
bam-9165	11	176	cytokines	cytokine	NOUN
bam-9165	11	177	in	in	ADP
bam-9165	11	178	the	the	DET
bam-9165	11	179	organism	organism	NOUN
bam-9165	11	180	are	be	AUX
bam-9165	11	181	balanced	balanced	ADJ
bam-9165	11	182	.	.	PUNCT
bam-9165	12	1	however	however	ADV
bam-9165	12	2	,	,	PUNCT
bam-9165	12	3	when	when	SCONJ
bam-9165	12	4	the	the	DET
bam-9165	12	5	virus	virus	NOUN
bam-9165	12	6	implants	implant	VERB
bam-9165	12	7	into	into	ADP
bam-9165	12	8	the	the	DET
bam-9165	12	9	body	body	NOUN
bam-9165	12	10	,	,	PUNCT
bam-9165	12	11	the	the	DET
bam-9165	12	12	general	general	ADJ
bam-9165	12	13	immune	immune	ADJ
bam-9165	12	14	response	response	NOUN
bam-9165	12	15	is	be	AUX
bam-9165	12	16	triggered	trigger	VERB
bam-9165	12	17	by	by	ADP
bam-9165	12	18	activation	activation	NOUN
bam-9165	12	19	of	of	ADP
bam-9165	12	20	neutrophils	neutrophil	NOUN
bam-9165	12	21	,	,	PUNCT
bam-9165	12	22	dendritic	dendritic	ADJ
bam-9165	12	23	cells	cell	NOUN
bam-9165	12	24	,	,	PUNCT
bam-9165	12	25	macrophages	macrophage	NOUN
bam-9165	12	26	,	,	PUNCT
bam-9165	12	27	lymphocytes	lymphocyte	NOUN
bam-9165	12	28	and	and	CCONJ
bam-9165	12	29	natural	natural	ADJ
bam-9165	12	30	killer	killer	NOUN
bam-9165	12	31	cells	cell	NOUN
bam-9165	12	32	,	,	PUNCT
bam-9165	12	33	along	along	ADP
bam-9165	12	34	with	with	ADP
bam-9165	12	35	initiation	initiation	NOUN
bam-9165	12	36	of	of	ADP
bam-9165	12	37	the	the	DET
bam-9165	12	38	local	local	ADJ
bam-9165	12	39	immune	immune	ADJ
bam-9165	12	40	response	response	NOUN
bam-9165	12	41	.	.	PUNCT
bam-9165	13	1	activated	activate	VERB
bam-9165	13	2	cells	cell	NOUN
bam-9165	13	3	release	release	VERB
bam-9165	13	4	a	a	DET
bam-9165	13	5	large	large	ADJ
bam-9165	13	6	number	number	NOUN
bam-9165	13	7	of	of	ADP
bam-9165	13	8	cytokines	cytokine	NOUN
bam-9165	13	9	,	,	PUNCT
bam-9165	13	10	especially	especially	ADV
bam-9165	13	11	of	of	ADP
bam-9165	13	12	inflammatory	inflammatory	ADJ
bam-9165	13	13	type	type	NOUN
bam-9165	13	14	,	,	PUNCT
bam-9165	13	15	triggering	trigger	VERB
bam-9165	13	16	immune	immune	ADJ
bam-9165	13	17	cells	cell	NOUN
bam-9165	13	18	,	,	PUNCT
bam-9165	13	19	which	which	PRON
bam-9165	13	20	,	,	PUNCT
bam-9165	13	21	in	in	ADP
bam-9165	13	22	turn	turn	NOUN
bam-9165	13	23	,	,	PUNCT
bam-9165	13	24	release	release	VERB
bam-9165	13	25	new	new	ADJ
bam-9165	13	26	cytokines	cytokine	NOUN
bam-9165	13	27	.	.	PUNCT
bam-9165	14	1	this	this	DET
bam-9165	14	2	positive	positive	ADJ
bam-9165	14	3	feedback	feedback	NOUN
bam-9165	14	4	effect	effect	NOUN
bam-9165	14	5	causes	cause	VERB
bam-9165	14	6	hyperexpression	hyperexpression	NOUN
bam-9165	14	7	of	of	ADP
bam-9165	14	8	cytokines	cytokine	NOUN
bam-9165	14	9	in	in	ADP
bam-9165	14	10	response	response	NOUN
bam-9165	14	11	to	to	ADP
bam-9165	14	12	the	the	DET
bam-9165	14	13	etiological	etiological	ADJ
bam-9165	14	14	stimulus	stimulus	NOUN
bam-9165	14	15	and	and	CCONJ
bam-9165	14	16	the	the	DET
bam-9165	14	17	development	development	NOUN
bam-9165	14	18	of	of	ADP
bam-9165	14	19	“	"	PUNCT
bam-9165	14	20	cytokine	cytokine	VERB
bam-9165	14	21	storm”.2,4	storm”.2,4	PROPN
bam-9165	14	22	this	this	DET
bam-9165	14	23	phenomenon	phenomenon	NOUN
bam-9165	14	24	is	be	AUX
bam-9165	14	25	most	most	ADV
bam-9165	14	26	often	often	ADV
bam-9165	14	27	observed	observe	VERB
bam-9165	14	28	in	in	ADP
bam-9165	14	29	patients	patient	NOUN
bam-9165	14	30	with	with	ADP
bam-9165	14	31	chronic	chronic	ADJ
bam-9165	14	32	diseases	disease	NOUN
bam-9165	14	33	,	,	PUNCT
bam-9165	14	34	compromised	compromise	VERB
bam-9165	14	35	immunity	immunity	NOUN
bam-9165	14	36	and	and	CCONJ
bam-9165	14	37	deep	deep	ADJ
bam-9165	14	38	hypoxia	hypoxia	NOUN
bam-9165	14	39	.	.	PUNCT
bam-9165	15	1	such	such	ADJ
bam-9165	15	2	patients	patient	NOUN
bam-9165	15	3	are	be	AUX
bam-9165	15	4	more	more	ADV
bam-9165	15	5	likely	likely	ADJ
bam-9165	15	6	to	to	PART
bam-9165	15	7	develop	develop	VERB
bam-9165	15	8	acute	acute	ADJ
bam-9165	15	9	respiratory	respiratory	ADJ
bam-9165	15	10	distress	distress	NOUN
bam-9165	15	11	syndrome	syndrome	NOUN
bam-9165	15	12	(	(	PUNCT
bam-9165	15	13	ards	ard	NOUN
bam-9165	15	14	)	)	PUNCT
bam-9165	15	15	and	and	CCONJ
bam-9165	15	16	multiple	multiple	ADJ
bam-9165	15	17	organ	organ	NOUN
bam-9165	15	18	dysfunction	dysfunction	NOUN
bam-9165	15	19	syndrome	syndrome	NOUN
bam-9165	15	20	(	(	PUNCT
bam-9165	15	21	mods	mod	NOUN
bam-9165	15	22	)	)	PUNCT
bam-9165	15	23	.	.	PUNCT
bam-9165	16	1	in	in	ADP
bam-9165	16	2	addition	addition	NOUN
bam-9165	16	3	,	,	PUNCT
bam-9165	16	4	they	they	PRON
bam-9165	16	5	demonstrate	demonstrate	VERB
bam-9165	16	6	high	high	ADJ
bam-9165	16	7	levels	level	NOUN
bam-9165	16	8	of	of	ADP
bam-9165	16	9	c	c	NOUN
bam-9165	16	10	-	-	PUNCT
bam-9165	16	11	reactive	reactive	ADJ
bam-9165	16	12	protein	protein	NOUN
bam-9165	16	13	(	(	PUNCT
bam-9165	16	14	crp	crp	PROPN
bam-9165	16	15	)	)	PUNCT
bam-9165	16	16	and	and	CCONJ
bam-9165	16	17	il-6	il-6	NOUN
bam-9165	16	18	,	,	PUNCT
bam-9165	16	19	a	a	DET
bam-9165	16	20	decrease	decrease	NOUN
bam-9165	16	21	in	in	ADP
bam-9165	16	22	the	the	DET
bam-9165	16	23	number	number	NOUN
bam-9165	16	24	of	of	ADP
bam-9165	16	25	lymphocytes	lymphocyte	NOUN
bam-9165	16	26	,	,	PUNCT
bam-9165	16	27	as	as	ADV
bam-9165	16	28	well	well	ADV
bam-9165	16	29	as	as	ADP
bam-9165	16	30	abnormal	abnormal	ADJ
bam-9165	16	31	hemostasis	hemostasis	NOUN
bam-9165	16	32	indicators.8	indicators.8	PROPN
bam-9165	16	33	thus	thus	ADV
bam-9165	16	34	,	,	PUNCT
bam-9165	16	35	the	the	DET
bam-9165	16	36	world	world	PROPN
bam-9165	16	37	medical	medical	ADJ
bam-9165	16	38	community	community	NOUN
bam-9165	16	39	is	be	AUX
bam-9165	16	40	challenged	challenge	VERB
bam-9165	16	41	to	to	PART
bam-9165	16	42	select	select	VERB
bam-9165	16	43	therapeutic	therapeutic	ADJ
bam-9165	16	44	methods	method	NOUN
bam-9165	16	45	that	that	PRON
bam-9165	16	46	allow	allow	VERB
bam-9165	16	47	to	to	PART
bam-9165	16	48	decrease	decrease	VERB
bam-9165	16	49	the	the	DET
bam-9165	16	50	amount	amount	NOUN
bam-9165	16	51	of	of	ADP
bam-9165	16	52	inflammatory	inflammatory	ADJ
bam-9165	16	53	cytokines	cytokine	NOUN
bam-9165	16	54	/	/	SYM
bam-9165	16	55	chemokines	chemokine	NOUN
bam-9165	16	56	and	and	CCONJ
bam-9165	16	57	,	,	PUNCT
bam-9165	16	58	consequently	consequently	ADV
bam-9165	16	59	,	,	PUNCT
bam-9165	16	60	to	to	PART
bam-9165	16	61	abate	abate	VERB
bam-9165	16	62	the	the	DET
bam-9165	16	63	cytokine	cytokine	NOUN
bam-9165	16	64	storm	storm	NOUN
bam-9165	16	65	,	,	PUNCT
bam-9165	16	66	which	which	PRON
bam-9165	16	67	aggravates	aggravate	VERB
bam-9165	16	68	the	the	DET
bam-9165	16	69	course	course	NOUN
bam-9165	16	70	of	of	ADP
bam-9165	16	71	covid-19	covid-19	PROPN
bam-9165	16	72	disease.6	disease.6	NOUN
bam-9165	16	73	emerging	emerge	VERB
bam-9165	16	74	data	datum	NOUN
bam-9165	16	75	point	point	NOUN
bam-9165	16	76	to	to	ADP
bam-9165	16	77	the	the	DET
bam-9165	16	78	logic	logic	NOUN
bam-9165	16	79	of	of	ADP
bam-9165	16	80	using	use	VERB
bam-9165	16	81	extracorporeal	extracorporeal	ADJ
bam-9165	16	82	haemocorrection	haemocorrection	NOUN
bam-9165	16	83	to	to	PART
bam-9165	16	84	normalise	normalise	VERB
bam-9165	16	85	cytokine	cytokine	ADJ
bam-9165	16	86	levels	level	NOUN
bam-9165	16	87	and	and	CCONJ
bam-9165	16	88	reduce	reduce	VERB
bam-9165	16	89	the	the	DET
bam-9165	16	90	severity	severity	NOUN
bam-9165	16	91	of	of	ADP
bam-9165	16	92	organ	organ	NOUN
bam-9165	16	93	disorders	disorder	NOUN
bam-9165	16	94	primarily	primarily	ADV
bam-9165	16	95	in	in	ADP
bam-9165	16	96	severe	severe	ADJ
bam-9165	16	97	and	and	CCONJ
bam-9165	16	98	critical	critical	ADJ
bam-9165	16	99	ill	ill	ADJ
bam-9165	16	100	patients.1,6,8	patients.1,6,8	NOUN
bam-9165	16	101	-	-	NOUN
bam-9165	16	102	10	10	NUM
bam-9165	16	103	however	however	ADV
bam-9165	16	104	,	,	PUNCT
bam-9165	16	105	the	the	DET
bam-9165	16	106	use	use	NOUN
bam-9165	16	107	of	of	ADP
bam-9165	16	108	extracorporeal	extracorporeal	ADJ
bam-9165	16	109	haemocorrection	haemocorrection	NOUN
bam-9165	16	110	methods	method	NOUN
bam-9165	16	111	in	in	ADP
bam-9165	16	112	less	less	ADV
bam-9165	16	113	severe	severe	ADJ
bam-9165	16	114	plasmapheresis	plasmapheresis	NOUN
bam-9165	16	115	methods	method	NOUN
bam-9165	16	116	for	for	ADP
bam-9165	16	117	covid-19	covid-19	PROPN
bam-9165	16	118	eur	eur	PROPN
bam-9165	16	119	j	j	PROPN
bam-9165	16	120	transl	transl	PROPN
bam-9165	16	121	myol	myol	NOUN
bam-9165	16	122	2020	2020	NUM
bam-9165	16	123	;	;	PUNCT
bam-9165	16	124	30	30	NUM
bam-9165	16	125	(	(	PUNCT
bam-9165	16	126	3	3	NUM
bam-9165	16	127	):	):	PUNCT
bam-9165	16	128	9165	9165	NUM
bam-9165	16	129	.	.	PUNCT
bam-9165	17	1	doi	doi	NOUN
bam-9165	17	2	:	:	PUNCT
bam-9165	17	3	10.4081	10.4081	NUM
bam-9165	17	4	/	/	SYM
bam-9165	17	5	ejtm.2020.9165	ejtm.2020.9165	ADJ
bam-9165	17	6	2	2	NUM
bam-9165	17	7	patients	patient	NOUN
bam-9165	17	8	is	be	AUX
bam-9165	17	9	also	also	ADV
bam-9165	17	10	possible	possible	ADJ
bam-9165	17	11	.	.	PUNCT
bam-9165	18	1	so	so	ADV
bam-9165	18	2	,	,	PUNCT
bam-9165	18	3	in	in	ADP
bam-9165	18	4	scientific	scientific	ADJ
bam-9165	18	5	publications	publication	NOUN
bam-9165	18	6	there	there	PRON
bam-9165	18	7	are	be	VERB
bam-9165	18	8	already	already	ADV
bam-9165	18	9	positive	positive	ADJ
bam-9165	18	10	results	result	NOUN
bam-9165	18	11	of	of	ADP
bam-9165	18	12	the	the	DET
bam-9165	18	13	use	use	NOUN
bam-9165	18	14	of	of	ADP
bam-9165	18	15	simple	simple	ADJ
bam-9165	18	16	plasmapheresis	plasmapheresis	NOUN
bam-9165	18	17	,	,	PUNCT
bam-9165	18	18	plasma	plasma	NOUN
bam-9165	18	19	exchange	exchange	NOUN
bam-9165	18	20	with	with	ADP
bam-9165	18	21	of	of	ADP
bam-9165	18	22	convalescent	convalescent	NOUN
bam-9165	18	23	plasma	plasma	NOUN
bam-9165	18	24	and	and	CCONJ
bam-9165	18	25	plasmapheresis	plasmapheresis	NOUN
bam-9165	18	26	with	with	ADP
bam-9165	18	27	immunoglobulin	immunoglobulin	NOUN
bam-9165	18	28	therapy.11	therapy.11	ADJ
bam-9165	18	29	plasmapheresis	plasmapheresis	NOUN
bam-9165	18	30	plasmapheresis	plasmapheresis	NOUN
bam-9165	18	31	is	be	AUX
bam-9165	18	32	the	the	DET
bam-9165	18	33	procedure	procedure	NOUN
bam-9165	18	34	of	of	ADP
bam-9165	18	35	removal	removal	NOUN
bam-9165	18	36	,	,	PUNCT
bam-9165	18	37	treatment	treatment	NOUN
bam-9165	18	38	,	,	PUNCT
bam-9165	18	39	and	and	CCONJ
bam-9165	18	40	return	return	NOUN
bam-9165	18	41	of	of	ADP
bam-9165	18	42	blood	blood	NOUN
bam-9165	18	43	plasma	plasma	NOUN
bam-9165	18	44	or	or	CCONJ
bam-9165	18	45	components	component	NOUN
bam-9165	18	46	thereof	thereof	ADV
bam-9165	18	47	from	from	ADP
bam-9165	18	48	and	and	CCONJ
bam-9165	18	49	to	to	ADP
bam-9165	18	50	the	the	DET
bam-9165	18	51	blood	blood	NOUN
bam-9165	18	52	circulation	circulation	NOUN
bam-9165	18	53	.	.	PUNCT
bam-9165	19	1	plasmapheresis	plasmapheresis	NOUN
bam-9165	19	2	can	can	AUX
bam-9165	19	3	be	be	AUX
bam-9165	19	4	either	either	CCONJ
bam-9165	19	5	therapeutic	therapeutic	ADJ
bam-9165	19	6	(	(	PUNCT
bam-9165	19	7	extracorporeal	extracorporeal	ADJ
bam-9165	19	8	methods	method	NOUN
bam-9165	19	9	of	of	ADP
bam-9165	19	10	blood	blood	NOUN
bam-9165	19	11	treatment	treatment	NOUN
bam-9165	19	12	by	by	ADP
bam-9165	19	13	removing	remove	VERB
bam-9165	19	14	some	some	DET
bam-9165	19	15	plasma	plasma	NOUN
bam-9165	19	16	components	component	NOUN
bam-9165	19	17	)	)	PUNCT
bam-9165	19	18	or	or	CCONJ
bam-9165	19	19	donated	donate	VERB
bam-9165	19	20	(	(	PUNCT
bam-9165	19	21	donated	donate	VERB
bam-9165	19	22	plasma	plasma	NOUN
bam-9165	19	23	is	be	AUX
bam-9165	19	24	obtained	obtain	VERB
bam-9165	19	25	from	from	ADP
bam-9165	19	26	stored	store	VERB
bam-9165	19	27	whole	whole	ADJ
bam-9165	19	28	donor	donor	NOUN
bam-9165	19	29	blood	blood	NOUN
bam-9165	19	30	with	with	ADP
bam-9165	19	31	subsequent	subsequent	ADJ
bam-9165	19	32	return	return	NOUN
bam-9165	19	33	of	of	ADP
bam-9165	19	34	cell	cell	NOUN
bam-9165	19	35	blood	blood	NOUN
bam-9165	19	36	elements).12	elements).12	PROPN
bam-9165	19	37	-	-	SYM
bam-9165	19	38	14	14	NUM
bam-9165	19	39	plasmapheresis	plasmapheresis	NOUN
bam-9165	19	40	has	have	AUX
bam-9165	19	41	been	be	AUX
bam-9165	19	42	used	use	VERB
bam-9165	19	43	for	for	ADP
bam-9165	19	44	treatment	treatment	NOUN
bam-9165	19	45	of	of	ADP
bam-9165	19	46	various	various	ADJ
bam-9165	19	47	diseases	disease	NOUN
bam-9165	19	48	for	for	ADP
bam-9165	19	49	many	many	ADJ
bam-9165	19	50	years	year	NOUN
bam-9165	19	51	.	.	PUNCT
bam-9165	20	1	apheresis	apheresis	NOUN
bam-9165	20	2	applications	application	NOUN
bam-9165	20	3	committee	committee	NOUN
bam-9165	20	4	of	of	ADP
bam-9165	20	5	the	the	DET
bam-9165	20	6	american	american	ADJ
bam-9165	20	7	society	society	NOUN
bam-9165	20	8	for	for	ADP
bam-9165	20	9	apheresis	apheresis	NOUN
bam-9165	20	10	(	(	PUNCT
bam-9165	20	11	asfa	asfa	NOUN
bam-9165	20	12	)	)	PUNCT
bam-9165	20	13	identified	identify	VERB
bam-9165	20	14	4	4	NUM
bam-9165	20	15	groups	group	NOUN
bam-9165	20	16	of	of	ADP
bam-9165	20	17	diseases	disease	NOUN
bam-9165	20	18	,	,	PUNCT
bam-9165	20	19	for	for	ADP
bam-9165	20	20	treatment	treatment	NOUN
bam-9165	20	21	of	of	ADP
bam-9165	20	22	which	which	DET
bam-9165	20	23	plasmapheresis	plasmapheresis	NOUN
bam-9165	20	24	can	can	AUX
bam-9165	20	25	be	be	AUX
bam-9165	20	26	used	use	VERB
bam-9165	20	27	.	.	PUNCT
bam-9165	21	1	the	the	DET
bam-9165	21	2	1st	1st	ADJ
bam-9165	21	3	group	group	NOUN
bam-9165	21	4	includes	include	VERB
bam-9165	21	5	diseases	disease	NOUN
bam-9165	21	6	that	that	PRON
bam-9165	21	7	reveal	reveal	VERB
bam-9165	21	8	maximum	maximum	ADJ
bam-9165	21	9	efficiency	efficiency	NOUN
bam-9165	21	10	of	of	ADP
bam-9165	21	11	treatment	treatment	NOUN
bam-9165	21	12	with	with	ADP
bam-9165	21	13	plasmapheresis	plasmapheresis	NOUN
bam-9165	21	14	.	.	PUNCT
bam-9165	22	1	the	the	DET
bam-9165	22	2	4th	4th	ADJ
bam-9165	22	3	group	group	NOUN
bam-9165	22	4	is	be	AUX
bam-9165	22	5	for	for	ADP
bam-9165	22	6	diseases	disease	NOUN
bam-9165	22	7	,	,	PUNCT
bam-9165	22	8	plasmapheresis	plasmapheresis	NOUN
bam-9165	22	9	treatment	treatment	NOUN
bam-9165	22	10	of	of	ADP
bam-9165	22	11	which	which	PRON
bam-9165	22	12	is	be	AUX
bam-9165	22	13	inefficient	inefficient	ADJ
bam-9165	22	14	.	.	PUNCT
bam-9165	23	1	for	for	ADP
bam-9165	23	2	instance	instance	NOUN
bam-9165	23	3	,	,	PUNCT
bam-9165	23	4	plasmapheresis	plasmapheresis	NOUN
bam-9165	23	5	proved	prove	VERB
bam-9165	23	6	best	good	ADJ
bam-9165	23	7	as	as	ADP
bam-9165	23	8	part	part	NOUN
bam-9165	23	9	of	of	ADP
bam-9165	23	10	a	a	DET
bam-9165	23	11	comprehensive	comprehensive	ADJ
bam-9165	23	12	treatment	treatment	NOUN
bam-9165	23	13	program	program	NOUN
bam-9165	23	14	for	for	ADP
bam-9165	23	15	kidney	kidney	NOUN
bam-9165	23	16	diseases	disease	NOUN
bam-9165	23	17	(	(	PUNCT
bam-9165	23	18	glomerulonephritis	glomerulonephritis	NOUN
bam-9165	23	19	,	,	PUNCT
bam-9165	23	20	goodpasture	goodpasture	NOUN
bam-9165	23	21	syndrome	syndrome	NOUN
bam-9165	23	22	,	,	PUNCT
bam-9165	23	23	focal	focal	ADJ
bam-9165	23	24	segmental	segmental	ADJ
bam-9165	23	25	glomerulosclerosis	glomerulosclerosis	NOUN
bam-9165	23	26	,	,	PUNCT
bam-9165	23	27	kidney	kidney	NOUN
bam-9165	23	28	transplantation	transplantation	NOUN
bam-9165	23	29	etc	etc	X
bam-9165	23	30	.	.	X
bam-9165	23	31	)	)	PUNCT
bam-9165	23	32	,	,	PUNCT
bam-9165	23	33	in	in	ADP
bam-9165	23	34	liver	liver	NOUN
bam-9165	23	35	transplantation	transplantation	NOUN
bam-9165	23	36	(	(	PUNCT
bam-9165	23	37	desensitization	desensitization	NOUN
bam-9165	23	38	)	)	PUNCT
bam-9165	23	39	,	,	PUNCT
bam-9165	23	40	for	for	ADP
bam-9165	23	41	treatment	treatment	NOUN
bam-9165	23	42	of	of	ADP
bam-9165	23	43	myasthenia	myasthenia	NOUN
bam-9165	23	44	,	,	PUNCT
bam-9165	23	45	thrombotic	thrombotic	ADJ
bam-9165	23	46	microangiopathy	microangiopathy	PROPN
bam-9165	23	47	,	,	PUNCT
bam-9165	23	48	thrombocytopenic	thrombocytopenic	ADJ
bam-9165	23	49	purpura	purpura	NOUN
bam-9165	23	50	,	,	PUNCT
bam-9165	23	51	wilson	wilson	PROPN
bam-9165	23	52	disease	disease	PROPN
bam-9165	23	53	,	,	PUNCT
bam-9165	23	54	antiphospholipid	antiphospholipid	NOUN
bam-9165	23	55	syndrome	syndrome	NOUN
bam-9165	23	56	,	,	PUNCT
bam-9165	23	57	drug	drug	NOUN
bam-9165	23	58	overdose	overdose	NOUN
bam-9165	23	59	,	,	PUNCT
bam-9165	23	60	intoxications	intoxication	NOUN
bam-9165	23	61	,	,	PUNCT
bam-9165	23	62	systemic	systemic	ADJ
bam-9165	23	63	lupus	lupus	NOUN
bam-9165	23	64	erythematosus	erythematosus	NOUN
bam-9165	23	65	and	and	CCONJ
bam-9165	23	66	various	various	ADJ
bam-9165	23	67	other	other	ADJ
bam-9165	23	68	diseases.15	diseases.15	NOUN
bam-9165	23	69	-	-	PUNCT
bam-9165	23	70	19	19	NUM
bam-9165	23	71	in	in	ADP
bam-9165	23	72	accordance	accordance	NOUN
bam-9165	23	73	with	with	ADP
bam-9165	23	74	the	the	DET
bam-9165	23	75	classification	classification	NOUN
bam-9165	23	76	of	of	ADP
bam-9165	23	77	methods	method	NOUN
bam-9165	23	78	of	of	ADP
bam-9165	23	79	extracorporeal	extracorporeal	ADJ
bam-9165	23	80	haemocorrection	haemocorrection	NOUN
bam-9165	23	81	(	(	PUNCT
bam-9165	23	82	sokolov	sokolov	NOUN
bam-9165	23	83	aa	aa	PROPN
bam-9165	23	84	,	,	PUNCT
bam-9165	23	85	2017)20	2017)20	NUM
bam-9165	23	86	the	the	DET
bam-9165	23	87	following	follow	VERB
bam-9165	23	88	methods	method	NOUN
bam-9165	23	89	relate	relate	VERB
bam-9165	23	90	to	to	ADP
bam-9165	23	91	the	the	DET
bam-9165	23	92	effect	effect	NOUN
bam-9165	23	93	on	on	ADP
bam-9165	23	94	blood	blood	NOUN
bam-9165	23	95	plasma	plasma	NOUN
bam-9165	23	96	:	:	PUNCT
bam-9165	23	97			NOUN
bam-9165	23	98	membrane	membrane	NOUN
bam-9165	23	99	technology	technology	NOUN
bam-9165	23	100	(	(	PUNCT
bam-9165	23	101	plasma	plasma	NOUN
bam-9165	23	102	filtration	filtration	NOUN
bam-9165	23	103	,	,	PUNCT
bam-9165	23	104	selective	selective	ADJ
bam-9165	23	105	plasma	plasma	NOUN
bam-9165	23	106	filtration	filtration	NOUN
bam-9165	23	107	or	or	CCONJ
bam-9165	23	108	selective	selective	ADJ
bam-9165	23	109	plasma	plasma	NOUN
bam-9165	23	110	exchange	exchange	NOUN
bam-9165	23	111	,	,	PUNCT
bam-9165	23	112	cascade	cascade	NOUN
bam-9165	23	113	plasma	plasma	NOUN
bam-9165	23	114	filtration	filtration	NOUN
bam-9165	23	115	,	,	PUNCT
bam-9165	23	116	plasmа	plasmа	NOUN
bam-9165	23	117	diafiltration	diafiltration	NOUN
bam-9165	23	118	)	)	PUNCT
bam-9165	23	119			NOUN
bam-9165	23	120	centrifuge	centrifuge	NOUN
bam-9165	23	121	technology	technology	NOUN
bam-9165	23	122	(	(	PUNCT
bam-9165	23	123	plasmapheresis	plasmapheresis	NOUN
bam-9165	23	124	)	)	PUNCT
bam-9165	23	125			NOUN
bam-9165	23	126	sorption	sorption	NOUN
bam-9165	23	127	technology	technology	NOUN
bam-9165	23	128	(	(	PUNCT
bam-9165	23	129	plasmosorption	plasmosorption	NOUN
bam-9165	23	130	)	)	PUNCT
bam-9165	23	131	and	and	CCONJ
bam-9165	23	132	others.20	others.20	NOUN
bam-9165	23	133	in	in	ADP
bam-9165	23	134	terms	term	NOUN
bam-9165	23	135	of	of	ADP
bam-9165	23	136	efficiency	efficiency	NOUN
bam-9165	23	137	and	and	CCONJ
bam-9165	23	138	safety	safety	NOUN
bam-9165	23	139	in	in	ADP
bam-9165	23	140	regard	regard	NOUN
bam-9165	23	141	to	to	ADP
bam-9165	23	142	severe	severe	ADJ
bam-9165	23	143	and	and	CCONJ
bam-9165	23	144	critical	critical	ADJ
bam-9165	23	145	patients	patient	NOUN
bam-9165	23	146	,	,	PUNCT
bam-9165	23	147	the	the	DET
bam-9165	23	148	procedure	procedure	NOUN
bam-9165	23	149	of	of	ADP
bam-9165	23	150	selective	selective	ADJ
bam-9165	23	151	and	and	CCONJ
bam-9165	23	152	cascade	cascade	NOUN
bam-9165	23	153	plasma	plasma	NOUN
bam-9165	23	154	filtration	filtration	NOUN
bam-9165	23	155	has	have	AUX
bam-9165	23	156	proved	prove	VERB
bam-9165	23	157	to	to	PART
bam-9165	23	158	be	be	AUX
bam-9165	23	159	the	the	DET
bam-9165	23	160	most	most	ADV
bam-9165	23	161	effective	effective	ADJ
bam-9165	23	162	and	and	CCONJ
bam-9165	23	163	safe	safe	ADJ
bam-9165	23	164	of	of	ADP
bam-9165	23	165	all	all	PRON
bam-9165	23	166	.	.	PUNCT
bam-9165	24	1	this	this	DET
bam-9165	24	2	technique	technique	NOUN
bam-9165	24	3	is	be	AUX
bam-9165	24	4	a	a	DET
bam-9165	24	5	method	method	NOUN
bam-9165	24	6	of	of	ADP
bam-9165	24	7	extracorporeal	extracorporeal	ADJ
bam-9165	24	8	haemocorrection	haemocorrection	NOUN
bam-9165	24	9	based	base	VERB
bam-9165	24	10	on	on	ADP
bam-9165	24	11	the	the	DET
bam-9165	24	12	principle	principle	NOUN
bam-9165	24	13	of	of	ADP
bam-9165	24	14	filtration	filtration	NOUN
bam-9165	24	15	and	and	CCONJ
bam-9165	24	16	convection	convection	NOUN
bam-9165	24	17	plasma	plasma	NOUN
bam-9165	24	18	mass	mass	NOUN
bam-9165	24	19	transfer	transfer	NOUN
bam-9165	24	20	through	through	ADP
bam-9165	24	21	a	a	DET
bam-9165	24	22	semipermeable	semipermeable	ADJ
bam-9165	24	23	membrane	membrane	NOUN
bam-9165	24	24	due	due	ADP
bam-9165	24	25	to	to	ADP
bam-9165	24	26	the	the	DET
bam-9165	24	27	pressure	pressure	NOUN
bam-9165	24	28	gradient	gradient	NOUN
bam-9165	24	29	,	,	PUNCT
bam-9165	24	30	which	which	PRON
bam-9165	24	31	contributes	contribute	VERB
bam-9165	24	32	to	to	ADP
bam-9165	24	33	the	the	DET
bam-9165	24	34	effective	effective	ADJ
bam-9165	24	35	removal	removal	NOUN
bam-9165	24	36	of	of	ADP
bam-9165	24	37	highmolecular	highmolecular	ADJ
bam-9165	24	38	large	large	ADJ
bam-9165	24	39	-	-	PUNCT
bam-9165	24	40	globular	globular	ADJ
bam-9165	24	41	blood	blood	NOUN
bam-9165	24	42	plasma	plasma	NOUN
bam-9165	24	43	components	component	NOUN
bam-9165	24	44	exceeding	exceed	VERB
bam-9165	24	45	the	the	DET
bam-9165	24	46	size	size	NOUN
bam-9165	24	47	of	of	ADP
bam-9165	24	48	the	the	DET
bam-9165	24	49	albumin	albumin	ADJ
bam-9165	24	50	molecule	molecule	NOUN
bam-9165	24	51	.	.	PUNCT
bam-9165	25	1	the	the	DET
bam-9165	25	2	plasma	plasma	NOUN
bam-9165	25	3	itself	itself	PRON
bam-9165	25	4	is	be	AUX
bam-9165	25	5	obtained	obtain	VERB
bam-9165	25	6	from	from	ADP
bam-9165	25	7	whole	whole	ADJ
bam-9165	25	8	blood	blood	NOUN
bam-9165	25	9	through	through	ADP
bam-9165	25	10	centrifugal	centrifugal	ADJ
bam-9165	25	11	or	or	CCONJ
bam-9165	25	12	membrane	membrane	NOUN
bam-9165	25	13	plasmapheresis.17,20,21	plasmapheresis.17,20,21	NOUN
bam-9165	25	14	ig	ig	PROPN
bam-9165	25	15	m	m	PROPN
bam-9165	25	16	,	,	PUNCT
bam-9165	25	17	circulating	circulate	VERB
bam-9165	25	18	immune	immune	ADJ
bam-9165	25	19	complexes	complex	NOUN
bam-9165	25	20	,	,	PUNCT
bam-9165	25	21	cryoglobulins	cryoglobulin	NOUN
bam-9165	25	22	,	,	PUNCT
bam-9165	25	23	some	some	DET
bam-9165	25	24	viruses	virus	NOUN
bam-9165	25	25	and	and	CCONJ
bam-9165	25	26	other	other	ADJ
bam-9165	25	27	large	large	ADJ
bam-9165	25	28	molecules	molecule	NOUN
bam-9165	25	29	and	and	CCONJ
bam-9165	25	30	supramolecular	supramolecular	ADJ
bam-9165	25	31	complexes	complex	NOUN
bam-9165	25	32	are	be	AUX
bam-9165	25	33	effectively	effectively	ADV
bam-9165	25	34	removed.13,20,22	removed.13,20,22	ADV
bam-9165	25	35	selective	selective	ADJ
bam-9165	25	36	plasma	plasma	NOUN
bam-9165	25	37	filtration	filtration	NOUN
bam-9165	25	38	may	may	AUX
bam-9165	25	39	be	be	AUX
bam-9165	25	40	accompanied	accompany	VERB
bam-9165	25	41	by	by	ADP
bam-9165	25	42	a	a	DET
bam-9165	25	43	plasma	plasma	NOUN
bam-9165	25	44	exchange	exchange	NOUN
bam-9165	25	45	procedure	procedure	NOUN
bam-9165	25	46	in	in	ADP
bam-9165	25	47	which	which	PRON
bam-9165	25	48	the	the	DET
bam-9165	25	49	exfused	exfuse	VERB
bam-9165	25	50	volume	volume	NOUN
bam-9165	25	51	is	be	AUX
bam-9165	25	52	replaced	replace	VERB
bam-9165	25	53	by	by	ADP
bam-9165	25	54	donor	donor	NOUN
bam-9165	25	55	plasma	plasma	NOUN
bam-9165	25	56	.	.	PUNCT
bam-9165	26	1	in	in	ADP
bam-9165	26	2	this	this	DET
bam-9165	26	3	case	case	NOUN
bam-9165	26	4	,	,	PUNCT
bam-9165	26	5	donor	donor	NOUN
bam-9165	26	6	convalescent	convalescent	NOUN
bam-9165	26	7	plasma	plasma	NOUN
bam-9165	26	8	containing	contain	VERB
bam-9165	26	9	antibodies	antibody	NOUN
bam-9165	26	10	against	against	ADP
bam-9165	26	11	sars	sar	NOUN
bam-9165	26	12	-	-	PUNCT
bam-9165	26	13	cov-2	cov-2	NUM
bam-9165	26	14	is	be	AUX
bam-9165	26	15	used.23	used.23	NOUN
bam-9165	26	16	-	-	ADJ
bam-9165	26	17	25	25	NUM
bam-9165	26	18	the	the	DET
bam-9165	26	19	use	use	NOUN
bam-9165	26	20	of	of	ADP
bam-9165	26	21	anti	anti	ADJ
bam-9165	26	22	-	-	ADJ
bam-9165	26	23	cov2	cov2	ADJ
bam-9165	26	24	immunoglobulins	immunoglobulin	NOUN
bam-9165	26	25	,	,	PUNCT
bam-9165	26	26	which	which	PRON
bam-9165	26	27	are	be	AUX
bam-9165	26	28	contained	contain	VERB
bam-9165	26	29	in	in	ADP
bam-9165	26	30	the	the	DET
bam-9165	26	31	covid19	covid19	NOUN
bam-9165	26	32	convalescent	convalescent	NOUN
bam-9165	26	33	plasma	plasma	NOUN
bam-9165	26	34	,	,	PUNCT
bam-9165	26	35	is	be	AUX
bam-9165	26	36	a	a	DET
bam-9165	26	37	highly	highly	ADV
bam-9165	26	38	logical	logical	ADJ
bam-9165	26	39	therapeutic	therapeutic	ADJ
bam-9165	26	40	approach	approach	NOUN
bam-9165	26	41	aimed	aim	VERB
bam-9165	26	42	at	at	ADP
bam-9165	26	43	forming	form	VERB
bam-9165	26	44	a	a	DET
bam-9165	26	45	passive	passive	ADJ
bam-9165	26	46	immunity	immunity	NOUN
bam-9165	26	47	.	.	PUNCT
bam-9165	27	1	it	it	PRON
bam-9165	27	2	should	should	AUX
bam-9165	27	3	be	be	AUX
bam-9165	27	4	noted	note	VERB
bam-9165	27	5	that	that	SCONJ
bam-9165	27	6	the	the	DET
bam-9165	27	7	safety	safety	NOUN
bam-9165	27	8	and	and	CCONJ
bam-9165	27	9	effectiveness	effectiveness	NOUN
bam-9165	27	10	of	of	ADP
bam-9165	27	11	this	this	DET
bam-9165	27	12	covid19	covid19	NOUN
bam-9165	27	13	treatment	treatment	NOUN
bam-9165	27	14	method	method	NOUN
bam-9165	27	15	has	have	AUX
bam-9165	27	16	not	not	PART
bam-9165	27	17	yet	yet	ADV
bam-9165	27	18	been	be	AUX
bam-9165	27	19	fully	fully	ADV
bam-9165	27	20	confirmed	confirm	VERB
bam-9165	27	21	.	.	PUNCT
bam-9165	28	1	an	an	DET
bam-9165	28	2	international	international	ADJ
bam-9165	28	3	survey	survey	NOUN
bam-9165	28	4	was	be	AUX
bam-9165	28	5	done	do	VERB
bam-9165	28	6	to	to	PART
bam-9165	28	7	question	question	VERB
bam-9165	28	8	centers	center	NOUN
bam-9165	28	9	that	that	PRON
bam-9165	28	10	studied	study	VERB
bam-9165	28	11	the	the	DET
bam-9165	28	12	use	use	NOUN
bam-9165	28	13	of	of	ADP
bam-9165	28	14	convalescent	convalescent	NOUN
bam-9165	28	15	plasma	plasma	NOUN
bam-9165	28	16	in	in	ADP
bam-9165	28	17	treatment	treatment	NOUN
bam-9165	28	18	of	of	ADP
bam-9165	28	19	covid-19	covid-19	PROPN
bam-9165	28	20	patients	patient	NOUN
bam-9165	28	21	.	.	PUNCT
bam-9165	29	1	the	the	DET
bam-9165	29	2	survey	survey	NOUN
bam-9165	29	3	identified	identify	VERB
bam-9165	29	4	64	64	NUM
bam-9165	29	5	research	research	NOUN
bam-9165	29	6	studies	study	NOUN
bam-9165	29	7	in	in	ADP
bam-9165	29	8	22	22	NUM
bam-9165	29	9	countries	country	NOUN
bam-9165	29	10	.	.	PUNCT
bam-9165	30	1	however	however	ADV
bam-9165	30	2	,	,	PUNCT
bam-9165	30	3	only	only	ADV
bam-9165	30	4	20	20	NUM
bam-9165	30	5	centers	center	NOUN
bam-9165	30	6	from	from	ADP
bam-9165	30	7	12	12	NUM
bam-9165	30	8	countries	country	NOUN
bam-9165	30	9	revealed	reveal	VERB
bam-9165	30	10	information	information	NOUN
bam-9165	30	11	on	on	ADP
bam-9165	30	12	their	their	PRON
bam-9165	30	13	studies	study	NOUN
bam-9165	30	14	.	.	PUNCT
bam-9165	31	1	out	out	ADP
bam-9165	31	2	of	of	ADP
bam-9165	31	3	all	all	DET
bam-9165	31	4	studies	study	NOUN
bam-9165	31	5	,	,	PUNCT
bam-9165	31	6	only	only	ADV
bam-9165	31	7	4	4	NUM
bam-9165	31	8	are	be	AUX
bam-9165	31	9	set	set	VERB
bam-9165	31	10	to	to	PART
bam-9165	31	11	comprise	comprise	VERB
bam-9165	31	12	400	400	NUM
bam-9165	31	13	or	or	CCONJ
bam-9165	31	14	more	more	ADJ
bam-9165	31	15	patients	patient	NOUN
bam-9165	31	16	.	.	PUNCT
bam-9165	32	1	the	the	DET
bam-9165	32	2	authors	author	NOUN
bam-9165	32	3	of	of	ADP
bam-9165	32	4	this	this	DET
bam-9165	32	5	research	research	NOUN
bam-9165	32	6	express	express	VERB
bam-9165	32	7	a	a	DET
bam-9165	32	8	hope	hope	NOUN
bam-9165	32	9	that	that	SCONJ
bam-9165	32	10	blind	blind	ADJ
bam-9165	32	11	studies	study	NOUN
bam-9165	32	12	,	,	PUNCT
bam-9165	32	13	randomization	randomization	NOUN
bam-9165	32	14	and	and	CCONJ
bam-9165	32	15	larger	large	ADJ
bam-9165	32	16	sampling	sampling	NOUN
bam-9165	32	17	would	would	AUX
bam-9165	32	18	allow	allow	VERB
bam-9165	32	19	these	these	DET
bam-9165	32	20	studies	study	NOUN
bam-9165	32	21	to	to	PART
bam-9165	32	22	provide	provide	VERB
bam-9165	32	23	objective	objective	ADJ
bam-9165	32	24	results	result	NOUN
bam-9165	32	25	of	of	ADP
bam-9165	32	26	high	high	ADJ
bam-9165	32	27	level	level	NOUN
bam-9165	32	28	of	of	ADP
bam-9165	32	29	evidence.26	evidence.26	ADJ
bam-9165	32	30	clinical	clinical	ADJ
bam-9165	32	31	studies	study	NOUN
bam-9165	32	32	on	on	ADP
bam-9165	32	33	this	this	DET
bam-9165	32	34	matter	matter	NOUN
bam-9165	32	35	are	be	AUX
bam-9165	32	36	being	be	AUX
bam-9165	32	37	conducted	conduct	VERB
bam-9165	32	38	in	in	ADP
bam-9165	32	39	china	china	PROPN
bam-9165	32	40	,	,	PUNCT
bam-9165	32	41	usa	usa	PROPN
bam-9165	32	42	,	,	PUNCT
bam-9165	32	43	russia	russia	PROPN
bam-9165	32	44	,	,	PUNCT
bam-9165	32	45	france	france	PROPN
bam-9165	32	46	,	,	PUNCT
bam-9165	32	47	and	and	CCONJ
bam-9165	32	48	some	some	DET
bam-9165	32	49	other	other	ADJ
bam-9165	32	50	countries	country	NOUN
bam-9165	32	51	.	.	PUNCT
bam-9165	33	1	however	however	ADV
bam-9165	33	2	,	,	PUNCT
bam-9165	33	3	some	some	DET
bam-9165	33	4	scientists	scientist	NOUN
bam-9165	33	5	have	have	AUX
bam-9165	33	6	already	already	ADV
bam-9165	33	7	published	publish	VERB
bam-9165	33	8	intermediate	intermediate	ADJ
bam-9165	33	9	data	datum	NOUN
bam-9165	33	10	indicating	indicate	VERB
bam-9165	33	11	the	the	DET
bam-9165	33	12	positive	positive	ADJ
bam-9165	33	13	effects	effect	NOUN
bam-9165	33	14	of	of	ADP
bam-9165	33	15	convalescent	convalescent	NOUN
bam-9165	33	16	plasma	plasma	NOUN
bam-9165	33	17	in	in	ADP
bam-9165	33	18	the	the	DET
bam-9165	33	19	treatment	treatment	NOUN
bam-9165	33	20	of	of	ADP
bam-9165	33	21	covid-19.23,27	covid-19.23,27	PROPN
bam-9165	33	22	the	the	DET
bam-9165	33	23	procedure	procedure	NOUN
bam-9165	33	24	of	of	ADP
bam-9165	33	25	donor	donor	NOUN
bam-9165	33	26	plasmapheresis	plasmapheresis	NOUN
bam-9165	33	27	is	be	AUX
bam-9165	33	28	not	not	PART
bam-9165	33	29	only	only	ADV
bam-9165	33	30	safe	safe	ADJ
bam-9165	33	31	for	for	ADP
bam-9165	33	32	donors	donor	NOUN
bam-9165	33	33	themselves	themselves	PRON
bam-9165	33	34	,	,	PUNCT
bam-9165	33	35	but	but	CCONJ
bam-9165	33	36	also	also	ADV
bam-9165	33	37	useful	useful	ADJ
bam-9165	33	38	in	in	ADP
bam-9165	33	39	terms	term	NOUN
bam-9165	33	40	of	of	ADP
bam-9165	33	41	improving	improve	VERB
bam-9165	33	42	blood	blood	NOUN
bam-9165	33	43	rheology	rheology	NOUN
bam-9165	33	44	and	and	CCONJ
bam-9165	33	45	correcting	correct	VERB
bam-9165	33	46	hypercoagulation	hypercoagulation	NOUN
bam-9165	33	47	.	.	PUNCT
bam-9165	34	1	this	this	DET
bam-9165	34	2	effect	effect	NOUN
bam-9165	34	3	is	be	AUX
bam-9165	34	4	achieved	achieve	VERB
bam-9165	34	5	through	through	ADP
bam-9165	34	6	the	the	DET
bam-9165	34	7	use	use	NOUN
bam-9165	34	8	of	of	ADP
bam-9165	34	9	anticoagulants	anticoagulant	NOUN
bam-9165	34	10	based	base	VERB
bam-9165	34	11	on	on	ADP
bam-9165	34	12	citrate	citrate	NOUN
bam-9165	34	13	and	and	CCONJ
bam-9165	34	14	removal	removal	NOUN
bam-9165	34	15	of	of	ADP
bam-9165	34	16	high	high	ADJ
bam-9165	34	17	-	-	PUNCT
bam-9165	34	18	molecular	molecular	ADJ
bam-9165	34	19	blood	blood	NOUN
bam-9165	34	20	components	component	NOUN
bam-9165	34	21	that	that	PRON
bam-9165	34	22	increase	increase	VERB
bam-9165	34	23	blood	blood	NOUN
bam-9165	34	24	viscosity.28	viscosity.28	NOUN
bam-9165	34	25	it	it	PRON
bam-9165	34	26	is	be	AUX
bam-9165	34	27	widely	widely	ADV
bam-9165	34	28	known	know	VERB
bam-9165	34	29	that	that	SCONJ
bam-9165	34	30	the	the	DET
bam-9165	34	31	majority	majority	NOUN
bam-9165	34	32	of	of	ADP
bam-9165	34	33	patients	patient	NOUN
bam-9165	34	34	with	with	ADP
bam-9165	34	35	covid-19	covid-19	PROPN
bam-9165	34	36	have	have	VERB
bam-9165	34	37	a	a	DET
bam-9165	34	38	hypercoagulation	hypercoagulation	NOUN
bam-9165	34	39	condition	condition	NOUN
bam-9165	34	40	characterised	characterise	VERB
bam-9165	34	41	by	by	ADP
bam-9165	34	42	an	an	DET
bam-9165	34	43	increase	increase	NOUN
bam-9165	34	44	in	in	ADP
bam-9165	34	45	prothrombin	prothrombin	ADJ
bam-9165	34	46	time	time	NOUN
bam-9165	34	47	,	,	PUNCT
bam-9165	34	48	d	d	NOUN
bam-9165	34	49	-	-	PUNCT
bam-9165	34	50	dimer	dimer	NOUN
bam-9165	34	51	and	and	CCONJ
bam-9165	34	52	fibrinogen	fibrinogen	NOUN
bam-9165	34	53	levels	level	NOUN
bam-9165	34	54	at	at	ADP
bam-9165	34	55	practically	practically	ADV
bam-9165	34	56	normal	normal	ADJ
bam-9165	34	57	values	value	NOUN
bam-9165	34	58	of	of	ADP
bam-9165	34	59	activated	activate	VERB
bam-9165	34	60	partial	partial	ADJ
bam-9165	34	61	thromboplastin	thromboplastin	NOUN
bam-9165	34	62	time.29,30	time.29,30	NOUN
bam-9165	34	63	operating	operate	VERB
bam-9165	34	64	principles	principle	NOUN
bam-9165	34	65	of	of	ADP
bam-9165	34	66	plasmapheresis	plasmapheresis	NOUN
bam-9165	34	67	methods	method	NOUN
bam-9165	34	68	figure	figure	VERB
bam-9165	34	69	1	1	NUM
bam-9165	34	70	shows	show	VERB
bam-9165	34	71	the	the	DET
bam-9165	34	72	basic	basic	ADJ
bam-9165	34	73	operating	operating	NOUN
bam-9165	34	74	principles	principle	NOUN
bam-9165	34	75	of	of	ADP
bam-9165	34	76	plasmapheresis	plasmapheresis	NOUN
bam-9165	34	77	methods	method	NOUN
bam-9165	34	78	in	in	ADP
bam-9165	34	79	patients	patient	NOUN
bam-9165	34	80	with	with	ADP
bam-9165	34	81	severe	severe	ADJ
bam-9165	34	82	form	form	NOUN
bam-9165	34	83	of	of	ADP
bam-9165	34	84	covid-19	covid-19	PROPN
bam-9165	34	85	,	,	PUNCT
bam-9165	34	86	that	that	PRON
bam-9165	34	87	mainly	mainly	ADV
bam-9165	34	88	include	include	VERB
bam-9165	34	89	the	the	DET
bam-9165	34	90	following:8,31,32	following:8,31,32	NOUN
bam-9165	34	91			NOUN
bam-9165	34	92	removing	remove	VERB
bam-9165	34	93	pathogenic	pathogenic	ADJ
bam-9165	34	94	circulating	circulate	VERB
bam-9165	34	95	molecules	molecule	NOUN
bam-9165	34	96	,	,	PUNCT
bam-9165	34	97	inflammatory	inflammatory	ADJ
bam-9165	34	98	cytokines	cytokine	NOUN
bam-9165	34	99	;	;	PUNCT
bam-9165	34	100			PRON
bam-9165	34	101	removing	remove	VERB
bam-9165	34	102	metabolic	metabolic	NOUN
bam-9165	34	103	products	product	NOUN
bam-9165	34	104	such	such	ADJ
bam-9165	34	105	as	as	ADP
bam-9165	34	106	creatinine	creatinine	NOUN
bam-9165	34	107	,	,	PUNCT
bam-9165	34	108	urea	urea	NOUN
bam-9165	34	109	nitrogen	nitrogen	NOUN
bam-9165	34	110	;	;	PUNCT
bam-9165	34	111			NOUN
bam-9165	34	112	maintaining	maintain	VERB
bam-9165	34	113	hemodynamic	hemodynamic	ADJ
bam-9165	34	114	stability	stability	NOUN
bam-9165	34	115	in	in	ADP
bam-9165	34	116	the	the	DET
bam-9165	34	117	organism	organism	NOUN
bam-9165	34	118	;	;	PUNCT
bam-9165	34	119			PUNCT
bam-9165	34	120	correction	correction	NOUN
bam-9165	34	121	of	of	ADP
bam-9165	34	122	blood	blood	NOUN
bam-9165	34	123	rheological	rheological	ADJ
bam-9165	34	124	disorders	disorder	NOUN
bam-9165	34	125	;	;	PUNCT
bam-9165	35	1			PUNCT
bam-9165	35	2	correction	correction	NOUN
bam-9165	35	3	of	of	ADP
bam-9165	35	4	electrolyte	electrolyte	NOUN
bam-9165	35	5	and	and	CCONJ
bam-9165	35	6	acid	acid	ADJ
bam-9165	35	7	-	-	PUNCT
bam-9165	35	8	alkaline	alkaline	NOUN
bam-9165	35	9	balance	balance	NOUN
bam-9165	35	10	disorders	disorder	NOUN
bam-9165	35	11	to	to	PART
bam-9165	35	12	maintain	maintain	VERB
bam-9165	35	13	stability	stability	NOUN
bam-9165	35	14	of	of	ADP
bam-9165	35	15	internal	internal	ADJ
bam-9165	35	16	environment	environment	NOUN
bam-9165	35	17	case	case	NOUN
bam-9165	35	18	reports	report	NOUN
bam-9165	35	19	and	and	CCONJ
bam-9165	35	20	reccommendations	reccommendation	NOUN
bam-9165	35	21	chinese	chinese	ADJ
bam-9165	35	22	scientists	scientist	NOUN
bam-9165	35	23	presented	present	VERB
bam-9165	35	24	the	the	DET
bam-9165	35	25	results	result	NOUN
bam-9165	35	26	of	of	ADP
bam-9165	35	27	treatment	treatment	NOUN
bam-9165	35	28	of	of	ADP
bam-9165	35	29	three	three	NUM
bam-9165	35	30	patients	patient	NOUN
bam-9165	35	31	in	in	ADP
bam-9165	35	32	severe	severe	ADJ
bam-9165	35	33	condition	condition	NOUN
bam-9165	35	34	with	with	ADP
bam-9165	35	35	bilateral	bilateral	ADJ
bam-9165	35	36	pneumonia	pneumonia	NOUN
bam-9165	35	37	and	and	CCONJ
bam-9165	35	38	confirmed	confirm	VERB
bam-9165	35	39	covid-19	covid-19	PROPN
bam-9165	35	40	in	in	ADP
bam-9165	35	41	wuhan	wuhan	PROPN
bam-9165	35	42	,	,	PUNCT
bam-9165	35	43	china	china	PROPN
bam-9165	35	44	in	in	ADP
bam-9165	35	45	the	the	DET
bam-9165	35	46	paper	paper	NOUN
bam-9165	35	47	published	publish	VERB
bam-9165	35	48	in	in	ADP
bam-9165	35	49	early	early	ADJ
bam-9165	35	50	april	april	PROPN
bam-9165	35	51	2020.1	2020.1	NUM
bam-9165	35	52	]	]	PUNCT
bam-9165	35	53	one	one	NUM
bam-9165	35	54	of	of	ADP
bam-9165	35	55	the	the	DET
bam-9165	35	56	patients	patient	NOUN
bam-9165	35	57	underwent	undergo	VERB
bam-9165	35	58	3	3	NUM
bam-9165	35	59	plasma	plasma	NOUN
bam-9165	35	60	exchange	exchange	NOUN
bam-9165	35	61	sessions	session	NOUN
bam-9165	35	62	and	and	CCONJ
bam-9165	35	63	two	two	NUM
bam-9165	35	64	patients	patient	NOUN
bam-9165	35	65	underwent	undergo	VERB
bam-9165	35	66	plasma	plasma	NOUN
bam-9165	35	67	filtration	filtration	NOUN
bam-9165	35	68	using	use	VERB
bam-9165	35	69	oxiris	oxiris	ADJ
bam-9165	35	70	®	®	NOUN
bam-9165	35	71	hemofilter	hemofilter	NOUN
bam-9165	35	72	(	(	PUNCT
bam-9165	35	73	baxter	baxter	PROPN
bam-9165	35	74	,	,	PUNCT
bam-9165	35	75	meyzieu	meyzieu	PROPN
bam-9165	35	76	,	,	PUNCT
bam-9165	35	77	france	france	PROPN
bam-9165	35	78	)	)	PUNCT
bam-9165	35	79	modified	modify	VERB
bam-9165	35	80	with	with	ADP
bam-9165	35	81	plasmapheresis	plasmapheresis	NOUN
bam-9165	35	82	methods	method	NOUN
bam-9165	35	83	for	for	ADP
bam-9165	35	84	covid-19	covid-19	PROPN
bam-9165	35	85	eur	eur	PROPN
bam-9165	35	86	j	j	PROPN
bam-9165	35	87	transl	transl	PROPN
bam-9165	35	88	myol	myol	NOUN
bam-9165	35	89	2020	2020	NUM
bam-9165	35	90	;	;	PUNCT
bam-9165	35	91	30	30	NUM
bam-9165	35	92	(	(	PUNCT
bam-9165	35	93	3	3	NUM
bam-9165	35	94	):	):	PUNCT
bam-9165	35	95	9165	9165	NUM
bam-9165	35	96	.	.	PUNCT
bam-9165	36	1	doi	doi	NOUN
bam-9165	36	2	:	:	PUNCT
bam-9165	36	3	10.4081	10.4081	NUM
bam-9165	36	4	/	/	SYM
bam-9165	36	5	ejtm.2020.9165	ejtm.2020.9165	VERB
bam-9165	36	6	3	3	NUM
bam-9165	36	7	an69	an69	PROPN
bam-9165	36	8	adsorbing	adsorb	VERB
bam-9165	36	9	membrane	membrane	NOUN
bam-9165	36	10	.	.	PUNCT
bam-9165	37	1	two	two	NUM
bam-9165	37	2	out	out	ADP
bam-9165	37	3	of	of	ADP
bam-9165	37	4	three	three	NUM
bam-9165	37	5	patients	patient	NOUN
bam-9165	37	6	recovered	recover	VERB
bam-9165	37	7	.	.	PUNCT
bam-9165	38	1	one	one	NUM
bam-9165	38	2	patient	patient	NOUN
bam-9165	38	3	died	die	VERB
bam-9165	38	4	due	due	ADJ
bam-9165	38	5	to	to	ADP
bam-9165	38	6	complications	complication	NOUN
bam-9165	38	7	(	(	PUNCT
bam-9165	38	8	dicsyndrome	dicsyndrome	ADJ
bam-9165	38	9	and	and	CCONJ
bam-9165	38	10	right	right	ADV
bam-9165	38	11	-	-	PUNCT
bam-9165	38	12	sided	side	VERB
bam-9165	38	13	pneumothorax	pneumothorax	NOUN
bam-9165	38	14	)	)	PUNCT
bam-9165	38	15	and	and	CCONJ
bam-9165	38	16	delayed	delay	VERB
bam-9165	38	17	application	application	NOUN
bam-9165	38	18	of	of	ADP
bam-9165	38	19	plasmafiltration	plasmafiltration	NOUN
bam-9165	38	20	.	.	PUNCT
bam-9165	39	1	this	this	DET
bam-9165	39	2	study	study	NOUN
bam-9165	39	3	reveals	reveal	VERB
bam-9165	39	4	the	the	DET
bam-9165	39	5	importance	importance	NOUN
bam-9165	39	6	of	of	ADP
bam-9165	39	7	timely	timely	ADJ
bam-9165	39	8	use	use	NOUN
bam-9165	39	9	of	of	ADP
bam-9165	39	10	plasmapheresis	plasmapheresis	NOUN
bam-9165	39	11	and	and	CCONJ
bam-9165	39	12	conveys	convey	VERB
bam-9165	39	13	the	the	DET
bam-9165	39	14	suggestion	suggestion	NOUN
bam-9165	39	15	to	to	PART
bam-9165	39	16	do	do	AUX
bam-9165	39	17	a	a	DET
bam-9165	39	18	separate	separate	ADJ
bam-9165	39	19	research	research	NOUN
bam-9165	39	20	on	on	ADP
bam-9165	39	21	efficiency	efficiency	NOUN
bam-9165	39	22	of	of	ADP
bam-9165	39	23	plasmapheresis	plasmapheresis	NOUN
bam-9165	39	24	in	in	ADP
bam-9165	39	25	treatment	treatment	NOUN
bam-9165	39	26	of	of	ADP
bam-9165	39	27	covid-19	covid-19	PROPN
bam-9165	39	28	(	(	PUNCT
bam-9165	39	29	considering	consider	VERB
bam-9165	39	30	the	the	DET
bam-9165	39	31	research	research	NOUN
bam-9165	39	32	timing	timing	NOUN
bam-9165	39	33	)	)	PUNCT
bam-9165	39	34	.	.	PUNCT
bam-9165	40	1	a	a	DET
bam-9165	40	2	retrospective	retrospective	ADJ
bam-9165	40	3	study	study	NOUN
bam-9165	40	4	of	of	ADP
bam-9165	40	5	the	the	DET
bam-9165	40	6	effectiveness	effectiveness	NOUN
bam-9165	40	7	and	and	CCONJ
bam-9165	40	8	safety	safety	NOUN
bam-9165	40	9	of	of	ADP
bam-9165	40	10	plasma	plasma	NOUN
bam-9165	40	11	exchange	exchange	NOUN
bam-9165	40	12	in	in	ADP
bam-9165	40	13	septic	septic	ADJ
bam-9165	40	14	shock	shock	NOUN
bam-9165	40	15	with	with	ADP
bam-9165	40	16	multiple	multiple	ADJ
bam-9165	40	17	organ	organ	NOUN
bam-9165	40	18	dysfunction	dysfunction	NOUN
bam-9165	40	19	was	be	AUX
bam-9165	40	20	conducted	conduct	VERB
bam-9165	40	21	at	at	ADP
bam-9165	40	22	the	the	DET
bam-9165	40	23	intensive	intensive	ADJ
bam-9165	40	24	care	care	NOUN
bam-9165	40	25	unit	unit	NOUN
bam-9165	40	26	of	of	ADP
bam-9165	40	27	lexington	lexington	PROPN
bam-9165	40	28	medical	medical	ADJ
bam-9165	40	29	centre	centre	PROPN
bam-9165	40	30	(	(	PUNCT
bam-9165	40	31	south	south	PROPN
bam-9165	40	32	carolina	carolina	PROPN
bam-9165	40	33	,	,	PUNCT
bam-9165	40	34	usa	usa	PROPN
bam-9165	40	35	)	)	PUNCT
bam-9165	40	36	,	,	PUNCT
bam-9165	40	37	involving	involve	VERB
bam-9165	40	38	80	80	NUM
bam-9165	40	39	patients	patient	NOUN
bam-9165	40	40	.	.	PUNCT
bam-9165	41	1	the	the	DET
bam-9165	41	2	mortality	mortality	NOUN
bam-9165	41	3	rate	rate	NOUN
bam-9165	41	4	in	in	ADP
bam-9165	41	5	pneumonia	pneumonia	NOUN
bam-9165	41	6	patients	patient	NOUN
bam-9165	41	7	treated	treat	VERB
bam-9165	41	8	with	with	ADP
bam-9165	41	9	plasma	plasma	NOUN
bam-9165	41	10	exchange	exchange	NOUN
bam-9165	41	11	as	as	ADP
bam-9165	41	12	an	an	DET
bam-9165	41	13	additional	additional	ADJ
bam-9165	41	14	method	method	NOUN
bam-9165	41	15	of	of	ADP
bam-9165	41	16	treatment	treatment	NOUN
bam-9165	41	17	amounted	amount	VERB
bam-9165	41	18	to	to	ADP
bam-9165	41	19	47.8	47.8	NUM
bam-9165	41	20	%	%	NOUN
bam-9165	41	21	against	against	ADP
bam-9165	41	22	81.3	81.3	NUM
bam-9165	41	23	%	%	NOUN
bam-9165	41	24	in	in	ADP
bam-9165	41	25	the	the	DET
bam-9165	41	26	standard	standard	PROPN
bam-9165	41	27	therapy	therapy	NOUN
bam-9165	41	28	group	group	NOUN
bam-9165	41	29	(	(	PUNCT
bam-9165	41	30	p<0.05).33	p<0.05).33	NOUN
bam-9165	41	31	in	in	ADP
bam-9165	41	32	the	the	DET
bam-9165	41	33	article	article	NOUN
bam-9165	41	34	published	publish	VERB
bam-9165	41	35	following	follow	VERB
bam-9165	41	36	the	the	DET
bam-9165	41	37	results	result	NOUN
bam-9165	41	38	of	of	ADP
bam-9165	41	39	the	the	DET
bam-9165	41	40	study	study	NOUN
bam-9165	41	41	,	,	PUNCT
bam-9165	41	42	the	the	DET
bam-9165	41	43	scientists	scientist	NOUN
bam-9165	41	44	note	note	VERB
bam-9165	41	45	that	that	SCONJ
bam-9165	41	46	they	they	PRON
bam-9165	41	47	revised	revise	VERB
bam-9165	41	48	approaches	approach	NOUN
bam-9165	41	49	to	to	ADP
bam-9165	41	50	the	the	DET
bam-9165	41	51	use	use	NOUN
bam-9165	41	52	of	of	ADP
bam-9165	41	53	plasma	plasma	NOUN
bam-9165	41	54	exchange	exchange	NOUN
bam-9165	41	55	method	method	NOUN
bam-9165	41	56	on	on	ADP
bam-9165	41	57	the	the	DET
bam-9165	41	58	basis	basis	NOUN
bam-9165	41	59	of	of	ADP
bam-9165	41	60	the	the	DET
bam-9165	41	61	experience	experience	NOUN
bam-9165	41	62	gained	gain	VERB
bam-9165	41	63	.	.	PUNCT
bam-9165	42	1	thus	thus	ADV
bam-9165	42	2	,	,	PUNCT
bam-9165	42	3	they	they	PRON
bam-9165	42	4	now	now	ADV
bam-9165	42	5	recommend	recommend	VERB
bam-9165	42	6	this	this	DET
bam-9165	42	7	method	method	NOUN
bam-9165	42	8	not	not	PART
bam-9165	42	9	only	only	ADV
bam-9165	42	10	as	as	ADP
bam-9165	42	11	a	a	DET
bam-9165	42	12	“	"	PUNCT
bam-9165	42	13	rescue	rescue	NOUN
bam-9165	42	14	therapy	therapy	NOUN
bam-9165	42	15	”	"	PUNCT
bam-9165	42	16	,	,	PUNCT
bam-9165	42	17	but	but	CCONJ
bam-9165	42	18	also	also	ADV
bam-9165	42	19	as	as	ADP
bam-9165	42	20	part	part	NOUN
bam-9165	42	21	of	of	ADP
bam-9165	42	22	earlier	early	ADJ
bam-9165	42	23	stages	stage	NOUN
bam-9165	42	24	of	of	ADP
bam-9165	42	25	treatment.9	treatment.9	PROPN
bam-9165	42	26	in	in	ADP
bam-9165	42	27	a	a	DET
bam-9165	42	28	published	publish	VERB
bam-9165	42	29	article	article	NOUN
bam-9165	42	30	professor	professor	NOUN
bam-9165	42	31	shi	shi	PROPN
bam-9165	42	32	and	and	CCONJ
bam-9165	42	33	his	his	PRON
bam-9165	42	34	colleagues	colleague	NOUN
bam-9165	42	35	provided	provide	VERB
bam-9165	42	36	results	result	NOUN
bam-9165	42	37	on	on	ADP
bam-9165	42	38	treatment	treatment	NOUN
bam-9165	42	39	of	of	ADP
bam-9165	42	40	50	50	NUM
bam-9165	42	41	-	-	PUNCT
bam-9165	42	42	year	year	NOUN
bam-9165	42	43	-	-	PUNCT
bam-9165	42	44	old	old	ADJ
bam-9165	42	45	critically	critically	ADV
bam-9165	42	46	ill	ill	ADJ
bam-9165	42	47	patient	patient	NOUN
bam-9165	42	48	with	with	ADP
bam-9165	42	49	covid-19	covid-19	PROPN
bam-9165	42	50	.	.	PUNCT
bam-9165	43	1	due	due	ADP
bam-9165	43	2	to	to	ADP
bam-9165	43	3	inefficient	inefficient	ADJ
bam-9165	43	4	drug	drug	NOUN
bam-9165	43	5	therapy	therapy	NOUN
bam-9165	43	6	,	,	PUNCT
bam-9165	43	7	this	this	DET
bam-9165	43	8	patient	patient	NOUN
bam-9165	43	9	received	receive	VERB
bam-9165	43	10	a	a	DET
bam-9165	43	11	course	course	NOUN
bam-9165	43	12	of	of	ADP
bam-9165	43	13	plasma	plasma	NOUN
bam-9165	43	14	exchange	exchange	NOUN
bam-9165	43	15	followed	follow	VERB
bam-9165	43	16	by	by	ADP
bam-9165	43	17	intravenous	intravenous	ADJ
bam-9165	43	18	injections	injection	NOUN
bam-9165	43	19	of	of	ADP
bam-9165	43	20	immunoglobulin	immunoglobulin	NOUN
bam-9165	43	21	.	.	PUNCT
bam-9165	44	1	the	the	DET
bam-9165	44	2	chosen	choose	VERB
bam-9165	44	3	treatment	treatment	NOUN
bam-9165	44	4	method	method	NOUN
bam-9165	44	5	allowed	allow	VERB
bam-9165	44	6	to	to	PART
bam-9165	44	7	stop	stop	VERB
bam-9165	44	8	the	the	DET
bam-9165	44	9	disease	disease	NOUN
bam-9165	44	10	progression	progression	NOUN
bam-9165	44	11	and	and	CCONJ
bam-9165	44	12	lower	low	ADJ
bam-9165	44	13	the	the	DET
bam-9165	44	14	need	need	NOUN
bam-9165	44	15	for	for	ADP
bam-9165	44	16	intensive	intensive	ADJ
bam-9165	44	17	supportive	supportive	ADJ
bam-9165	44	18	therapy.34	therapy.34	NOUN
bam-9165	44	19	this	this	DET
bam-9165	44	20	case	case	NOUN
bam-9165	44	21	requires	require	VERB
bam-9165	44	22	a	a	DET
bam-9165	44	23	larger	large	ADJ
bam-9165	44	24	clinical	clinical	ADJ
bam-9165	44	25	study	study	NOUN
bam-9165	44	26	including	include	VERB
bam-9165	44	27	the	the	DET
bam-9165	44	28	use	use	NOUN
bam-9165	44	29	of	of	ADP
bam-9165	44	30	immunoglobulin	immunoglobulin	NOUN
bam-9165	44	31	,	,	PUNCT
bam-9165	44	32	apart	apart	ADV
bam-9165	44	33	from	from	ADP
bam-9165	44	34	plasmapheresis	plasmapheresis	NOUN
bam-9165	44	35	.	.	PUNCT
bam-9165	45	1	on	on	ADP
bam-9165	45	2	april	april	PROPN
bam-9165	45	3	10	10	NUM
bam-9165	45	4	,	,	PUNCT
bam-9165	45	5	2020	2020	NUM
bam-9165	45	6	,	,	PUNCT
bam-9165	45	7	the	the	DET
bam-9165	45	8	u.s	u.s	PROPN
bam-9165	45	9	.	.	PROPN
bam-9165	45	10	food	food	PROPN
bam-9165	45	11	and	and	CCONJ
bam-9165	45	12	drug	drug	PROPN
bam-9165	45	13	administration	administration	NOUN
bam-9165	45	14	(	(	PUNCT
bam-9165	45	15	fda	fda	PROPN
bam-9165	45	16	usa	usa	PROPN
bam-9165	45	17	)	)	PUNCT
bam-9165	45	18	issued	issue	VERB
bam-9165	45	19	an	an	DET
bam-9165	45	20	emergency	emergency	NOUN
bam-9165	45	21	use	use	NOUN
bam-9165	45	22	authorisation	authorisation	NOUN
bam-9165	45	23	for	for	ADP
bam-9165	45	24	terumo	terumo	ADJ
bam-9165	45	25	bct	bct	PROPN
bam-9165	45	26	inc	inc	PROPN
bam-9165	45	27	.	.	PROPN
bam-9165	45	28	and	and	CCONJ
bam-9165	45	29	marker	marker	NOUN
bam-9165	45	30	therapeutics	therapeutic	NOUN
bam-9165	45	31	ag	ag	PROPN
bam-9165	45	32	to	to	PART
bam-9165	45	33	use	use	VERB
bam-9165	45	34	their	their	PRON
bam-9165	45	35	spectra	spectra	ADJ
bam-9165	45	36	optia	optia	PROPN
bam-9165	45	37	aphereis	aphereis	NOUN
bam-9165	45	38	blood	blood	NOUN
bam-9165	45	39	purification	purification	NOUN
bam-9165	45	40	systems	system	NOUN
bam-9165	45	41	and	and	CCONJ
bam-9165	45	42	depuro	depuro	NOUN
bam-9165	45	43	d2000	d2000	NOUN
bam-9165	45	44	adsorption	adsorption	NOUN
bam-9165	45	45	cartridges	cartridge	NOUN
bam-9165	45	46	to	to	PART
bam-9165	45	47	treat	treat	VERB
bam-9165	45	48	laboratory	laboratory	NOUN
bam-9165	45	49	-	-	PUNCT
bam-9165	45	50	confirmed	confirm	VERB
bam-9165	45	51	covid-19	covid-19	PROPN
bam-9165	45	52	patients	patient	NOUN
bam-9165	45	53	over	over	ADP
bam-9165	45	54	18	18	NUM
bam-9165	45	55	years	year	NOUN
bam-9165	45	56	of	of	ADP
bam-9165	45	57	age	age	NOUN
bam-9165	45	58	admitted	admit	VERB
bam-9165	45	59	to	to	ADP
bam-9165	45	60	the	the	DET
bam-9165	45	61	icu	icu	PROPN
bam-9165	45	62	with	with	ADP
bam-9165	45	63	respiratory	respiratory	ADJ
bam-9165	45	64	failure	failure	NOUN
bam-9165	45	65	syndrome	syndrome	NOUN
bam-9165	45	66	.	.	PUNCT
bam-9165	46	1	the	the	DET
bam-9165	46	2	purpose	purpose	NOUN
bam-9165	46	3	of	of	ADP
bam-9165	46	4	use	use	NOUN
bam-9165	46	5	is	be	AUX
bam-9165	46	6	the	the	DET
bam-9165	46	7	reduction	reduction	NOUN
bam-9165	46	8	of	of	ADP
bam-9165	46	9	inflammatory	inflammatory	ADJ
bam-9165	46	10	cytokines	cytokine	NOUN
bam-9165	46	11	concentration	concentration	NOUN
bam-9165	46	12	.	.	PUNCT
bam-9165	47	1	according	accord	VERB
bam-9165	47	2	to	to	ADP
bam-9165	47	3	the	the	DET
bam-9165	47	4	manufacturers	manufacturer	NOUN
bam-9165	47	5	'	'	PART
bam-9165	47	6	statement	statement	NOUN
bam-9165	47	7	,	,	PUNCT
bam-9165	47	8	the	the	DET
bam-9165	47	9	adsorption	adsorption	NOUN
bam-9165	47	10	cartridge	cartridge	NOUN
bam-9165	47	11	d2000	d2000	PROPN
bam-9165	47	12	is	be	AUX
bam-9165	47	13	effective	effective	ADJ
bam-9165	47	14	in	in	ADP
bam-9165	47	15	reducing	reduce	VERB
bam-9165	47	16	the	the	DET
bam-9165	47	17	level	level	NOUN
bam-9165	47	18	of	of	ADP
bam-9165	47	19	il-3	il-3	NUM
bam-9165	47	20	,	,	PUNCT
bam-9165	47	21	ifn	ifn	PROPN
bam-9165	47	22	-	-	PUNCT
bam-9165	47	23	gamma	gamma	NOUN
bam-9165	47	24	,	,	PUNCT
bam-9165	47	25	il-10	il-10	PRON
bam-9165	47	26	,	,	PUNCT
bam-9165	47	27	il-1b	il-1b	PROPN
bam-9165	47	28	,	,	PUNCT
bam-9165	47	29	il-6	il-6	NOUN
bam-9165	47	30	,	,	PUNCT
bam-9165	47	31	il-8	il-8	NOUN
bam-9165	47	32	,	,	PUNCT
bam-9165	47	33	mcp-1	mcp-1	X
bam-9165	47	34	and	and	CCONJ
bam-9165	47	35	tnf	tnf	PROPN
bam-9165	47	36	-	-	PUNCT
bam-9165	47	37	alpha.35	alpha.35	NOUN
bam-9165	47	38	the	the	DET
bam-9165	47	39	use	use	NOUN
bam-9165	47	40	of	of	ADP
bam-9165	47	41	fda	fda	PROPN
bam-9165	47	42	-	-	PUNCT
bam-9165	47	43	approved	approve	VERB
bam-9165	47	44	technology	technology	NOUN
bam-9165	47	45	is	be	AUX
bam-9165	47	46	allowed	allow	VERB
bam-9165	47	47	for	for	ADP
bam-9165	47	48	patients	patient	NOUN
bam-9165	47	49	over	over	ADP
bam-9165	47	50	18	18	NUM
bam-9165	47	51	years	year	NOUN
bam-9165	47	52	of	of	ADP
bam-9165	47	53	age	age	NOUN
bam-9165	47	54	who	who	PRON
bam-9165	47	55	have	have	VERB
bam-9165	47	56	any	any	PRON
bam-9165	47	57	of	of	ADP
bam-9165	47	58	the	the	DET
bam-9165	47	59	following	follow	VERB
bam-9165	47	60	symptoms	symptom	NOUN
bam-9165	47	61	:	:	PUNCT
bam-9165	47	62	i	i	NOUN
bam-9165	47	63	)	)	PUNCT
bam-9165	47	64	early	early	ADJ
bam-9165	47	65	acute	acute	ADJ
bam-9165	47	66	lung	lung	NOUN
bam-9165	47	67	injury	injury	PROPN
bam-9165	47	68	/	/	SYM
bam-9165	47	69	early	early	ADJ
bam-9165	47	70	acute	acute	ADJ
bam-9165	47	71	respiratory	respiratory	ADJ
bam-9165	47	72	distress	distress	NOUN
bam-9165	47	73	syndrome	syndrome	NOUN
bam-9165	47	74	;	;	PUNCT
bam-9165	47	75	or	or	CCONJ
bam-9165	47	76	ii	ii	X
bam-9165	47	77	)	)	PUNCT
bam-9165	47	78	severe	severe	ADJ
bam-9165	47	79	health	health	NOUN
bam-9165	47	80	condition	condition	NOUN
bam-9165	47	81	characterized	characterize	VERB
bam-9165	47	82	by:35	by:35	PROPN
bam-9165	47	83	respiratory	respiratory	ADJ
bam-9165	47	84	embarrassment	embarrassment	NOUN
bam-9165	47	85	;	;	PUNCT
bam-9165	48	1	respiratory	respiratory	ADJ
bam-9165	48	2	rate	rate	NOUN
bam-9165	48	3	≥	≥	NOUN
bam-9165	48	4	30	30	NUM
bam-9165	48	5	/	/	SYM
bam-9165	48	6	min	min	NOUN
bam-9165	48	7	;	;	PUNCT
bam-9165	48	8	spo2	spo2	PROPN
bam-9165	48	9	level	level	NOUN
bam-9165	48	10	≤	≤	NUM
bam-9165	48	11	93	93	NUM
bam-9165	48	12	%	%	NOUN
bam-9165	48	13	;	;	PUNCT
bam-9165	48	14	oxygenation	oxygenation	NOUN
bam-9165	48	15	(	(	PUNCT
bam-9165	48	16	respiratory	respiratory	ADJ
bam-9165	48	17	)	)	PUNCT
bam-9165	48	18	index	index	NOUN
bam-9165	48	19	<	<	NOUN
bam-9165	48	20	300	300	NUM
bam-9165	48	21	,	,	PUNCT
bam-9165	48	22	and/or	and/or	CCONJ
bam-9165	48	23	increase	increase	VERB
bam-9165	48	24	in	in	ADP
bam-9165	48	25	lung	lung	NOUN
bam-9165	48	26	infiltrates	infiltrate	NOUN
bam-9165	48	27	>	>	PUNCT
bam-9165	48	28	50	50	NUM
bam-9165	48	29	%	%	NOUN
bam-9165	48	30	within	within	ADP
bam-9165	48	31	24–48	24–48	NUM
bam-9165	48	32	hours	hour	NOUN
bam-9165	48	33	;	;	PUNCT
bam-9165	48	34	iii	iii	X
bam-9165	48	35	)	)	PUNCT
bam-9165	48	36	critical	critical	ADJ
bam-9165	48	37	health	health	NOUN
bam-9165	48	38	condition	condition	NOUN
bam-9165	48	39	,	,	PUNCT
bam-9165	48	40	determined	determine	VERB
bam-9165	48	41	by	by	ADP
bam-9165	48	42	:	:	PUNCT
bam-9165	48	43	respiratory	respiratory	ADJ
bam-9165	48	44	failure	failure	NOUN
bam-9165	48	45	;	;	PUNCT
bam-9165	48	46	toxic	toxic	ADJ
bam-9165	48	47	shock	shock	NOUN
bam-9165	48	48	syndrome	syndrome	NOUN
bam-9165	48	49	and/or	and/or	CCONJ
bam-9165	48	50	multiple	multiple	ADJ
bam-9165	48	51	organ	organ	NOUN
bam-9165	48	52	dysfunction	dysfunction	NOUN
bam-9165	48	53	.	.	PUNCT
bam-9165	49	1	the	the	DET
bam-9165	49	2	issue	issue	NOUN
bam-9165	49	3	of	of	ADP
bam-9165	49	4	using	use	VERB
bam-9165	49	5	plasmapheresis	plasmapheresis	NOUN
bam-9165	49	6	technologies	technology	NOUN
bam-9165	49	7	was	be	AUX
bam-9165	49	8	also	also	ADV
bam-9165	49	9	addressed	address	VERB
bam-9165	49	10	in	in	ADP
bam-9165	49	11	the	the	DET
bam-9165	49	12	russian	russian	PROPN
bam-9165	49	13	federation	federation	PROPN
bam-9165	49	14	.	.	PUNCT
bam-9165	50	1	thus	thus	ADV
bam-9165	50	2	,	,	PUNCT
bam-9165	50	3	the	the	DET
bam-9165	50	4	scientific	scientific	ADJ
bam-9165	50	5	society	society	NOUN
bam-9165	50	6	of	of	ADP
bam-9165	50	7	experts	expert	NOUN
bam-9165	50	8	of	of	ADP
bam-9165	50	9	extracorporeal	extracorporeal	ADJ
bam-9165	50	10	blood	blood	NOUN
bam-9165	50	11	treatment	treatment	NOUN
bam-9165	50	12	in	in	ADP
bam-9165	50	13	intensive	intensive	ADJ
bam-9165	50	14	carepresented	carepresente	VERB
bam-9165	50	15	interim	interim	ADJ
bam-9165	50	16	recommendations	recommendation	NOUN
bam-9165	50	17	“	"	PUNCT
bam-9165	50	18	on	on	ADP
bam-9165	50	19	the	the	DET
bam-9165	50	20	use	use	NOUN
bam-9165	50	21	of	of	ADP
bam-9165	50	22	methods	method	NOUN
bam-9165	50	23	of	of	ADP
bam-9165	50	24	extracorporeal	extracorporeal	ADJ
bam-9165	50	25	haemocorrection	haemocorrection	NOUN
bam-9165	50	26	in	in	ADP
bam-9165	50	27	the	the	DET
bam-9165	50	28	complex	complex	ADJ
bam-9165	50	29	treatment	treatment	NOUN
bam-9165	50	30	of	of	ADP
bam-9165	50	31	patients	patient	NOUN
bam-9165	50	32	with	with	ADP
bam-9165	50	33	new	new	ADJ
bam-9165	50	34	coronavirus	coronavirus	NOUN
bam-9165	50	35	disease	disease	NOUN
bam-9165	50	36	covid-19	covid-19	PROPN
bam-9165	50	37	”	"	PUNCT
bam-9165	50	38	.	.	PUNCT
bam-9165	51	1	according	accord	VERB
bam-9165	51	2	to	to	ADP
bam-9165	51	3	these	these	DET
bam-9165	51	4	recommendations	recommendation	NOUN
bam-9165	51	5	,	,	PUNCT
bam-9165	51	6	a	a	DET
bam-9165	51	7	key	key	ADJ
bam-9165	51	8	point	point	NOUN
bam-9165	51	9	of	of	ADP
bam-9165	51	10	reaching	reach	VERB
bam-9165	51	11	the	the	DET
bam-9165	51	12	maximum	maximum	ADJ
bam-9165	51	13	efficiency	efficiency	NOUN
bam-9165	51	14	of	of	ADP
bam-9165	51	15	the	the	DET
bam-9165	51	16	extracorporeal	extracorporeal	NOUN
bam-9165	51	17	haemocorrection	haemocorrection	NOUN
bam-9165	51	18	technique	technique	NOUN
bam-9165	51	19	is	be	AUX
bam-9165	51	20	its	its	PRON
bam-9165	51	21	early	early	ADJ
bam-9165	51	22	application	application	NOUN
bam-9165	51	23	,	,	PUNCT
bam-9165	51	24	namely	namely	ADV
bam-9165	51	25	,	,	PUNCT
bam-9165	51	26	during	during	ADP
bam-9165	51	27	the	the	DET
bam-9165	51	28	early	early	ADJ
bam-9165	51	29	stages	stage	NOUN
bam-9165	51	30	of	of	ADP
bam-9165	51	31	clinical	clinical	ADJ
bam-9165	51	32	and	and	CCONJ
bam-9165	51	33	laboratory	laboratory	NOUN
bam-9165	51	34	manifestation	manifestation	NOUN
bam-9165	51	35	of	of	ADP
bam-9165	51	36	cytokine	cytokine	ADJ
bam-9165	51	37	storm	storm	NOUN
bam-9165	51	38	syndrome	syndrome	NOUN
bam-9165	51	39	and	and	CCONJ
bam-9165	51	40	multiple	multiple	ADJ
bam-9165	51	41	organ	organ	NOUN
bam-9165	51	42	dysfunction	dysfunction	NOUN
bam-9165	51	43	.	.	PUNCT
bam-9165	52	1	below	below	ADP
bam-9165	52	2	are	be	AUX
bam-9165	52	3	indications	indication	NOUN
bam-9165	52	4	for	for	ADP
bam-9165	52	5	an	an	DET
bam-9165	52	6	urgent	urgent	ADJ
bam-9165	52	7	start	start	NOUN
bam-9165	52	8	of	of	ADP
bam-9165	52	9	extracorporeal	extracorporeal	NOUN
bam-9165	52	10	treatment	treatment	NOUN
bam-9165	52	11	(	(	PUNCT
bam-9165	52	12	figure	figure	NOUN
bam-9165	52	13	2	2	NUM
bam-9165	52	14	):	):	PUNCT
bam-9165	52	15			NOUN
bam-9165	52	16	clinical	clinical	ADJ
bam-9165	52	17	signs	sign	NOUN
bam-9165	52	18	of	of	ADP
bam-9165	52	19	progressive	progressive	ADJ
bam-9165	52	20	respiratory	respiratory	ADJ
bam-9165	52	21	failure	failure	NOUN
bam-9165	52	22	;	;	PUNCT
bam-9165	52	23			DET
bam-9165	52	24	signs	sign	NOUN
bam-9165	52	25	of	of	ADP
bam-9165	52	26	severe	severe	ADJ
bam-9165	52	27	coronavirus	coronavirus	NOUN
bam-9165	52	28	infection	infection	NOUN
bam-9165	52	29	(	(	PUNCT
bam-9165	52	30	respiration	respiration	NOUN
bam-9165	52	31	rate	rate	NOUN
bam-9165	52	32	≥	≥	NOUN
bam-9165	52	33	30	30	NUM
bam-9165	52	34	/	/	SYM
bam-9165	52	35	min	min	NOUN
bam-9165	52	36	and/or	and/or	CCONJ
bam-9165	52	37	blood	blood	NOUN
bam-9165	52	38	oxygen	oxygen	NOUN
bam-9165	52	39	saturation	saturation	NOUN
bam-9165	52	40	≤	≤	NOUN
bam-9165	52	41	93	93	NUM
bam-9165	52	42	%	%	NOUN
bam-9165	52	43	and/or	and/or	CCONJ
bam-9165	52	44	po2	po2	PROPN
bam-9165	52	45	/	/	SYM
bam-9165	52	46	fio2	fio2	PROPN
bam-9165	52	47	index	index	NOUN
bam-9165	52	48	≤	≤	NOUN
bam-9165	52	49	200	200	NUM
bam-9165	52	50	mm	mm	NUM
bam-9165	52	51	hg	hg	NOUN
bam-9165	52	52	)	)	PUNCT
bam-9165	52	53	;	;	PUNCT
bam-9165	52	54			PRON
bam-9165	52	55	progression	progression	NOUN
bam-9165	52	56	of	of	ADP
bam-9165	52	57	lung	lung	NOUN
bam-9165	52	58	damage	damage	NOUN
bam-9165	52	59	at	at	ADP
bam-9165	52	60	the	the	DET
bam-9165	52	61	rate	rate	NOUN
bam-9165	52	62	of	of	ADP
bam-9165	52	63	≥10	≥10	NOUN
bam-9165	52	64	%	%	NOUN
bam-9165	52	65	per	per	ADP
bam-9165	52	66	day	day	NOUN
bam-9165	52	67	,	,	PUNCT
bam-9165	52	68	identified	identify	VERB
bam-9165	52	69	using	use	VERB
bam-9165	52	70	one	one	NUM
bam-9165	52	71	of	of	ADP
bam-9165	52	72	the	the	DET
bam-9165	52	73	imaging	imaging	NOUN
bam-9165	52	74	methods	method	NOUN
bam-9165	52	75	;	;	PUNCT
bam-9165	52	76			NOUN
bam-9165	52	77	progressive	progressive	ADJ
bam-9165	52	78	increase	increase	NOUN
bam-9165	52	79	in	in	ADP
bam-9165	52	80	inflammatory	inflammatory	ADJ
bam-9165	52	81	marker	marker	NOUN
bam-9165	52	82	levels	level	NOUN
bam-9165	52	83	(	(	PUNCT
bam-9165	52	84	crb	crb	PROPN
bam-9165	52	85	,	,	PUNCT
bam-9165	52	86	il-6	il-6	NUM
bam-9165	52	87	etc	etc	X
bam-9165	52	88	.	.	PUNCT
bam-9165	52	89	)	)	PUNCT
bam-9165	53	1	following	follow	VERB
bam-9165	53	2	these	these	DET
bam-9165	53	3	recommendations	recommendation	NOUN
bam-9165	53	4	,	,	PUNCT
bam-9165	53	5	the	the	DET
bam-9165	53	6	choice	choice	NOUN
bam-9165	53	7	of	of	ADP
bam-9165	53	8	extracorporeal	extracorporeal	ADJ
bam-9165	53	9	haemocorrection	haemocorrection	NOUN
bam-9165	53	10	method	method	NOUN
bam-9165	53	11	depends	depend	VERB
bam-9165	53	12	the	the	DET
bam-9165	53	13	basic	basic	ADJ
bam-9165	53	14	operating	operate	VERB
bam-9165	53	15	principles	principle	NOUN
bam-9165	53	16	of	of	ADP
bam-9165	53	17	plasmapheresis	plasmapheresis	NOUN
bam-9165	53	18	methods	method	NOUN
bam-9165	53	19	in	in	ADP
bam-9165	53	20	patients	patient	NOUN
bam-9165	53	21	with	with	ADP
bam-9165	53	22	severe	severe	ADJ
bam-9165	53	23	form	form	NOUN
bam-9165	53	24	of	of	ADP
bam-9165	53	25	covid-19	covid-19	PROPN
bam-9165	53	26	mainly	mainly	ADV
bam-9165	53	27	include	include	VERB
bam-9165	53	28	the	the	DET
bam-9165	53	29	following:8,31,32	following:8,31,32	NOUN
bam-9165	53	30			NOUN
bam-9165	53	31	removing	remove	VERB
bam-9165	53	32	pathogenic	pathogenic	ADJ
bam-9165	53	33	circulating	circulate	VERB
bam-9165	53	34	molecules	molecule	NOUN
bam-9165	53	35	,	,	PUNCT
bam-9165	53	36	inflammatory	inflammatory	ADJ
bam-9165	53	37	cytokines	cytokine	NOUN
bam-9165	53	38	;	;	PUNCT
bam-9165	54	1			PRON
bam-9165	54	2	removing	remove	VERB
bam-9165	54	3	metabolic	metabolic	NOUN
bam-9165	54	4	products	product	NOUN
bam-9165	54	5	such	such	ADJ
bam-9165	54	6	as	as	ADP
bam-9165	54	7	creatinine	creatinine	NOUN
bam-9165	54	8	,	,	PUNCT
bam-9165	54	9	urea	urea	NOUN
bam-9165	54	10	nitrogen	nitrogen	NOUN
bam-9165	54	11	;	;	PUNCT
bam-9165	54	12			NOUN
bam-9165	54	13	maintaining	maintain	VERB
bam-9165	54	14	hemodynamic	hemodynamic	ADJ
bam-9165	54	15	stability	stability	NOUN
bam-9165	54	16	in	in	ADP
bam-9165	54	17	the	the	DET
bam-9165	54	18	organism	organism	NOUN
bam-9165	54	19	;	;	PUNCT
bam-9165	54	20			PUNCT
bam-9165	54	21	correction	correction	NOUN
bam-9165	54	22	of	of	ADP
bam-9165	54	23	blood	blood	NOUN
bam-9165	54	24	rheological	rheological	ADJ
bam-9165	54	25	disorders	disorder	NOUN
bam-9165	54	26	;	;	PUNCT
bam-9165	54	27			PUNCT
bam-9165	54	28	correction	correction	NOUN
bam-9165	54	29	of	of	ADP
bam-9165	54	30	electrolyte	electrolyte	NOUN
bam-9165	54	31	and	and	CCONJ
bam-9165	54	32	acid	acid	ADJ
bam-9165	54	33	-	-	PUNCT
bam-9165	54	34	alkaline	alkaline	NOUN
bam-9165	54	35	balance	balance	NOUN
bam-9165	54	36	disorders	disorder	NOUN
bam-9165	54	37	to	to	PART
bam-9165	54	38	maintain	maintain	VERB
bam-9165	54	39	stability	stability	NOUN
bam-9165	54	40	of	of	ADP
bam-9165	54	41	internal	internal	ADJ
bam-9165	54	42	environment	environment	NOUN
bam-9165	54	43	fig	fig	NOUN
bam-9165	54	44	1	1	NUM
bam-9165	54	45	.	.	PUNCT
bam-9165	54	46	operating	operate	VERB
bam-9165	54	47	principles	principle	NOUN
bam-9165	54	48	of	of	ADP
bam-9165	54	49	plasmapheresis	plasmapheresis	NOUN
bam-9165	54	50	methods	method	NOUN
bam-9165	54	51	indications	indication	NOUN
bam-9165	54	52	for	for	ADP
bam-9165	54	53	an	an	DET
bam-9165	54	54	urgent	urgent	ADJ
bam-9165	54	55	start	start	NOUN
bam-9165	54	56	of	of	ADP
bam-9165	54	57	treatment	treatment	NOUN
bam-9165	54	58	:	:	PUNCT
bam-9165	54	59			X
bam-9165	54	60	clinical	clinical	ADJ
bam-9165	54	61	signs	sign	NOUN
bam-9165	54	62	of	of	ADP
bam-9165	54	63	progressive	progressive	ADJ
bam-9165	54	64	respiratory	respiratory	ADJ
bam-9165	54	65	failure	failure	NOUN
bam-9165	54	66	;	;	PUNCT
bam-9165	54	67			DET
bam-9165	54	68	signs	sign	NOUN
bam-9165	54	69	of	of	ADP
bam-9165	54	70	severe	severe	ADJ
bam-9165	54	71	coronavirus	coronavirus	NOUN
bam-9165	54	72	infection	infection	NOUN
bam-9165	54	73	(	(	PUNCT
bam-9165	54	74	respiration	respiration	NOUN
bam-9165	54	75	rate	rate	NOUN
bam-9165	54	76	≥	≥	NOUN
bam-9165	54	77	30	30	NUM
bam-9165	54	78	/	/	SYM
bam-9165	54	79	min	min	NOUN
bam-9165	54	80	and/or	and/or	CCONJ
bam-9165	54	81	blood	blood	NOUN
bam-9165	54	82	oxygen	oxygen	NOUN
bam-9165	54	83	saturation	saturation	NOUN
bam-9165	54	84	≥	≥	NUM
bam-9165	54	85	93	93	NUM
bam-9165	54	86	%	%	NOUN
bam-9165	54	87	and/or	and/or	CCONJ
bam-9165	54	88	po2	po2	PROPN
bam-9165	54	89	/	/	SYM
bam-9165	54	90	fio2	fio2	PROPN
bam-9165	54	91	index	index	NOUN
bam-9165	54	92	≥	≥	NUM
bam-9165	54	93	200	200	NUM
bam-9165	54	94	mm	mm	NUM
bam-9165	54	95	hg	hg	NOUN
bam-9165	54	96	)	)	PUNCT
bam-9165	54	97	;	;	PUNCT
bam-9165	54	98			DET
bam-9165	54	99	progression	progression	NOUN
bam-9165	54	100	of	of	ADP
bam-9165	54	101	lung	lung	NOUN
bam-9165	54	102	damage	damage	NOUN
bam-9165	54	103	at	at	ADP
bam-9165	54	104	the	the	DET
bam-9165	54	105	rate	rate	NOUN
bam-9165	54	106	of	of	ADP
bam-9165	54	107	≥10	≥10	NOUN
bam-9165	54	108	%	%	NOUN
bam-9165	54	109	per	per	ADP
bam-9165	54	110	day	day	NOUN
bam-9165	54	111	,	,	PUNCT
bam-9165	54	112	identified	identify	VERB
bam-9165	54	113	using	use	VERB
bam-9165	54	114	one	one	NUM
bam-9165	54	115	of	of	ADP
bam-9165	54	116	the	the	DET
bam-9165	54	117	imaging	imaging	NOUN
bam-9165	54	118	methods	method	NOUN
bam-9165	54	119	;	;	PUNCT
bam-9165	54	120			NOUN
bam-9165	54	121	progressive	progressive	ADJ
bam-9165	54	122	increase	increase	NOUN
bam-9165	54	123	of	of	ADP
bam-9165	54	124	inflammatory	inflammatory	ADJ
bam-9165	54	125	marker	marker	NOUN
bam-9165	54	126	levels	level	NOUN
bam-9165	54	127	fig	fig	VERB
bam-9165	54	128	2	2	NUM
bam-9165	54	129	.	.	PUNCT
bam-9165	55	1	the	the	DET
bam-9165	55	2	choice	choice	NOUN
bam-9165	55	3	of	of	ADP
bam-9165	55	4	methods	method	NOUN
bam-9165	55	5	depends	depend	VERB
bam-9165	55	6	primarily	primarily	ADV
bam-9165	55	7	on	on	ADP
bam-9165	55	8	the	the	DET
bam-9165	55	9	capabilities	capability	NOUN
bam-9165	55	10	of	of	ADP
bam-9165	55	11	the	the	DET
bam-9165	55	12	medical	medical	ADJ
bam-9165	55	13	staff	staff	NOUN
bam-9165	55	14	plasmapheresis	plasmapheresis	NOUN
bam-9165	55	15	methods	method	NOUN
bam-9165	55	16	for	for	ADP
bam-9165	55	17	covid-19	covid-19	PROPN
bam-9165	55	18	eur	eur	PROPN
bam-9165	55	19	j	j	PROPN
bam-9165	55	20	transl	transl	PROPN
bam-9165	55	21	myol	myol	NOUN
bam-9165	55	22	2020	2020	NUM
bam-9165	55	23	;	;	PUNCT
bam-9165	55	24	30	30	NUM
bam-9165	55	25	(	(	PUNCT
bam-9165	55	26	3	3	NUM
bam-9165	55	27	):	):	PUNCT
bam-9165	55	28	9165	9165	NUM
bam-9165	55	29	.	.	PUNCT
bam-9165	56	1	doi	doi	NOUN
bam-9165	56	2	:	:	PUNCT
bam-9165	56	3	10.4081	10.4081	NUM
bam-9165	56	4	/	/	SYM
bam-9165	56	5	ejtm.2020.9165	ejtm.2020.9165	VERB
bam-9165	56	6	4	4	NUM
bam-9165	56	7	primarily	primarily	ADV
bam-9165	56	8	on	on	ADP
bam-9165	56	9	the	the	DET
bam-9165	56	10	capabilities	capability	NOUN
bam-9165	56	11	of	of	ADP
bam-9165	56	12	the	the	DET
bam-9165	56	13	medical	medical	ADJ
bam-9165	56	14	staff	staff	NOUN
bam-9165	56	15	as	as	ADV
bam-9165	56	16	well	well	ADV
bam-9165	56	17	as	as	ADP
bam-9165	56	18	on	on	ADP
bam-9165	56	19	the	the	DET
bam-9165	56	20	clinical	clinical	ADJ
bam-9165	56	21	situation	situation	NOUN
bam-9165	56	22	presented.36	presented.36	NOUN
bam-9165	56	23	in	in	ADP
bam-9165	56	24	conclusion	conclusion	NOUN
bam-9165	56	25	,	,	PUNCT
bam-9165	56	26	there	there	PRON
bam-9165	56	27	is	be	VERB
bam-9165	56	28	a	a	DET
bam-9165	56	29	need	need	NOUN
bam-9165	56	30	for	for	ADP
bam-9165	56	31	more	more	ADJ
bam-9165	56	32	statistical	statistical	ADJ
bam-9165	56	33	data	datum	NOUN
bam-9165	56	34	and	and	CCONJ
bam-9165	56	35	,	,	PUNCT
bam-9165	56	36	consequently	consequently	ADV
bam-9165	56	37	,	,	PUNCT
bam-9165	56	38	for	for	ADP
bam-9165	56	39	carefully	carefully	ADV
bam-9165	56	40	planned	plan	VERB
bam-9165	56	41	clinical	clinical	ADJ
bam-9165	56	42	tests	test	NOUN
bam-9165	56	43	to	to	PART
bam-9165	56	44	further	far	ADV
bam-9165	56	45	evaluate	evaluate	VERB
bam-9165	56	46	effectiveness	effectiveness	NOUN
bam-9165	56	47	and	and	CCONJ
bam-9165	56	48	safety	safety	NOUN
bam-9165	56	49	of	of	ADP
bam-9165	56	50	plasmapheresis	plasmapheresis	NOUN
bam-9165	56	51	treatment	treatment	NOUN
bam-9165	56	52	and	and	CCONJ
bam-9165	56	53	of	of	ADP
bam-9165	56	54	the	the	DET
bam-9165	56	55	combined	combine	VERB
bam-9165	56	56	techniques	technique	NOUN
bam-9165	56	57	described	describe	VERB
bam-9165	56	58	in	in	ADP
bam-9165	56	59	this	this	DET
bam-9165	56	60	narrative	narrative	NOUN
bam-9165	56	61	review	review	NOUN
bam-9165	56	62	.	.	PUNCT
bam-9165	57	1	list	list	NOUN
bam-9165	57	2	of	of	ADP
bam-9165	57	3	acronyms	acronym	NOUN
bam-9165	57	4	ards	ard	NOUN
bam-9165	57	5	acute	acute	ADJ
bam-9165	57	6	respiratory	respiratory	ADJ
bam-9165	57	7	distress	distress	NOUN
bam-9165	57	8	syndrome	syndrome	PROPN
bam-9165	57	9	covid-19	covid-19	PROPN
bam-9165	57	10	coronavirus	coronavirus	NOUN
bam-9165	57	11	disease	disease	NOUN
bam-9165	57	12	2019	2019	NUM
bam-9165	57	13	crp	crp	PROPN
bam-9165	57	14	c	c	NOUN
bam-9165	57	15	-	-	ADJ
bam-9165	57	16	reactive	reactive	ADJ
bam-9165	57	17	protein	protein	NOUN
bam-9165	57	18	ictv	ictv	PROPN
bam-9165	57	19	international	international	PROPN
bam-9165	57	20	committee	committee	NOUN
bam-9165	57	21	on	on	ADP
bam-9165	57	22	taxonomy	taxonomy	NOUN
bam-9165	57	23	of	of	ADP
bam-9165	57	24	viruses	virus	NOUN
bam-9165	57	25	mods	mod	NOUN
bam-9165	57	26	multiple	multiple	ADJ
bam-9165	57	27	organ	organ	NOUN
bam-9165	57	28	dysfunction	dysfunction	NOUN
bam-9165	57	29	syndrome	syndrome	NOUN
bam-9165	57	30	sars	sar	NOUN
bam-9165	57	31	-	-	PUNCT
bam-9165	57	32	cov-2	cov-2	NOUN
bam-9165	57	33	severe	severe	ADJ
bam-9165	57	34	acute	acute	ADJ
bam-9165	57	35	respiratory	respiratory	ADJ
bam-9165	57	36	syndrome	syndrome	NOUN
bam-9165	57	37	coronavirus	coronavirus	NOUN
bam-9165	57	38	2	2	NUM
bam-9165	57	39	authors	author	NOUN
bam-9165	57	40	contributions	contribution	NOUN
bam-9165	57	41	ilmira	ilmira	PROPN
bam-9165	57	42	r.	r.	PROPN
bam-9165	57	43	gilmutdinova	gilmutdinova	PROPN
bam-9165	57	44	,	,	PUNCT
bam-9165	57	45	yu	yu	PROPN
bam-9165	57	46	m.	m.	PROPN
bam-9165	57	47	yakovlev	yakovlev	PROPN
bam-9165	57	48	,	,	PUNCT
bam-9165	57	49	petr	petr	PROPN
bam-9165	57	50	s.	s.	PROPN
bam-9165	57	51	eremin	eremin	VERB
bam-9165	57	52	and	and	CCONJ
bam-9165	57	53	anatoliy	anatoliy	PROPN
bam-9165	57	54	d.	d.	PROPN
bam-9165	57	55	fesun	fesun	PROPN
bam-9165	57	56	have	have	AUX
bam-9165	57	57	contributed	contribute	VERB
bam-9165	57	58	equally	equally	ADV
bam-9165	57	59	to	to	ADP
bam-9165	57	60	this	this	DET
bam-9165	57	61	work	work	NOUN
bam-9165	57	62	.	.	PUNCT
bam-9165	58	1	acknowledgments	acknowledgment	NOUN
bam-9165	58	2	the	the	DET
bam-9165	58	3	authors	author	NOUN
bam-9165	58	4	thank	thank	VERB
bam-9165	58	5	the	the	DET
bam-9165	58	6	a&c	a&c	PROPN
bam-9165	58	7	m	m	PROPN
bam-9165	58	8	-	-	PROPN
bam-9165	58	9	c	c	PROPN
bam-9165	58	10	foundation	foundation	NOUN
bam-9165	58	11	for	for	ADP
bam-9165	58	12	translational	translational	ADJ
bam-9165	58	13	myology	myology	NOUN
bam-9165	58	14	,	,	PUNCT
bam-9165	58	15	padova	padova	PROPN
bam-9165	58	16	,	,	PUNCT
bam-9165	58	17	italy	italy	PROPN
bam-9165	58	18	and	and	CCONJ
bam-9165	58	19	the	the	DET
bam-9165	58	20	federal	federal	ADJ
bam-9165	58	21	state	state	NOUN
bam-9165	58	22	budgetary	budgetary	ADJ
bam-9165	58	23	institution	institution	NOUN
bam-9165	58	24	“	"	PUNCT
bam-9165	58	25	national	national	PROPN
bam-9165	58	26	medical	medical	ADJ
bam-9165	58	27	research	research	NOUN
bam-9165	58	28	centre	centre	NOUN
bam-9165	58	29	for	for	ADP
bam-9165	58	30	rehabilitation	rehabilitation	NOUN
bam-9165	58	31	and	and	CCONJ
bam-9165	58	32	balneology	balneology	NOUN
bam-9165	58	33	”	"	PUNCT
bam-9165	58	34	of	of	ADP
bam-9165	58	35	the	the	DET
bam-9165	58	36	ministry	ministry	PROPN
bam-9165	58	37	of	of	ADP
bam-9165	58	38	health	health	PROPN
bam-9165	58	39	of	of	ADP
bam-9165	58	40	russia	russia	PROPN
bam-9165	58	41	,	,	PUNCT
bam-9165	58	42	moscow	moscow	PROPN
bam-9165	58	43	,	,	PUNCT
bam-9165	58	44	russia	russia	PROPN
bam-9165	58	45	for	for	ADP
bam-9165	58	46	supporting	support	VERB
bam-9165	58	47	this	this	DET
bam-9165	58	48	publication	publication	NOUN
bam-9165	58	49	.	.	PUNCT
bam-9165	59	1	funding	fund	VERB
bam-9165	59	2	none	none	NOUN
bam-9165	59	3	conflict	conflict	NOUN
bam-9165	59	4	of	of	ADP
bam-9165	59	5	interest	interest	NOUN
bam-9165	59	6	the	the	DET
bam-9165	59	7	authors	author	NOUN
bam-9165	59	8	declare	declare	VERB
bam-9165	59	9	they	they	PRON
bam-9165	59	10	have	have	VERB
bam-9165	59	11	no	no	DET
bam-9165	59	12	financial	financial	ADJ
bam-9165	59	13	,	,	PUNCT
bam-9165	59	14	personal	personal	ADJ
bam-9165	59	15	,	,	PUNCT
bam-9165	59	16	or	or	CCONJ
bam-9165	59	17	other	other	ADJ
bam-9165	59	18	conflicts	conflict	NOUN
bam-9165	59	19	of	of	ADP
bam-9165	59	20	interest	interest	NOUN
bam-9165	59	21	.	.	PUNCT
bam-9165	60	1	ethical	ethical	ADJ
bam-9165	60	2	publication	publication	NOUN
bam-9165	60	3	statement	statement	NOUN
bam-9165	60	4	we	we	PRON
bam-9165	60	5	confirm	confirm	VERB
bam-9165	60	6	that	that	SCONJ
bam-9165	60	7	we	we	PRON
bam-9165	60	8	have	have	AUX
bam-9165	60	9	read	read	VERB
bam-9165	60	10	the	the	DET
bam-9165	60	11	journal	journal	NOUN
bam-9165	60	12	’s	’s	PART
bam-9165	60	13	position	position	NOUN
bam-9165	60	14	on	on	ADP
bam-9165	60	15	issues	issue	NOUN
bam-9165	60	16	involved	involve	VERB
bam-9165	60	17	in	in	ADP
bam-9165	60	18	ethical	ethical	ADJ
bam-9165	60	19	publication	publication	NOUN
bam-9165	60	20	and	and	CCONJ
bam-9165	60	21	affirm	affirm	NOUN
bam-9165	60	22	that	that	SCONJ
bam-9165	60	23	this	this	DET
bam-9165	60	24	report	report	NOUN
bam-9165	60	25	is	be	AUX
bam-9165	60	26	consistent	consistent	ADJ
bam-9165	60	27	with	with	ADP
bam-9165	60	28	those	those	DET
bam-9165	60	29	guidelines	guideline	NOUN
bam-9165	60	30	.	.	PUNCT
bam-9165	61	1	corresponding	correspond	VERB
bam-9165	61	2	author	author	NOUN
bam-9165	61	3	gilmutdinova	gilmutdinova	PROPN
bam-9165	61	4	ilmira	ilmira	PROPN
bam-9165	61	5	r.	r.	PROPN
bam-9165	61	6	,	,	PUNCT
bam-9165	61	7	federal	federal	ADJ
bam-9165	61	8	state	state	NOUN
bam-9165	61	9	budgetary	budgetary	ADJ
bam-9165	61	10	institution	institution	NOUN
bam-9165	61	11	“	"	PUNCT
bam-9165	61	12	national	national	PROPN
bam-9165	61	13	medical	medical	ADJ
bam-9165	61	14	research	research	NOUN
bam-9165	61	15	centre	centre	NOUN
bam-9165	61	16	for	for	ADP
bam-9165	61	17	rehabilitation	rehabilitation	NOUN
bam-9165	61	18	and	and	CCONJ
bam-9165	61	19	balneology	balneology	NOUN
bam-9165	61	20	”	"	PUNCT
bam-9165	61	21	of	of	ADP
bam-9165	61	22	the	the	DET
bam-9165	61	23	ministry	ministry	PROPN
bam-9165	61	24	of	of	ADP
bam-9165	61	25	health	health	PROPN
bam-9165	61	26	of	of	ADP
bam-9165	61	27	russia	russia	PROPN
bam-9165	61	28	,	,	PUNCT
bam-9165	61	29	moscow	moscow	PROPN
bam-9165	61	30	,	,	PUNCT
bam-9165	61	31	russia	russia	PROPN
bam-9165	61	32	.	.	PUNCT
bam-9165	62	1	orcid	orcid	PROPN
bam-9165	63	1	i	i	PRON
bam-9165	63	2	d	d	NOUN
bam-9165	63	3	:	:	PUNCT
bam-9165	63	4	0000	0000	NUM
bam-9165	63	5	-	-	PUNCT
bam-9165	63	6	0001	0001	NUM
bam-9165	63	7	-	-	PUNCT
bam-9165	63	8	6743	6743	NUM
bam-9165	63	9	-	-	PUNCT
bam-9165	63	10	2615	2615	NUM
bam-9165	63	11	email	email	NOUN
bam-9165	63	12	:	:	PUNCT
bam-9165	63	13	gilm.ilmira@mail.ru	gilm.ilmira@mail.ru	VERB
bam-9165	63	14	emails	email	NOUN
bam-9165	63	15	and	and	CCONJ
bam-9165	63	16	orcid	orcid	NOUN
bam-9165	64	1	i	i	INTJ
bam-9165	64	2	d	d	PROPN
bam-9165	64	3	of	of	ADP
bam-9165	64	4	coauthors	coauthors	PROPN
bam-9165	64	5	maksim	maksim	PROPN
bam-9165	64	6	yu	yu	PROPN
bam-9165	64	7	.	.	PROPN
bam-9165	64	8	yakovlev	yakovlev	PROPN
bam-9165	64	9	:	:	PUNCT
bam-9165	65	1	masdat@mail.ru	masdat@mail.ru	PROPN
bam-9165	65	2	orcid	orcid	NOUN
bam-9165	66	1	i	i	PRON
bam-9165	66	2	d	d	NOUN
bam-9165	66	3	:	:	PUNCT
bam-9165	66	4	0000	0000	NUM
bam-9165	66	5	-	-	PUNCT
bam-9165	66	6	0002	0002	NUM
bam-9165	66	7	-	-	PUNCT
bam-9165	66	8	5260	5260	NUM
bam-9165	66	9	-	-	SYM
bam-9165	66	10	8304	8304	NUM
bam-9165	66	11	petr	petr	PROPN
bam-9165	66	12	s	s	PROPN
bam-9165	66	13	eremin	eremin	PROPN
bam-9165	66	14	:	:	PUNCT
bam-9165	67	1	ereminps@gmail.com	ereminps@gmail.com	X
bam-9165	67	2	orcid	orcid	NOUN
bam-9165	68	1	i	i	PRON
bam-9165	68	2	d	d	NOUN
bam-9165	68	3	:	:	PUNCT
bam-9165	68	4	0000	0000	NUM
bam-9165	68	5	-	-	PUNCT
bam-9165	68	6	0001	0001	NUM
bam-9165	68	7	-	-	PUNCT
bam-9165	68	8	8832	8832	NUM
bam-9165	68	9	-	-	SYM
bam-9165	68	10	8470	8470	NUM
bam-9165	68	11	anatoliy	anatoliy	VERB
bam-9165	68	12	d	d	X
bam-9165	68	13	fesun	fesun	NOUN
bam-9165	68	14	:	:	PUNCT
bam-9165	68	15	nmicrk@nmicrk.ru	nmicrk@nmicrk.ru	PROPN
bam-9165	68	16	orcid	orcid	NOUN
bam-9165	69	1	i	i	NOUN
bam-9165	69	2	d	d	NOUN
bam-9165	69	3	:	:	PUNCT
bam-9165	69	4	0000	0000	NUM
bam-9165	69	5	-	-	PUNCT
bam-9165	69	6	0003	0003	NUM
bam-9165	69	7	-	-	PUNCT
bam-9165	69	8	3097	3097	NUM
bam-9165	69	9	-	-	PUNCT
bam-9165	69	10	8889	8889	NUM
bam-9165	69	11	references	reference	NOUN
bam-9165	69	12	1	1	NUM
bam-9165	69	13	.	.	PUNCT
bam-9165	70	1	ma	ma	PROPN
bam-9165	70	2	j	j	PROPN
bam-9165	70	3	,	,	PUNCT
bam-9165	70	4	xia	xia	PROPN
bam-9165	71	1	p	p	PROPN
bam-9165	71	2	,	,	PUNCT
bam-9165	71	3	zhou	zhou	PROPN
bam-9165	71	4	y	y	PROPN
bam-9165	71	5	,	,	PUNCT
bam-9165	71	6	et	et	PROPN
bam-9165	71	7	al	al	PROPN
bam-9165	71	8	.	.	PROPN
bam-9165	71	9	potential	potential	ADJ
bam-9165	71	10	effect	effect	NOUN
bam-9165	71	11	of	of	ADP
bam-9165	71	12	blood	blood	NOUN
bam-9165	71	13	purification	purification	NOUN
bam-9165	71	14	therapy	therapy	NOUN
bam-9165	71	15	in	in	ADP
bam-9165	71	16	reducing	reduce	VERB
bam-9165	71	17	cytokine	cytokine	NOUN
bam-9165	71	18	storm	storm	NOUN
bam-9165	71	19	as	as	ADP
bam-9165	71	20	a	a	DET
bam-9165	71	21	late	late	ADJ
bam-9165	71	22	complication	complication	NOUN
bam-9165	71	23	of	of	ADP
bam-9165	71	24	critically	critically	ADV
bam-9165	71	25	ill	ill	ADJ
bam-9165	71	26	covid-19	covid-19	PROPN
bam-9165	71	27	.	.	PUNCT
bam-9165	72	1	clin	clin	PROPN
bam-9165	72	2	immunol	immunol	PROPN
bam-9165	72	3	2020;214:108408	2020;214:108408	PROPN
bam-9165	72	4	.	.	PUNCT
bam-9165	73	1	doi	doi	NOUN
bam-9165	73	2	:	:	PUNCT
bam-9165	73	3	10.1016	10.1016	NUM
bam-9165	73	4	/	/	SYM
bam-9165	73	5	j.clim.2020.108408	j.clim.2020.108408	ADJ
bam-9165	73	6	.	.	PUNCT
bam-9165	74	1	2	2	X
bam-9165	74	2	.	.	X
bam-9165	74	3	chen	chen	PROPN
bam-9165	74	4	c	c	PROPN
bam-9165	74	5	,	,	PUNCT
bam-9165	74	6	zhang	zhang	PROPN
bam-9165	74	7	xr	xr	PROPN
bam-9165	74	8	,	,	PUNCT
bam-9165	74	9	ju	ju	PROPN
bam-9165	74	10	zy	zy	PROPN
bam-9165	74	11	,	,	PUNCT
bam-9165	74	12	he	he	PRON
bam-9165	74	13	wf	wf	PROPN
bam-9165	74	14	.	.	PUNCT
bam-9165	74	15	advances	advance	NOUN
bam-9165	74	16	in	in	ADP
bam-9165	74	17	the	the	DET
bam-9165	74	18	research	research	NOUN
bam-9165	74	19	of	of	ADP
bam-9165	74	20	cytokine	cytokine	ADJ
bam-9165	74	21	storm	storm	NOUN
bam-9165	74	22	mechanism	mechanism	NOUN
bam-9165	74	23	induced	induce	VERB
bam-9165	74	24	by	by	ADP
bam-9165	74	25	corona	corona	NOUN
bam-9165	74	26	virus	virus	NOUN
bam-9165	74	27	disease	disease	NOUN
bam-9165	74	28	2019	2019	NUM
bam-9165	74	29	and	and	CCONJ
bam-9165	74	30	the	the	DET
bam-9165	74	31	corresponding	corresponding	ADJ
bam-9165	74	32	immunotherapies	immunotherapy	NOUN
bam-9165	74	33	.	.	PUNCT
bam-9165	75	1	zhonghua	zhonghua	PROPN
bam-9165	75	2	shao	shao	PROPN
bam-9165	75	3	shang	shang	PROPN
bam-9165	75	4	za	za	PROPN
bam-9165	75	5	zhi	zhi	PROPN
bam-9165	75	6	2020;36(0):e005	2020;36(0):e005	PROPN
bam-9165	75	7	.	.	PUNCT
bam-9165	76	1	doi	doi	NOUN
bam-9165	76	2	:	:	PUNCT
bam-9165	76	3	10.3760	10.3760	NUM
bam-9165	76	4	/	/	SYM
bam-9165	76	5	cma.j.cn501120	cma.j.cn501120	NOUN
bam-9165	76	6	-	-	PUNCT
bam-9165	76	7	20	20	NUM
bam-9165	76	8	200224	200224	NUM
bam-9165	76	9	-	-	SYM
bam-9165	76	10	00088	00088	NUM
bam-9165	76	11	3	3	NUM
bam-9165	76	12	.	.	PUNCT
bam-9165	76	13	guo	guo	PROPN
bam-9165	77	1	yr	yr	PROPN
bam-9165	77	2	,	,	PUNCT
bam-9165	77	3	cao	cao	PROPN
bam-9165	77	4	qd	qd	PROPN
bam-9165	77	5	,	,	PUNCT
bam-9165	77	6	hong	hong	PROPN
bam-9165	77	7	zs	zs	PROPN
bam-9165	77	8	,	,	PUNCT
bam-9165	77	9	et	et	PROPN
bam-9165	77	10	al	al	PROPN
bam-9165	77	11	.	.	PUNCT
bam-9165	78	1	the	the	DET
bam-9165	78	2	origin	origin	NOUN
bam-9165	78	3	,	,	PUNCT
bam-9165	78	4	transmission	transmission	NOUN
bam-9165	78	5	and	and	CCONJ
bam-9165	78	6	clinical	clinical	ADJ
bam-9165	78	7	therapies	therapy	NOUN
bam-9165	78	8	on	on	ADP
bam-9165	78	9	coronavirus	coronavirus	NOUN
bam-9165	78	10	disease	disease	NOUN
bam-9165	78	11	2019	2019	NUM
bam-9165	78	12	(	(	PUNCT
bam-9165	78	13	covid-19	covid-19	PROPN
bam-9165	78	14	)	)	PUNCT
bam-9165	78	15	outbreak	outbreak	NOUN
bam-9165	78	16	an	an	DET
bam-9165	78	17	update	update	NOUN
bam-9165	78	18	on	on	ADP
bam-9165	78	19	the	the	DET
bam-9165	78	20	status	status	NOUN
bam-9165	78	21	.	.	PUNCT
bam-9165	79	1	mil	mil	PROPN
bam-9165	79	2	med	me	VERB
bam-9165	79	3	res	re	NOUN
bam-9165	79	4	2020;7(1):11	2020;7(1):11	PROPN
bam-9165	79	5	.	.	PUNCT
bam-9165	80	1	doi	doi	NOUN
bam-9165	80	2	:	:	PUNCT
bam-9165	80	3	10.1186	10.1186	NUM
bam-9165	80	4	/	/	SYM
bam-9165	80	5	s40779	s40779	PROPN
bam-9165	80	6	-	-	PUNCT
bam-9165	80	7	020	020	NUM
bam-9165	80	8	-	-	PUNCT
bam-9165	80	9	00240	00240	NUM
bam-9165	80	10	-	-	SYM
bam-9165	80	11	0	0	NUM
bam-9165	80	12	4	4	NUM
bam-9165	80	13	.	.	PUNCT
bam-9165	81	1	liu	liu	PROPN
bam-9165	81	2	y	y	PROPN
bam-9165	81	3	,	,	PUNCT
bam-9165	81	4	zhang	zhang	PROPN
bam-9165	81	5	c	c	PROPN
bam-9165	81	6	,	,	PUNCT
bam-9165	81	7	huang	huang	PROPN
bam-9165	81	8	f	f	PROPN
bam-9165	81	9	,	,	PUNCT
bam-9165	81	10	et	et	PROPN
bam-9165	81	11	al	al	PROPN
bam-9165	81	12	.	.	PROPN
bam-9165	81	13	2019	2019	NUM
bam-9165	81	14	-	-	PUNCT
bam-9165	81	15	novel	novel	NOUN
bam-9165	81	16	coronavirus	coronavirus	NOUN
bam-9165	81	17	(	(	PUNCT
bam-9165	81	18	2019	2019	NUM
bam-9165	81	19	-	-	PUNCT
bam-9165	81	20	ncov	ncov	NOUN
bam-9165	81	21	)	)	PUNCT
bam-9165	81	22	infections	infection	NOUN
bam-9165	81	23	trigger	trigger	VERB
bam-9165	81	24	an	an	DET
bam-9165	81	25	exaggerated	exaggerated	ADJ
bam-9165	81	26	cytokine	cytokine	ADJ
bam-9165	81	27	response	response	NOUN
bam-9165	81	28	aggravating	aggravate	VERB
bam-9165	81	29	lung	lung	NOUN
bam-9165	81	30	injury	injury	NOUN
bam-9165	81	31	.	.	PUNCT
bam-9165	82	1	2020	2020	NUM
bam-9165	82	2	.	.	PUNCT
bam-9165	83	1	http://www.chinaxiv.org/abs/202	http://www.chinaxiv.org/abs/202	PROPN
bam-9165	83	2	002.00018	002.00018	NUM
bam-9165	83	3	accessed	access	VERB
bam-9165	83	4	18	18	NUM
bam-9165	83	5	feb	feb	NOUN
bam-9165	83	6	2020	2020	NUM
bam-9165	83	7	5	5	NUM
bam-9165	83	8	.	.	PUNCT
bam-9165	84	1	huang	huang	PROPN
bam-9165	84	2	c	c	PROPN
bam-9165	84	3	,	,	PUNCT
bam-9165	84	4	wang	wang	PROPN
bam-9165	84	5	y	y	PROPN
bam-9165	84	6	,	,	PUNCT
bam-9165	84	7	li	li	PROPN
bam-9165	84	8	x	x	PROPN
bam-9165	84	9	,	,	PUNCT
bam-9165	84	10	et	et	PROPN
bam-9165	84	11	al	al	PROPN
bam-9165	84	12	.	.	PUNCT
bam-9165	85	1	clinical	clinical	ADJ
bam-9165	85	2	features	feature	NOUN
bam-9165	85	3	of	of	ADP
bam-9165	85	4	patients	patient	NOUN
bam-9165	85	5	infected	infect	VERB
bam-9165	85	6	with	with	ADP
bam-9165	85	7	2019	2019	NUM
bam-9165	85	8	novel	novel	ADJ
bam-9165	85	9	coronavirus	coronavirus	NOUN
bam-9165	85	10	in	in	ADP
bam-9165	85	11	wuhan	wuhan	PROPN
bam-9165	85	12	,	,	PUNCT
bam-9165	85	13	china	china	PROPN
bam-9165	85	14	.	.	PUNCT
bam-9165	86	1	lancet	lancet	PROPN
bam-9165	86	2	.	.	PUNCT
bam-9165	87	1	2020;395(10223	2020;395(10223	NUM
bam-9165	87	2	):	):	PUNCT
bam-9165	88	1	497–506	497–506	NUM
bam-9165	88	2	.	.	PUNCT
bam-9165	89	1	doi	doi	NOUN
bam-9165	89	2	:	:	PUNCT
bam-9165	89	3	10.1016	10.1016	NUM
bam-9165	89	4	/	/	SYM
bam-9165	89	5	s0140	s0140	PROPN
bam-9165	89	6	-	-	PUNCT
bam-9165	89	7	6736(20)30183	6736(20)30183	NUM
bam-9165	89	8	-	-	SYM
bam-9165	89	9	5	5	NUM
bam-9165	89	10	6	6	NUM
bam-9165	89	11	.	.	PUNCT
bam-9165	90	1	mehta	mehta	PROPN
bam-9165	90	2	p	p	PROPN
bam-9165	90	3	,	,	PUNCT
bam-9165	90	4	mcauley	mcauley	PROPN
bam-9165	90	5	df	df	PROPN
bam-9165	90	6	,	,	PUNCT
bam-9165	90	7	brown	brown	PROPN
bam-9165	90	8	m	m	PROPN
bam-9165	90	9	,	,	PUNCT
bam-9165	90	10	et	et	PROPN
bam-9165	90	11	al	al	PROPN
bam-9165	90	12	.	.	PROPN
bam-9165	90	13	covid19	covid19	PROPN
bam-9165	90	14	:	:	PUNCT
bam-9165	90	15	consider	consider	VERB
bam-9165	90	16	cytokine	cytokine	ADJ
bam-9165	90	17	storm	storm	NOUN
bam-9165	90	18	syndrome	syndrome	NOUN
bam-9165	90	19	and	and	CCONJ
bam-9165	90	20	immunosuppresion	immunosuppresion	NOUN
bam-9165	90	21	.	.	PUNCT
bam-9165	91	1	lancet	lancet	PROPN
bam-9165	91	2	2020;395(10229):1033–4	2020;395(10229):1033–4	PROPN
bam-9165	91	3	.	.	PUNCT
bam-9165	92	1	7	7	X
bam-9165	92	2	.	.	X
bam-9165	92	3	tabibi	tabibi	NOUN
bam-9165	92	4	s	s	PROPN
bam-9165	92	5	,	,	PUNCT
bam-9165	92	6	tabibi	tabibi	NOUN
bam-9165	92	7	t	t	PROPN
bam-9165	92	8	,	,	PUNCT
bam-9165	92	9	conic	conic	ADJ
bam-9165	92	10	rrz	rrz	NOUN
bam-9165	92	11	,	,	PUNCT
bam-9165	92	12	et	et	PROPN
bam-9165	92	13	al	al	PROPN
bam-9165	92	14	.	.	PUNCT
bam-9165	93	1	therapeutic	therapeutic	ADJ
bam-9165	93	2	plasma	plasma	NOUN
bam-9165	93	3	exchange	exchange	NOUN
bam-9165	93	4	:	:	PUNCT
bam-9165	93	5	a	a	DET
bam-9165	93	6	potential	potential	ADJ
bam-9165	93	7	management	management	NOUN
bam-9165	93	8	strategy	strategy	NOUN
bam-9165	93	9	for	for	ADP
bam-9165	93	10	critically	critically	ADV
bam-9165	93	11	ill	ill	ADJ
bam-9165	93	12	covid-19	covid-19	PROPN
bam-9165	93	13	patients	patient	NOUN
bam-9165	93	14	.	.	PUNCT
bam-9165	94	1	j	j	PROPN
bam-9165	94	2	intensive	intensive	ADJ
bam-9165	94	3	care	care	NOUN
bam-9165	94	4	med	me	VERB
bam-9165	94	5	2020;35:827	2020;35:827	PROPN
bam-9165	94	6	-	-	SYM
bam-9165	94	7	35	35	NUM
bam-9165	94	8	.	.	PUNCT
bam-9165	95	1	doi	doi	NOUN
bam-9165	95	2	:	:	PUNCT
bam-9165	95	3	10.1177/0885066620940259	10.1177/0885066620940259	NUM
bam-9165	95	4	8	8	NUM
bam-9165	95	5	.	.	PUNCT
bam-9165	96	1	yang	yang	PROPN
bam-9165	96	2	x	x	PROPN
bam-9165	96	3	-	-	PROPN
bam-9165	96	4	h	h	PROPN
bam-9165	96	5	,	,	PUNCT
bam-9165	96	6	sun	sun	NOUN
bam-9165	96	7	r	r	PROPN
bam-9165	96	8	-	-	PUNCT
bam-9165	96	9	h	h	NOUN
bam-9165	96	10	,	,	PUNCT
bam-9165	96	11	zhao	zhao	PROPN
bam-9165	96	12	m	m	PROPN
bam-9165	96	13	-	-	PROPN
bam-9165	96	14	y	y	PROPN
bam-9165	96	15	,	,	PUNCT
bam-9165	96	16	et	et	PROPN
bam-9165	96	17	al	al	PROPN
bam-9165	96	18	.	.	PUNCT
bam-9165	97	1	expert	expert	ADJ
bam-9165	97	2	recommendations	recommendation	NOUN
bam-9165	97	3	on	on	ADP
bam-9165	97	4	blood	blood	NOUN
bam-9165	97	5	purification	purification	NOUN
bam-9165	97	6	treatment	treatment	NOUN
bam-9165	97	7	protocol	protocol	NOUN
bam-9165	97	8	for	for	ADP
bam-9165	97	9	patients	patient	NOUN
bam-9165	97	10	with	with	ADP
bam-9165	97	11	severe	severe	ADJ
bam-9165	97	12	covid-19	covid-19	PROPN
bam-9165	97	13	.	.	PUNCT
bam-9165	98	1	chronic	chronic	PROPN
bam-9165	98	2	dis	dis	PROPN
bam-9165	98	3	transl	transl	PROPN
bam-9165	98	4	med	med	PROPN
bam-9165	98	5	2020	2020	NUM
bam-9165	98	6	apr	apr	NOUN
bam-9165	98	7	28;6(2):106	28;6(2):106	NUM
bam-9165	98	8	-	-	SYM
bam-9165	98	9	114	114	NUM
bam-9165	98	10	.	.	PUNCT
bam-9165	99	1	doi	doi	NOUN
bam-9165	99	2	:	:	PUNCT
bam-9165	99	3	10.1016	10.1016	NUM
bam-9165	99	4	/	/	SYM
bam-9165	99	5	j.cdtm.2020.04.002	j.cdtm.2020.04.002	PROPN
bam-9165	99	6	9	9	NUM
bam-9165	99	7	.	.	PUNCT
bam-9165	100	1	keith	keith	PROPN
bam-9165	100	2	p	p	PROPN
bam-9165	100	3	,	,	PUNCT
bam-9165	100	4	day	day	NOUN
bam-9165	100	5	m	m	PROPN
bam-9165	100	6	,	,	PUNCT
bam-9165	100	7	perkins	perkins	PROPN
bam-9165	100	8	let	let	VERB
bam-9165	100	9	al	al	PROPN
bam-9165	100	10	.	.	PUNCT
bam-9165	101	1	a	a	DET
bam-9165	101	2	novel	novel	ADJ
bam-9165	101	3	treatment	treatment	NOUN
bam-9165	101	4	approach	approach	NOUN
bam-9165	101	5	to	to	ADP
bam-9165	101	6	the	the	DET
bam-9165	101	7	novel	novel	ADJ
bam-9165	101	8	coronavirus	coronavirus	NOUN
bam-9165	101	9	:	:	PUNCT
bam-9165	101	10	an	an	DET
bam-9165	101	11	argument	argument	NOUN
bam-9165	101	12	for	for	ADP
bam-9165	101	13	the	the	DET
bam-9165	101	14	use	use	NOUN
bam-9165	101	15	of	of	ADP
bam-9165	101	16	therapeutic	therapeutic	ADJ
bam-9165	101	17	plasma	plasma	NOUN
bam-9165	101	18	exchange	exchange	NOUN
bam-9165	101	19	for	for	ADP
bam-9165	101	20	fulminant	fulminant	ADJ
bam-9165	101	21	covid-19	covid-19	PROPN
bam-9165	101	22	.	.	PUNCT
bam-9165	101	23	crit	crit	PROPN
bam-9165	101	24	care	care	PROPN
bam-9165	101	25	2020;24:128	2020;24:128	PROPN
bam-9165	101	26	.	.	PUNCT
bam-9165	102	1	doi	doi	NOUN
bam-9165	102	2	:	:	PUNCT
bam-9165	102	3	10.1186	10.1186	NUM
bam-9165	102	4	/	/	SYM
bam-9165	102	5	s13054	s13054	NOUN
bam-9165	102	6	-	-	PUNCT
bam-9165	102	7	020	020	NUM
bam-9165	102	8	-	-	PUNCT
bam-9165	102	9	2836	2836	NUM
bam-9165	102	10	-	-	SYM
bam-9165	102	11	4	4	NUM
bam-9165	102	12	10	10	NUM
bam-9165	102	13	.	.	PUNCT
bam-9165	102	14	avdeev	avdeev	PROPN
bam-9165	102	15	sn	sn	PROPN
bam-9165	102	16	.	.	PUNCT
bam-9165	103	1	acute	acute	ADJ
bam-9165	103	2	respiratory	respiratory	ADJ
bam-9165	103	3	distissue	distissue	NOUN
bam-9165	103	4	syndrome	syndrome	NOUN
bam-9165	103	5	.	.	PUNCT
bam-9165	104	1	consilium	consilium	PROPN
bam-9165	104	2	medicum	medicum	PROPN
bam-9165	104	3	2005;7	2005;7	NUM
bam-9165	104	4	:	:	PUNCT
bam-9165	104	5	330	330	NUM
bam-9165	104	6	-	-	SYM
bam-9165	104	7	8	8	NUM
bam-9165	104	8	.	.	PUNCT
bam-9165	105	1	(	(	PUNCT
bam-9165	105	2	in	in	ADP
bam-9165	105	3	russ	russ	NOUN
bam-9165	105	4	.	.	PUNCT
bam-9165	105	5	)	)	PUNCT
bam-9165	105	6	.	.	PUNCT
bam-9165	106	1	11	11	NUM
bam-9165	106	2	.	.	X
bam-9165	107	1	pourahmad	pourahmad	PROPN
bam-9165	107	2	r	r	NOUN
bam-9165	107	3	,	,	PUNCT
bam-9165	107	4	moazzami	moazzami	NOUN
bam-9165	107	5	b	b	X
bam-9165	107	6	,	,	PUNCT
bam-9165	107	7	rezaei	rezaei	PROPN
bam-9165	107	8	n.	n.	PROPN
bam-9165	107	9	efficacy	efficacy	PROPN
bam-9165	107	10	of	of	ADP
bam-9165	107	11	plasmapheresis	plasmapheresis	NOUN
bam-9165	107	12	and	and	CCONJ
bam-9165	107	13	immunoglobulin	immunoglobulin	NOUN
bam-9165	107	14	replacement	replacement	NOUN
bam-9165	107	15	therapy	therapy	NOUN
bam-9165	107	16	(	(	PUNCT
bam-9165	107	17	ivig	ivig	NOUN
bam-9165	107	18	)	)	PUNCT
bam-9165	107	19	on	on	ADP
bam-9165	107	20	patients	patient	NOUN
bam-9165	107	21	with	with	ADP
bam-9165	107	22	covid-19	covid-19	PROPN
bam-9165	107	23	.	.	PUNCT
bam-9165	107	24	sn	sn	PROPN
bam-9165	107	25	compr	compr	PROPN
bam-9165	107	26	clin	clin	PROPN
bam-9165	107	27	med	med	PROPN
bam-9165	107	28	.	.	PUNCT
bam-9165	108	1	2020	2020	NUM
bam-9165	108	2	jul	jul	PROPN
bam-9165	108	3	31:1	31:1	NUM
bam-9165	108	4	-	-	SYM
bam-9165	108	5	5	5	NUM
bam-9165	108	6	.	.	PUNCT
bam-9165	109	1	doi	doi	NOUN
bam-9165	109	2	:	:	PUNCT
bam-9165	109	3	10.1007	10.1007	NUM
bam-9165	109	4	/	/	SYM
bam-9165	109	5	s42399	s42399	NOUN
bam-9165	109	6	-	-	PUNCT
bam-9165	109	7	020	020	NUM
bam-9165	109	8	-	-	PUNCT
bam-9165	109	9	00438	00438	NUM
bam-9165	109	10	-	-	SYM
bam-9165	109	11	2	2	NUM
bam-9165	109	12	.	.	NOUN
bam-9165	109	13	12	12	NUM
bam-9165	109	14	.	.	PUNCT
bam-9165	110	1	kalinin	kalinin	PROPN
bam-9165	110	2	nn	nn	PROPN
bam-9165	110	3	.	.	PROPN
bam-9165	110	4	clinical	clinical	ADJ
bam-9165	110	5	application	application	NOUN
bam-9165	110	6	of	of	ADP
bam-9165	110	7	extracorporeal	extracorporeal	NOUN
bam-9165	110	8	treatment	treatment	NOUN
bam-9165	110	9	methods	method	NOUN
bam-9165	110	10	.	.	PUNCT
bam-9165	111	1	publishing	publish	VERB
bam-9165	111	2	house	house	NOUN
bam-9165	111	3	:	:	PUNCT
bam-9165	111	4	trackpore	trackpore	NOUN
bam-9165	111	5	technology	technology	NOUN
bam-9165	111	6	cjsc	cjsc	NOUN
bam-9165	111	7	,	,	PUNCT
bam-9165	111	8	2006	2006	NUM
bam-9165	111	9	,	,	PUNCT
bam-9165	111	10	pp	pp	ADJ
bam-9165	111	11	.	.	PUNCT
bam-9165	112	1	168	168	NUM
bam-9165	112	2	.	.	PUNCT
bam-9165	113	1	(	(	PUNCT
bam-9165	113	2	in	in	ADP
bam-9165	113	3	russ	russ	NOUN
bam-9165	113	4	.	.	PUNCT
bam-9165	113	5	)	)	PUNCT
bam-9165	113	6	13	13	NUM
bam-9165	113	7	.	.	PUNCT
bam-9165	114	1	ragimov	ragimov	PROPN
bam-9165	114	2	aa	aa	PROPN
bam-9165	114	3	,	,	PUNCT
bam-9165	114	4	poreshina	poreshina	PROPN
bam-9165	114	5	sa	sa	PROPN
bam-9165	114	6	,	,	PUNCT
bam-9165	114	7	salimov	salimov	PROPN
bam-9165	114	8	el	el	PROPN
bam-9165	114	9	.	.	PROPN
bam-9165	114	10	plasmapheresis	plasmapheresis	NOUN
bam-9165	114	11	in	in	ADP
bam-9165	114	12	systemic	systemic	ADJ
bam-9165	114	13	inflammatory	inflammatory	ADJ
bam-9165	114	14	response	response	NOUN
bam-9165	114	15	at	at	ADP
bam-9165	114	16	p14	p14	PROPN
bam-9165	114	17	.	.	PUNCT
bam-9165	115	1	practical	practical	ADJ
bam-9165	115	2	medicine	medicine	NOUN
bam-9165	115	3	2008;124	2008;124	NUM
bam-9165	115	4	.	.	PUNCT
bam-9165	116	1	(	(	PUNCT
bam-9165	116	2	in	in	ADP
bam-9165	116	3	russ	russ	NOUN
bam-9165	116	4	.	.	PUNCT
bam-9165	116	5	)	)	PUNCT
bam-9165	116	6	.	.	PUNCT
bam-9165	117	1	14	14	NUM
bam-9165	117	2	.	.	PUNCT
bam-9165	118	1	madore	madore	VERB
bam-9165	118	2	f.	f.	NOUN
bam-9165	118	3	plasmapheresis	plasmapheresis	PROPN
bam-9165	118	4	.	.	PUNCT
bam-9165	119	1	technical	technical	ADJ
bam-9165	119	2	aspects	aspect	NOUN
bam-9165	119	3	and	and	CCONJ
bam-9165	119	4	indications	indication	NOUN
bam-9165	119	5	.	.	PUNCT
bam-9165	120	1	crit	crit	PROPN
bam-9165	120	2	care	care	PROPN
bam-9165	120	3	clin	clin	PROPN
bam-9165	120	4	2002;18:375–92	2002;18:375–92	PROPN
bam-9165	120	5	.	.	PUNCT
bam-9165	121	1	mailto:gilm.ilmira@mail.ru	mailto:gilm.ilmira@mail.ru	PROPN
bam-9165	121	2	http://www.chinaxiv.org/abs/202%20002.00018	http://www.chinaxiv.org/abs/202%20002.00018	NOUN
bam-9165	121	3	http://www.chinaxiv.org/abs/202%20002.00018	http://www.chinaxiv.org/abs/202%20002.00018	NOUN
bam-9165	121	4	plasmapheresis	plasmapheresis	NOUN
bam-9165	121	5	methods	method	NOUN
bam-9165	121	6	for	for	ADP
bam-9165	121	7	covid-19	covid-19	PROPN
bam-9165	121	8	eur	eur	PROPN
bam-9165	121	9	j	j	PROPN
bam-9165	121	10	transl	transl	PROPN
bam-9165	121	11	myol	myol	NOUN
bam-9165	121	12	2020	2020	NUM
bam-9165	121	13	;	;	PUNCT
bam-9165	121	14	30	30	NUM
bam-9165	121	15	(	(	PUNCT
bam-9165	121	16	3	3	NUM
bam-9165	121	17	):	):	PUNCT
bam-9165	121	18	9165	9165	NUM
bam-9165	121	19	.	.	PUNCT
bam-9165	122	1	doi	doi	NOUN
bam-9165	122	2	:	:	PUNCT
bam-9165	122	3	10.4081	10.4081	NUM
bam-9165	122	4	/	/	SYM
bam-9165	122	5	ejtm.2020.9165	ejtm.2020.9165	VERB
bam-9165	122	6	5	5	NUM
bam-9165	122	7	15	15	NUM
bam-9165	122	8	.	.	PUNCT
bam-9165	123	1	hirano	hirano	PROPN
bam-9165	123	2	r	r	PROPN
bam-9165	123	3	,	,	PUNCT
bam-9165	123	4	namazuda	namazuda	NOUN
bam-9165	123	5	k	k	NOUN
bam-9165	123	6	,	,	PUNCT
bam-9165	123	7	hirata	hirata	NOUN
bam-9165	123	8	n.	n.	NOUN
bam-9165	123	9	double	double	ADJ
bam-9165	123	10	filtration	filtration	NOUN
bam-9165	123	11	plasmapheresis	plasmapheresis	NOUN
bam-9165	123	12	:	:	PUNCT
bam-9165	123	13	review	review	NOUN
bam-9165	123	14	of	of	ADP
bam-9165	123	15	current	current	ADJ
bam-9165	123	16	clinical	clinical	ADJ
bam-9165	123	17	applications	application	NOUN
bam-9165	123	18	.	.	PUNCT
bam-9165	124	1	ther	ther	VERB
bam-9165	124	2	apher	apher	ADJ
bam-9165	124	3	dial	dial	NOUN
bam-9165	124	4	2020	2020	NUM
bam-9165	124	5	.	.	PUNCT
bam-9165	125	1	doi	doi	NOUN
bam-9165	125	2	:	:	PUNCT
bam-9165	125	3	10.1111/1744	10.1111/1744	NUM
bam-9165	125	4	-	-	SYM
bam-9165	125	5	9987.13548	9987.13548	NUM
bam-9165	125	6	16	16	NUM
bam-9165	125	7	.	.	PUNCT
bam-9165	126	1	navarro	navarro	PROPN
bam-9165	126	2	-	-	PUNCT
bam-9165	126	3	martínez	martínez	PROPN
bam-9165	126	4	r	r	NOUN
bam-9165	126	5	,	,	PUNCT
bam-9165	126	6	cauli	cauli	NOUN
bam-9165	126	7	o.	o.	NOUN
bam-9165	126	8	therapeutic	therapeutic	ADJ
bam-9165	126	9	plasmapheresis	plasmapheresis	NOUN
bam-9165	126	10	with	with	ADP
bam-9165	126	11	albumin	albumin	ADJ
bam-9165	126	12	replacement	replacement	NOUN
bam-9165	126	13	in	in	ADP
bam-9165	126	14	alzheimer	alzheimer	PROPN
bam-9165	126	15	's	's	PART
bam-9165	126	16	disease	disease	NOUN
bam-9165	126	17	and	and	CCONJ
bam-9165	126	18	chronic	chronic	ADJ
bam-9165	126	19	progressive	progressive	ADJ
bam-9165	126	20	multiple	multiple	ADJ
bam-9165	126	21	sclerosis	sclerosis	NOUN
bam-9165	126	22	:	:	PUNCT
bam-9165	126	23	a	a	DET
bam-9165	126	24	review	review	NOUN
bam-9165	126	25	.	.	PUNCT
bam-9165	127	1	pharmaceuticals	pharmaceutical	NOUN
bam-9165	127	2	(	(	PUNCT
bam-9165	127	3	basel	basel	PROPN
bam-9165	127	4	)	)	PUNCT
bam-9165	127	5	.	.	PUNCT
bam-9165	128	1	2020;13:28	2020;13:28	NOUN
bam-9165	128	2	.	.	PUNCT
bam-9165	129	1	doi	doi	NOUN
bam-9165	129	2	:	:	PUNCT
bam-9165	129	3	10.3390	10.3390	NUM
bam-9165	129	4	/	/	SYM
bam-9165	129	5	ph13020028	ph13020028	ADJ
bam-9165	129	6	17	17	NUM
bam-9165	129	7	.	.	PUNCT
bam-9165	130	1	sergent	sergent	PROPN
bam-9165	130	2	sr	sr	PROPN
bam-9165	130	3	,	,	PUNCT
bam-9165	130	4	ashurst	ashurst	PROPN
bam-9165	130	5	jv	jv	PROPN
bam-9165	130	6	.	.	PROPN
bam-9165	130	7	plasmapheresis	plasmapheresis	NOUN
bam-9165	130	8	.	.	PUNCT
bam-9165	131	1	2020	2020	NUM
bam-9165	131	2	jul	jul	PROPN
bam-9165	131	3	15	15	NUM
bam-9165	131	4	.	.	PUNCT
bam-9165	132	1	in	in	ADP
bam-9165	132	2	:	:	PUNCT
bam-9165	132	3	statpearls	statpearl	NOUN
bam-9165	133	1	[	[	X
bam-9165	133	2	internet	internet	NOUN
bam-9165	133	3	]	]	PUNCT
bam-9165	133	4	.	.	PUNCT
bam-9165	134	1	treasure	treasure	NOUN
bam-9165	134	2	island	island	NOUN
bam-9165	134	3	(	(	PUNCT
bam-9165	134	4	fl	fl	PROPN
bam-9165	134	5	):	):	PUNCT
bam-9165	134	6	statpearls	statpearls	PROPN
bam-9165	134	7	publishing	publishing	NOUN
bam-9165	134	8	;	;	PUNCT
bam-9165	134	9	2020	2020	NUM
bam-9165	134	10	jan	jan	PROPN
bam-9165	134	11	.	.	PROPN
bam-9165	134	12	18	18	NUM
bam-9165	134	13	.	.	PUNCT
bam-9165	135	1	schwartz	schwartz	PROPN
bam-9165	135	2	j	j	PROPN
bam-9165	135	3	,	,	PUNCT
bam-9165	135	4	padmanabhan	padmanabhan	PROPN
bam-9165	135	5	a	a	PROPN
bam-9165	135	6	,	,	PUNCT
bam-9165	135	7	aqui	aqui	PROPN
bam-9165	135	8	n	n	CCONJ
bam-9165	135	9	,	,	PUNCT
bam-9165	135	10	et	et	PROPN
bam-9165	135	11	al	al	PROPN
bam-9165	135	12	guidelines	guideline	VERB
bam-9165	135	13	on	on	ADP
bam-9165	135	14	the	the	DET
bam-9165	135	15	use	use	NOUN
bam-9165	135	16	of	of	ADP
bam-9165	135	17	therapeutic	therapeutic	ADJ
bam-9165	135	18	apheresis	apheresis	NOUN
bam-9165	135	19	in	in	ADP
bam-9165	135	20	clinical	clinical	ADJ
bam-9165	135	21	practice	practice	NOUN
bam-9165	135	22	-	-	PUNCT
bam-9165	135	23	evidence	evidence	NOUN
bam-9165	135	24	-	-	PUNCT
bam-9165	135	25	based	base	VERB
bam-9165	135	26	approach	approach	NOUN
bam-9165	135	27	from	from	ADP
bam-9165	135	28	the	the	DET
bam-9165	135	29	writing	writing	NOUN
bam-9165	135	30	committee	committee	NOUN
bam-9165	135	31	of	of	ADP
bam-9165	135	32	the	the	DET
bam-9165	135	33	american	american	ADJ
bam-9165	135	34	society	society	NOUN
bam-9165	135	35	for	for	ADP
bam-9165	135	36	apheresis	apheresis	NOUN
bam-9165	135	37	:	:	PUNCT
bam-9165	135	38	the	the	DET
bam-9165	135	39	seventh	seventh	ADJ
bam-9165	135	40	special	special	ADJ
bam-9165	135	41	issue	issue	NOUN
bam-9165	135	42	.	.	PUNCT
bam-9165	136	1	j	j	PROPN
bam-9165	136	2	clin	clin	PROPN
bam-9165	136	3	apher	apher	ADV
bam-9165	136	4	2016;31:149	2016;31:149	NUM
bam-9165	136	5	-	-	NUM
bam-9165	136	6	62	62	NUM
bam-9165	136	7	.	.	PUNCT
bam-9165	137	1	19	19	NUM
bam-9165	137	2	.	.	PUNCT
bam-9165	137	3	clark	clark	PROPN
bam-9165	137	4	wf	wf	PROPN
bam-9165	137	5	,	,	PUNCT
bam-9165	137	6	huang	huang	PROPN
bam-9165	137	7	ss	ss	PROPN
bam-9165	137	8	.	.	PROPN
bam-9165	137	9	introduction	introduction	NOUN
bam-9165	137	10	to	to	ADP
bam-9165	137	11	therapeutic	therapeutic	ADJ
bam-9165	137	12	plasma	plasma	NOUN
bam-9165	137	13	exchange	exchange	NOUN
bam-9165	137	14	.	.	PUNCT
bam-9165	138	1	transfus	transfus	PROPN
bam-9165	139	1	apher	apher	ADV
bam-9165	139	2	sci	sci	PROPN
bam-9165	139	3	2019;58:2289	2019;58:2289	NUM
bam-9165	139	4	.	.	PUNCT
bam-9165	140	1	doi	doi	NOUN
bam-9165	140	2	:	:	PUNCT
bam-9165	140	3	10.1016	10.1016	NUM
bam-9165	140	4	/	/	SYM
bam-9165	140	5	j.transci.2019.04.004	j.transci.2019.04.004	PROPN
bam-9165	140	6	.	.	PROPN
bam-9165	141	1	20	20	NUM
bam-9165	141	2	.	.	PUNCT
bam-9165	142	1	sokolov	sokolov	PROPN
bam-9165	142	2	aa	aa	PROPN
bam-9165	142	3	,	,	PUNCT
bam-9165	142	4	popov	popov	PROPN
bam-9165	142	5	av	av	PROPN
bam-9165	142	6	.	.	PUNCT
bam-9165	142	7	cascade	cascade	NOUN
bam-9165	142	8	plasmofiltration	plasmofiltration	NOUN
bam-9165	142	9	:	:	PUNCT
bam-9165	142	10	method	method	NOUN
bam-9165	142	11	characteristic	characteristic	ADJ
bam-9165	142	12	and	and	CCONJ
bam-9165	142	13	equipment	equipment	NOUN
bam-9165	142	14	selection	selection	NOUN
bam-9165	142	15	.	.	PUNCT
bam-9165	143	1	tverskoi	tverskoi	PROPN
bam-9165	143	2	meditsinskii	meditsinskii	PROPN
bam-9165	143	3	zhurnal	zhurnal	ADJ
bam-9165	143	4	2017;5:46	2017;5:46	NOUN
bam-9165	143	5	-	-	PUNCT
bam-9165	143	6	58	58	NUM
bam-9165	143	7	.	.	PUNCT
bam-9165	144	1	(	(	PUNCT
bam-9165	144	2	in	in	ADP
bam-9165	144	3	russ	russ	NOUN
bam-9165	144	4	.	.	PUNCT
bam-9165	144	5	)	)	PUNCT
bam-9165	145	1	21	21	NUM
bam-9165	145	2	.	.	PUNCT
bam-9165	145	3	sokolov	sokolov	PROPN
bam-9165	145	4	aa	aa	PROPN
bam-9165	145	5	,	,	PUNCT
bam-9165	145	6	tishko	tishko	ADJ
bam-9165	145	7	vv	vv	NOUN
bam-9165	145	8	,	,	PUNCT
bam-9165	145	9	belskikh	belskikh	NOUN
bam-9165	145	10	an	an	PRON
bam-9165	145	11	,	,	PUNCT
bam-9165	145	12	esipov	esipov	PROPN
bam-9165	145	13	av	av	PROPN
bam-9165	145	14	.	.	PUNCT
bam-9165	145	15	modern	modern	ADJ
bam-9165	145	16	extracorporal	extracorporal	ADJ
bam-9165	145	17	technologies	technology	NOUN
bam-9165	145	18	:	:	PUNCT
bam-9165	145	19	prospects	prospect	NOUN
bam-9165	145	20	of	of	ADP
bam-9165	145	21	use	use	NOUN
bam-9165	145	22	.	.	PUNCT
bam-9165	146	1	gospital'naya	gospital'naya	NOUN
bam-9165	146	2	medicina	medicina	PROPN
bam-9165	146	3	:	:	PUNCT
bam-9165	146	4	nauka	nauka	PROPN
bam-9165	146	5	i	i	PROPN
bam-9165	146	6	praktika	praktika	NOUN
bam-9165	146	7	.	.	PROPN
bam-9165	146	8	2019	2019	NUM
bam-9165	146	9	;	;	PUNCT
bam-9165	146	10	1	1	NUM
bam-9165	146	11	:	:	SYM
bam-9165	146	12	32	32	NUM
bam-9165	146	13	-	-	SYM
bam-9165	146	14	41	41	NUM
bam-9165	146	15	.	.	PUNCT
bam-9165	147	1	(	(	PUNCT
bam-9165	147	2	in	in	ADP
bam-9165	147	3	russ	russ	NOUN
bam-9165	147	4	.	.	PUNCT
bam-9165	147	5	)	)	PUNCT
bam-9165	148	1	22	22	NUM
bam-9165	148	2	.	.	PUNCT
bam-9165	149	1	rubtsov	rubtsov	PROPN
bam-9165	149	2	ms	ms	PROPN
bam-9165	149	3	,	,	PUNCT
bam-9165	149	4	shukevich	shukevich	PROPN
bam-9165	149	5	dl	dl	PROPN
bam-9165	149	6	.	.	PROPN
bam-9165	149	7	modern	modern	ADJ
bam-9165	149	8	extracorporeal	extracorporeal	NOUN
bam-9165	149	9	methods	method	NOUN
bam-9165	149	10	for	for	ADP
bam-9165	149	11	critical	critical	ADJ
bam-9165	149	12	conditions	condition	NOUN
bam-9165	149	13	caused	cause	VERB
bam-9165	149	14	by	by	ADP
bam-9165	149	15	systemic	systemic	ADJ
bam-9165	149	16	inflammatory	inflammatory	ADJ
bam-9165	149	17	response	response	NOUN
bam-9165	149	18	(	(	PUNCT
bam-9165	149	19	review	review	NOUN
bam-9165	149	20	)	)	PUNCT
bam-9165	149	21	.	.	PUNCT
bam-9165	150	1	anesteziologiya	anesteziologiya	PROPN
bam-9165	151	1	i	i	PRON
bam-9165	151	2	reanimatologiya	reanimatologiya	PROPN
bam-9165	151	3	.	.	PUNCT
bam-9165	152	1	2019;(4	2019;(4	NUM
bam-9165	152	2	):	):	PUNCT
bam-9165	152	3	20	20	NUM
bam-9165	152	4	-	-	SYM
bam-9165	152	5	30	30	NUM
bam-9165	152	6	.	.	PUNCT
bam-9165	153	1	(	(	PUNCT
bam-9165	153	2	in	in	ADP
bam-9165	153	3	russ	russ	NOUN
bam-9165	153	4	.	.	PUNCT
bam-9165	153	5	)	)	PUNCT
bam-9165	154	1	doi	doi	NOUN
bam-9165	154	2	:	:	PUNCT
bam-9165	154	3	10.17116/	10.17116/	NUM
bam-9165	154	4	anaesthesiology201904120	anaesthesiology201904120	PROPN
bam-9165	154	5	23	23	NUM
bam-9165	154	6	.	.	PUNCT
bam-9165	155	1	shen	shen	PROPN
bam-9165	155	2	c	c	X
bam-9165	155	3	,	,	PUNCT
bam-9165	155	4	wang	wang	PROPN
bam-9165	155	5	z	z	PROPN
bam-9165	155	6	,	,	PUNCT
bam-9165	155	7	zhao	zhao	PROPN
bam-9165	155	8	f	f	PROPN
bam-9165	155	9	,	,	PUNCT
bam-9165	155	10	et	et	PROPN
bam-9165	155	11	al	al	PROPN
bam-9165	155	12	.	.	PROPN
bam-9165	156	1	treatment	treatment	NOUN
bam-9165	156	2	of	of	ADP
bam-9165	156	3	5	5	NUM
bam-9165	156	4	critically	critically	ADV
bam-9165	156	5	ill	ill	ADJ
bam-9165	156	6	patients	patient	NOUN
bam-9165	156	7	with	with	ADP
bam-9165	156	8	covid-19	covid-19	PROPN
bam-9165	156	9	with	with	ADP
bam-9165	156	10	convalescent	convalescent	NOUN
bam-9165	156	11	plasma	plasma	NOUN
bam-9165	156	12	.	.	PUNCT
bam-9165	157	1	jama	jama	PROPN
bam-9165	157	2	2020	2020	NUM
bam-9165	157	3	mar	mar	PROPN
bam-9165	157	4	27	27	NUM
bam-9165	157	5	.	.	PUNCT
bam-9165	158	1	doi	doi	NOUN
bam-9165	158	2	:	:	PUNCT
bam-9165	158	3	10.1001	10.1001	NUM
bam-9165	158	4	/	/	SYM
bam-9165	158	5	jama.2020.4783	jama.2020.4783	NOUN
bam-9165	158	6	.	.	PROPN
bam-9165	159	1	24	24	NUM
bam-9165	159	2	.	.	PUNCT
bam-9165	160	1	bloch	bloch	PROPN
bam-9165	160	2	em	em	PRON
bam-9165	160	3	,	,	PUNCT
bam-9165	160	4	shoham	shoham	VERB
bam-9165	160	5	s	s	PROPN
bam-9165	160	6	,	,	PUNCT
bam-9165	160	7	casadevall	casadevall	PROPN
bam-9165	160	8	a	a	X
bam-9165	160	9	,	,	PUNCT
bam-9165	160	10	et	et	PROPN
bam-9165	160	11	al	al	PROPN
bam-9165	160	12	.	.	PUNCT
bam-9165	160	13	deployment	deployment	NOUN
bam-9165	160	14	of	of	ADP
bam-9165	160	15	convalescent	convalescent	NOUN
bam-9165	160	16	plasma	plasma	NOUN
bam-9165	160	17	for	for	ADP
bam-9165	160	18	the	the	DET
bam-9165	160	19	prevention	prevention	NOUN
bam-9165	160	20	and	and	CCONJ
bam-9165	160	21	treatment	treatment	NOUN
bam-9165	160	22	of	of	ADP
bam-9165	160	23	covid-19	covid-19	PROPN
bam-9165	160	24	.	.	PUNCT
bam-9165	161	1	j	j	PROPN
bam-9165	161	2	clin	clin	PROPN
bam-9165	161	3	invest	invest	VERB
bam-9165	161	4	2020	2020	NUM
bam-9165	161	5	apr	apr	VERB
bam-9165	161	6	7	7	NUM
bam-9165	161	7	.	.	PUNCT
bam-9165	161	8	pii	pii	PROPN
bam-9165	161	9	:	:	PUNCT
bam-9165	161	10	138745	138745	NUM
bam-9165	161	11	.	.	PUNCT
bam-9165	162	1	doi	doi	NOUN
bam-9165	162	2	:	:	PUNCT
bam-9165	162	3	10.1172	10.1172	NUM
bam-9165	162	4	/	/	SYM
bam-9165	162	5	jci138745	jci138745	NOUN
bam-9165	162	6	.	.	PUNCT
bam-9165	163	1	25	25	NUM
bam-9165	163	2	.	.	PUNCT
bam-9165	164	1	chen	chen	PROPN
bam-9165	164	2	l	l	PROPN
bam-9165	164	3	,	,	PUNCT
bam-9165	164	4	xiong	xiong	PROPN
bam-9165	164	5	j	j	PROPN
bam-9165	164	6	,	,	PUNCT
bam-9165	164	7	bao	bao	PROPN
bam-9165	164	8	l	l	PROPN
bam-9165	164	9	,	,	PUNCT
bam-9165	164	10	shi	shi	PROPN
bam-9165	164	11	y.	y.	PROPN
bam-9165	164	12	convalescent	convalescent	NOUN
bam-9165	164	13	plasma	plasma	NOUN
bam-9165	164	14	as	as	ADP
bam-9165	164	15	a	a	DET
bam-9165	164	16	potential	potential	ADJ
bam-9165	164	17	therapy	therapy	NOUN
bam-9165	164	18	for	for	ADP
bam-9165	164	19	covid-19	covid-19	PROPN
bam-9165	164	20	.	.	PUNCT
bam-9165	165	1	lancet	lancet	PROPN
bam-9165	165	2	infect	infect	VERB
bam-9165	165	3	dis	dis	PROPN
bam-9165	165	4	2020;20:398	2020;20:398	NOUN
bam-9165	165	5	-	-	PUNCT
bam-9165	165	6	400	400	NUM
bam-9165	165	7	.	.	PUNCT
bam-9165	166	1	doi	doi	NOUN
bam-9165	166	2	:	:	PUNCT
bam-9165	166	3	10.1016	10.1016	NUM
bam-9165	166	4	/	/	SYM
bam-9165	166	5	s1473	s1473	NOUN
bam-9165	166	6	-	-	PUNCT
bam-9165	166	7	3099(20)30141	3099(20)30141	NUM
bam-9165	166	8	-	-	SYM
bam-9165	166	9	9	9	NUM
bam-9165	166	10	26	26	NUM
bam-9165	166	11	.	.	PUNCT
bam-9165	167	1	murphy	murphy	PROPN
bam-9165	167	2	m	m	PROPN
bam-9165	167	3	,	,	PUNCT
bam-9165	167	4	estcourt	estcourt	PROPN
bam-9165	167	5	l	l	NOUN
bam-9165	167	6	,	,	PUNCT
bam-9165	167	7	grant	grant	NOUN
bam-9165	167	8	-	-	PUNCT
bam-9165	167	9	casey	casey	NOUN
bam-9165	167	10	j	j	PROPN
bam-9165	167	11	,	,	PUNCT
bam-9165	167	12	dzik	dzik	PROPN
bam-9165	167	13	s.	s.	PROPN
bam-9165	167	14	international	international	PROPN
bam-9165	167	15	survey	survey	NOUN
bam-9165	167	16	of	of	ADP
bam-9165	167	17	trials	trial	NOUN
bam-9165	167	18	of	of	ADP
bam-9165	167	19	convalescent	convalescent	NOUN
bam-9165	167	20	plasma	plasma	NOUN
bam-9165	167	21	to	to	PART
bam-9165	167	22	treat	treat	VERB
bam-9165	167	23	covid-19	covid-19	PROPN
bam-9165	167	24	infection	infection	NOUN
bam-9165	167	25	.	.	PUNCT
bam-9165	168	1	transfus	transfus	PROPN
bam-9165	168	2	med	med	PROPN
bam-9165	168	3	rev	rev	PROPN
bam-9165	168	4	2020	2020	NUM
bam-9165	168	5	:	:	PUNCT
bam-9165	168	6	s0887	s0887	PROPN
bam-9165	168	7	-	-	PROPN
bam-9165	168	8	7963(20)30031	7963(20)30031	NOUN
bam-9165	168	9	-	-	PUNCT
bam-9165	168	10	6	6	NUM
bam-9165	168	11	.	.	PUNCT
bam-9165	169	1	doi	doi	NOUN
bam-9165	169	2	:	:	PUNCT
bam-9165	169	3	10.1016	10.1016	NUM
bam-9165	169	4	/	/	SYM
bam-9165	169	5	j.tmrv.2020.06.003	j.tmrv.2020.06.003	PROPN
bam-9165	169	6	27	27	NUM
bam-9165	169	7	.	.	PUNCT
bam-9165	170	1	rajendran	rajendran	PROPN
bam-9165	170	2	k	k	PROPN
bam-9165	170	3	,	,	PUNCT
bam-9165	170	4	narayanasamy	narayanasamy	NOUN
bam-9165	170	5	k	k	PROPN
bam-9165	170	6	,	,	PUNCT
bam-9165	170	7	rangarajan	rangarajan	PROPN
bam-9165	170	8	j	j	PROPN
bam-9165	170	9	,	,	PUNCT
bam-9165	170	10	et	et	PROPN
bam-9165	170	11	al	al	PROPN
bam-9165	170	12	.	.	PUNCT
bam-9165	170	13	convalescent	convalescent	NOUN
bam-9165	170	14	plasma	plasma	NOUN
bam-9165	170	15	transfusion	transfusion	NOUN
bam-9165	170	16	for	for	ADP
bam-9165	170	17	the	the	DET
bam-9165	170	18	treatment	treatment	NOUN
bam-9165	170	19	of	of	ADP
bam-9165	170	20	covid-19	covid-19	PROPN
bam-9165	170	21	:	:	PUNCT
bam-9165	170	22	systematic	systematic	ADJ
bam-9165	170	23	review	review	NOUN
bam-9165	170	24	.	.	PUNCT
bam-9165	171	1	j	j	PROPN
bam-9165	171	2	med	med	PROPN
bam-9165	171	3	virol	virol	NOUN
bam-9165	171	4	2020	2020	NUM
bam-9165	171	5	may	may	AUX
bam-9165	171	6	1	1	NUM
bam-9165	171	7	.	.	PUNCT
bam-9165	172	1	doi	doi	NOUN
bam-9165	172	2	:	:	PUNCT
bam-9165	172	3	10.1002	10.1002	NUM
bam-9165	172	4	/	/	SYM
bam-9165	172	5	jmv.25961	jmv.25961	PROPN
bam-9165	172	6	28	28	NUM
bam-9165	172	7	.	.	PUNCT
bam-9165	173	1	seghatchian	seghatchian	PROPN
bam-9165	173	2	j	j	PROPN
bam-9165	173	3	,	,	PUNCT
bam-9165	173	4	lanza	lanza	PROPN
bam-9165	173	5	f.	f.	PROPN
bam-9165	173	6	convalescent	convalescent	PROPN
bam-9165	173	7	plasma	plasma	PROPN
bam-9165	173	8	,	,	PUNCT
bam-9165	173	9	an	an	DET
bam-9165	173	10	apheresis	apheresis	NOUN
bam-9165	173	11	research	research	NOUN
bam-9165	173	12	project	project	NOUN
bam-9165	173	13	targeting	target	VERB
bam-9165	173	14	and	and	CCONJ
bam-9165	173	15	motivating	motivate	VERB
bam-9165	173	16	the	the	DET
bam-9165	173	17	fully	fully	ADV
bam-9165	173	18	recovered	recover	VERB
bam-9165	173	19	covid	covid	PROPN
bam-9165	173	20	19	19	NUM
bam-9165	173	21	patients	patient	NOUN
bam-9165	173	22	:	:	PUNCT
bam-9165	173	23	a	a	DET
bam-9165	173	24	rousing	rouse	VERB
bam-9165	173	25	message	message	NOUN
bam-9165	173	26	of	of	ADP
bam-9165	173	27	clinical	clinical	ADJ
bam-9165	173	28	benefit	benefit	NOUN
bam-9165	173	29	to	to	ADP
bam-9165	173	30	both	both	DET
bam-9165	173	31	donors	donor	NOUN
bam-9165	173	32	and	and	CCONJ
bam-9165	173	33	recipients	recipient	NOUN
bam-9165	173	34	alike	alike	ADV
bam-9165	173	35	.	.	PUNCT
bam-9165	174	1	transfus	transfus	PROPN
bam-9165	175	1	apher	apher	ADV
bam-9165	175	2	sci	sci	PROPN
bam-9165	175	3	2020	2020	NUM
bam-9165	175	4	apr	apr	NOUN
bam-9165	175	5	23	23	NUM
bam-9165	175	6	:	:	SYM
bam-9165	175	7	102794	102794	NUM
bam-9165	175	8	.	.	PUNCT
bam-9165	176	1	doi	doi	NOUN
bam-9165	176	2	:	:	PUNCT
bam-9165	176	3	10.1016	10.1016	NUM
bam-9165	176	4	/j.transci.2020.102794	/j.transci.2020.102794	PUNCT
bam-9165	177	1	29	29	NUM
bam-9165	177	2	.	.	PUNCT
bam-9165	178	1	cao	cao	PROPN
bam-9165	178	2	w	w	PROPN
bam-9165	178	3	,	,	PUNCT
bam-9165	178	4	li	li	PROPN
bam-9165	178	5	t.	t.	PROPN
bam-9165	178	6	covid-19	covid-19	PROPN
bam-9165	178	7	:	:	PUNCT
bam-9165	178	8	towards	towards	ADP
bam-9165	178	9	understanding	understanding	NOUN
bam-9165	178	10	of	of	ADP
bam-9165	178	11	pathogenesis	pathogenesis	NOUN
bam-9165	178	12	.	.	PUNCT
bam-9165	179	1	cell	cell	NOUN
bam-9165	179	2	res	re	NOUN
bam-9165	179	3	2020	2020	NUM
bam-9165	179	4	apr	apr	NOUN
bam-9165	179	5	28	28	NUM
bam-9165	179	6	:	:	PUNCT
bam-9165	179	7	1–3	1–3	NUM
bam-9165	179	8	.	.	PUNCT
bam-9165	179	9	doi	doi	NOUN
bam-9165	179	10	:	:	PUNCT
bam-9165	179	11	10.1038	10.1038	NUM
bam-9165	179	12	/	/	SYM
bam-9165	179	13	s41422	s41422	VERB
bam-9165	179	14	-	-	PUNCT
bam-9165	179	15	020	020	NUM
bam-9165	179	16	-	-	PUNCT
bam-9165	179	17	0327	0327	NUM
bam-9165	179	18	-	-	PUNCT
bam-9165	179	19	4	4	NUM
bam-9165	179	20	30	30	NUM
bam-9165	179	21	.	.	PUNCT
bam-9165	179	22	tang	tang	PROPN
bam-9165	179	23	n	n	CCONJ
bam-9165	179	24	,	,	PUNCT
bam-9165	179	25	li	li	PROPN
bam-9165	179	26	d	d	PROPN
bam-9165	179	27	,	,	PUNCT
bam-9165	179	28	wang	wang	PROPN
bam-9165	179	29	x	x	PROPN
bam-9165	179	30	,	,	PUNCT
bam-9165	179	31	sun	sun	PROPN
bam-9165	179	32	z.	z.	PROPN
bam-9165	179	33	abnormal	abnormal	ADJ
bam-9165	179	34	coagulation	coagulation	NOUN
bam-9165	179	35	parameters	parameter	NOUN
bam-9165	179	36	are	be	AUX
bam-9165	179	37	associated	associate	VERB
bam-9165	179	38	with	with	ADP
bam-9165	179	39	poor	poor	ADJ
bam-9165	179	40	prognosis	prognosis	NOUN
bam-9165	179	41	in	in	ADP
bam-9165	179	42	patients	patient	NOUN
bam-9165	179	43	with	with	ADP
bam-9165	179	44	novel	novel	ADJ
bam-9165	179	45	coronavirus	coronavirus	NOUN
bam-9165	179	46	pneumonia	pneumonia	NOUN
bam-9165	179	47	.	.	PUNCT
bam-9165	180	1	j	j	PROPN
bam-9165	180	2	thromb	thromb	PROPN
bam-9165	180	3	haemost	haemost	VERB
bam-9165	180	4	2020;18:844	2020;18:844	NOUN
bam-9165	180	5	-	-	SYM
bam-9165	180	6	847	847	NUM
bam-9165	180	7	.	.	PUNCT
bam-9165	181	1	doi	doi	NOUN
bam-9165	181	2	:	:	PUNCT
bam-9165	181	3	10.1111	10.1111	NUM
bam-9165	181	4	/	/	SYM
bam-9165	181	5	jth.14768	jth.14768	NUM
bam-9165	181	6	31	31	NUM
bam-9165	181	7	.	.	PUNCT
bam-9165	182	1	sloan	sloan	PROPN
bam-9165	182	2	sr	sr	PROPN
bam-9165	182	3	,	,	PUNCT
bam-9165	182	4	andrzejewski	andrzejewski	VERB
bam-9165	182	5	c	c	NOUN
bam-9165	182	6	,	,	PUNCT
bam-9165	182	7	aqui	aqui	NOUN
bam-9165	182	8	na	na	NOUN
bam-9165	182	9	,	,	PUNCT
bam-9165	182	10	et	et	PROPN
bam-9165	182	11	al	al	PROPN
bam-9165	182	12	.	.	PUNCT
bam-9165	183	1	role	role	NOUN
bam-9165	183	2	of	of	ADP
bam-9165	183	3	therapeutic	therapeutic	ADJ
bam-9165	183	4	apheresis	apheresis	NOUN
bam-9165	183	5	in	in	ADP
bam-9165	183	6	infectious	infectious	ADJ
bam-9165	183	7	and	and	CCONJ
bam-9165	183	8	inflammatory	inflammatory	ADJ
bam-9165	183	9	diseases	disease	NOUN
bam-9165	183	10	:	:	PUNCT
bam-9165	183	11	current	current	ADJ
bam-9165	183	12	knowledge	knowledge	NOUN
bam-9165	183	13	and	and	CCONJ
bam-9165	183	14	unanswered	unanswered	ADJ
bam-9165	183	15	questions	question	NOUN
bam-9165	183	16	.	.	PUNCT
bam-9165	184	1	j	j	PROPN
bam-9165	184	2	clinl	clinl	VERB
bam-9165	184	3	apher	apher	ADJ
bam-9165	184	4	2014;30:259	2014;30:259	NOUN
bam-9165	184	5	–	–	PUNCT
bam-9165	184	6	64	64	NUM
bam-9165	184	7	.	.	PUNCT
bam-9165	185	1	doi	doi	NOUN
bam-9165	185	2	:	:	PUNCT
bam-9165	185	3	10.1002	10.1002	NUM
bam-9165	185	4	/	/	SYM
bam-9165	185	5	jca.21370	jca.21370	NOUN
bam-9165	185	6	.	.	PROPN
bam-9165	186	1	32	32	NUM
bam-9165	186	2	.	.	PUNCT
bam-9165	187	1	yang	yang	PROPN
bam-9165	187	2	xh	xh	PROPN
bam-9165	187	3	,	,	PUNCT
bam-9165	187	4	sun	sun	PROPN
bam-9165	187	5	rh	rh	PROPN
bam-9165	187	6	,	,	PUNCT
bam-9165	187	7	zhao	zhao	PROPN
bam-9165	187	8	my	my	PRON
bam-9165	187	9	,	,	PUNCT
bam-9165	187	10	et	et	PROPN
bam-9165	187	11	al	al	PROPN
bam-9165	187	12	.	.	PUNCT
bam-9165	188	1	expert	expert	ADJ
bam-9165	188	2	recommendations	recommendation	NOUN
bam-9165	188	3	on	on	ADP
bam-9165	188	4	blood	blood	NOUN
bam-9165	188	5	purification	purification	NOUN
bam-9165	188	6	treatment	treatment	NOUN
bam-9165	188	7	protocol	protocol	NOUN
bam-9165	188	8	for	for	ADP
bam-9165	188	9	patients	patient	NOUN
bam-9165	188	10	with	with	ADP
bam-9165	188	11	severe	severe	ADJ
bam-9165	188	12	covid-19	covid-19	PROPN
bam-9165	188	13	:	:	PUNCT
bam-9165	188	14	recommendation	recommendation	NOUN
bam-9165	188	15	and	and	CCONJ
bam-9165	188	16	consensus	consensus	NOUN
bam-9165	188	17	.	.	PUNCT
bam-9165	189	1	chronic	chronic	ADJ
bam-9165	189	2	dis	dis	PROPN
bam-9165	189	3	transl	transl	PROPN
bam-9165	189	4	med	med	PROPN
bam-9165	189	5	2020	2020	NUM
bam-9165	189	6	apr	apr	PROPN
bam-9165	189	7	28	28	NUM
bam-9165	189	8	.	.	PUNCT
bam-9165	190	1	doi	doi	NOUN
bam-9165	190	2	:	:	PUNCT
bam-9165	190	3	10.1016	10.1016	NUM
bam-9165	190	4	/	/	SYM
bam-9165	190	5	j.cdtm	j.cdtm	NOUN
bam-9165	190	6	.	.	PUNCT
bam-9165	191	1	2020.04.002	2020.04.002	NUM
bam-9165	191	2	.	.	PUNCT
bam-9165	192	1	33	33	NUM
bam-9165	192	2	.	.	PUNCT
bam-9165	193	1	keith	keith	PROPN
bam-9165	193	2	p	p	PROPN
bam-9165	193	3	,	,	PUNCT
bam-9165	193	4	wells	wells	PROPN
bam-9165	193	5	a	a	PROPN
bam-9165	193	6	,	,	PUNCT
bam-9165	193	7	hodges	hodges	PROPN
bam-9165	193	8	j	j	PROPN
bam-9165	193	9	,	,	PUNCT
bam-9165	193	10	et	et	PROPN
bam-9165	193	11	al	al	PROPN
bam-9165	193	12	.	.	PUNCT
bam-9165	194	1	the	the	DET
bam-9165	194	2	therapeutic	therapeutic	ADJ
bam-9165	194	3	efficacy	efficacy	NOUN
bam-9165	194	4	of	of	ADP
bam-9165	194	5	adjunct	adjunct	ADJ
bam-9165	194	6	therapeutic	therapeutic	ADJ
bam-9165	194	7	plasma	plasma	NOUN
bam-9165	194	8	exchange	exchange	NOUN
bam-9165	194	9	for	for	ADP
bam-9165	194	10	septic	septic	ADJ
bam-9165	194	11	shock	shock	NOUN
bam-9165	194	12	with	with	ADP
bam-9165	194	13	multiple	multiple	ADJ
bam-9165	194	14	organ	organ	NOUN
bam-9165	194	15	failure	failure	NOUN
bam-9165	194	16	:	:	PUNCT
bam-9165	194	17	a	a	DET
bam-9165	194	18	single	single	ADJ
bam-9165	194	19	center	center	NOUN
bam-9165	194	20	retrospective	retrospective	ADJ
bam-9165	194	21	review	review	NOUN
bam-9165	194	22	.	.	PUNCT
bam-9165	195	1	2020	2020	NUM
bam-9165	195	2	.	.	PUNCT
bam-9165	196	1	preprint	preprint	NOUN
bam-9165	196	2	at	at	ADP
bam-9165	196	3	https://www.researchsquare.com/article/rs16022/v1	https://www.researchsquare.com/article/rs16022/v1	PROPN
bam-9165	196	4	.	.	PUNCT
bam-9165	197	1	doi	doi	PROPN
bam-9165	197	2	:	:	PUNCT
bam-9165	197	3	10.1186	10.1186	NUM
bam-9165	197	4	/	/	SYM
bam-9165	197	5	s13054	s13054	NOUN
bam-9165	197	6	-	-	PUNCT
bam-9165	197	7	020	020	NUM
bam-9165	197	8	-	-	PUNCT
bam-9165	197	9	03241	03241	NUM
bam-9165	197	10	-	-	SYM
bam-9165	197	11	6	6	NUM
bam-9165	197	12	34	34	NUM
bam-9165	197	13	.	.	PUNCT
bam-9165	198	1	shi	shi	PROPN
bam-9165	198	2	h	h	PROPN
bam-9165	198	3	,	,	PUNCT
bam-9165	198	4	zhou	zhou	PROPN
bam-9165	198	5	c	c	X
bam-9165	198	6	,	,	PUNCT
bam-9165	198	7	he	he	PRON
bam-9165	198	8	p	p	X
bam-9165	198	9	,	,	PUNCT
bam-9165	198	10	et	et	PROPN
bam-9165	198	11	al	al	PROPN
bam-9165	198	12	.	.	PROPN
bam-9165	199	1	successful	successful	ADJ
bam-9165	199	2	treatment	treatment	NOUN
bam-9165	199	3	of	of	ADP
bam-9165	199	4	plasma	plasma	NOUN
bam-9165	199	5	exchange	exchange	NOUN
bam-9165	199	6	followed	follow	VERB
bam-9165	199	7	by	by	ADP
bam-9165	199	8	intravenous	intravenous	ADJ
bam-9165	199	9	immunogloblin	immunogloblin	NOUN
bam-9165	199	10	in	in	ADP
bam-9165	199	11	a	a	DET
bam-9165	199	12	critically	critically	ADV
bam-9165	199	13	ill	ill	ADJ
bam-9165	199	14	patient	patient	NOUN
bam-9165	199	15	with	with	ADP
bam-9165	199	16	2019	2019	NUM
bam-9165	199	17	novel	novel	ADJ
bam-9165	199	18	coronavirus	coronavirus	NOUN
bam-9165	199	19	infection	infection	NOUN
bam-9165	199	20	.	.	PUNCT
bam-9165	200	1	int	int	NOUN
bam-9165	200	2	j	j	PROPN
bam-9165	200	3	antimicrob	antimicrob	PROPN
bam-9165	200	4	agents	agent	NOUN
bam-9165	200	5	2020:105974	2020:105974	NUM
bam-9165	200	6	.	.	PUNCT
bam-9165	201	1	doi	doi	NOUN
bam-9165	201	2	:	:	PUNCT
bam-9165	201	3	10.1016	10.1016	NUM
bam-9165	201	4	/	/	SYM
bam-9165	201	5	j.ijantimicag	j.ijantimicag	PROPN
bam-9165	201	6	.	.	PUNCT
bam-9165	202	1	2020.105974	2020.105974	NUM
bam-9165	202	2	35	35	NUM
bam-9165	202	3	.	.	PUNCT
bam-9165	203	1	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdaauthorizes-blood-purification-device-treat-covid19	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdaauthorizes-blood-purification-device-treat-covid19	PROPN
bam-9165	203	2	.	.	PUNCT
bam-9165	204	1	36	36	NUM
bam-9165	204	2	.	.	PUNCT
bam-9165	204	3	central	central	ADJ
bam-9165	204	4	board	board	NOUN
bam-9165	204	5	of	of	ADP
bam-9165	204	6	the	the	DET
bam-9165	204	7	scientific	scientific	ADJ
bam-9165	204	8	society	society	NOUN
bam-9165	204	9	of	of	ADP
bam-9165	204	10	experts	expert	NOUN
bam-9165	204	11	of	of	ADP
bam-9165	204	12	extracorporeal	extracorporeal	ADJ
bam-9165	204	13	blood	blood	NOUN
bam-9165	204	14	treatment	treatment	NOUN
bam-9165	204	15	in	in	ADP
bam-9165	204	16	intensive	intensive	ADJ
bam-9165	204	17	care	care	NOUN
bam-9165	204	18	.	.	PUNCT
bam-9165	205	1	interim	interim	ADJ
bam-9165	205	2	recommendations	recommendation	NOUN
bam-9165	205	3	on	on	ADP
bam-9165	205	4	the	the	DET
bam-9165	205	5	use	use	NOUN
bam-9165	205	6	of	of	ADP
bam-9165	205	7	methods	method	NOUN
bam-9165	205	8	of	of	ADP
bam-9165	205	9	extracorporeal	extracorporeal	ADJ
bam-9165	205	10	haemocorrection	haemocorrection	NOUN
bam-9165	205	11	in	in	ADP
bam-9165	205	12	the	the	DET
bam-9165	205	13	complex	complex	ADJ
bam-9165	205	14	treatment	treatment	NOUN
bam-9165	205	15	of	of	ADP
bam-9165	205	16	patients	patient	NOUN
bam-9165	205	17	with	with	ADP
bam-9165	205	18	new	new	ADJ
bam-9165	205	19	coronavirus	coronavirus	NOUN
bam-9165	205	20	disease	disease	NOUN
bam-9165	205	21	covid-19	covid-19	PROPN
bam-9165	205	22	.	.	PROPN
bam-9165	205	23	http://www.rusnephrology.org/	http://www.rusnephrology.org/	PROPN
bam-9165	205	24	wpcontent	wpcontent	PROPN
bam-9165	205	25	/	/	SYM
bam-9165	205	26	uploads/2020/04	uploads/2020/04	PROPN
bam-9165	205	27	/	/	SYM
bam-9165	205	28	extracorp_hemocorrec	extracorp_hemocorrec	PROPN
bam-9165	205	29	t.pdf	t.pdf	NUM
bam-9165	205	30	submission	submission	NOUN
bam-9165	205	31	:	:	PUNCT
bam-9165	205	32	june	june	PROPN
bam-9165	205	33	5	5	NUM
bam-9165	205	34	,	,	PUNCT
bam-9165	205	35	2020	2020	NUM
bam-9165	205	36	revision	revision	NOUN
bam-9165	205	37	received	receive	VERB
bam-9165	205	38	:	:	PUNCT
bam-9165	205	39	september	september	PROPN
bam-9165	205	40	2	2	NUM
bam-9165	205	41	,	,	PUNCT
bam-9165	205	42	2020	2020	NUM
bam-9165	205	43	accepted	accept	VERB
bam-9165	205	44	for	for	ADP
bam-9165	205	45	pubblication	pubblication	NOUN
bam-9165	205	46	:	:	PUNCT
bam-9165	205	47	september	september	PROPN
bam-9165	205	48	2	2	NUM
bam-9165	205	49	,	,	PUNCT
bam-9165	205	50	2020	2020	NUM
bam-9165	205	51	https://www.researchsquare.com/article/rs-16022/v1	https://www.researchsquare.com/article/rs-16022/v1	SYM
bam-9165	205	52	https://www.researchsquare.com/article/rs-16022/v1	https://www.researchsquare.com/article/rs-16022/v1	PROPN
bam-9165	205	53	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	PROPN
bam-9165	205	54	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	PROPN
bam-9165	205	55	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	PROPN
bam-9165	205	56	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19	PROPN
bam-9165	205	57	http://www.rusnephrology.org/	http://www.rusnephrology.org/	NOUN